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Abstract
In-vitro cell cultures are a fundamental step in preclinical drug test-
ing and are of great interest to the pharmaceutical industry. The
most common method for culturing cells is in cell culture incuba-
tors. These are large and cumbersome and all mechanical stimuli
are absent. They are nevertheless used ubiquitously and their results
quoted as “standards” of in-vitro protocols. Several alternative cul-
ture methods have been proposed, and many systems are currently
available commercially. Indeed, systems and devices for maintain-
ing cells and tissues in controlled physical conditions, or bioreactors,
have become an important tool in many areas of research. This is
not only due to the growing interest in tissue engineering but also
because it is now being increasingly recognised that cells respond
not only to their biochemical, but also to their physical environ-
ment, and both cues are necessary to create a biomimetic habitat.
However most bioreactors for cell culture and tissue engineering are
cumbersome and only provide a few cues such as flow or strain, al-
lowing limited control and flexibility.
Since drug testing involves a large number of tests on identical
cell cultures, a single well culture is inadequate and costly both in
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time and money. The “High Throughput Screening” (HTS), is a
methodology for scientific experimentation widely used in drug dis-
covery, based on a brute-force approach to collect a large amount
of experimental data in less time and using less animals. The par-
allel nature of HTS makes it possible to collect a large amount of
data from a small number of experiments and in a very short time.
HTS, however, suffers from a significant problem that may affect the
relevance of tests: the environment discrepancy problem. Another
problem related with the actual drug testing and tissue engineer-
ing experiments is the enormous number of animals that have to be
scarified every year.
The aim of this study was to develop a generic platform or SUITE
(Supervising Unit for In-vitro TEsting) for cell, tissue and organ cul-
ture composed of two main components: a universal control unit and
an array of bioreactor chambers. The platform provides a biomimetic
habitat to cells and tissues since the environment in the chambers is
controlled and regulated to provide biomechanical and biophysical
stimuli similar to those found in-vivo. In this work I describe how a
new concept of cell culture bioreactor was developed by integrating
different technologies and research fields. The data extracted using
this new cell culture approach is more predictive of the in vivo re-
sponse with respect to the multi-well approach, particularly for drug
related studies.
The starting point was a thorough analysis of currently used in-
vitro methods; their pros and cons were assessed to exploit their ad-
vantages and overcome or circumvent their disadvantages. As far as
the culture chamber is concerned, the approach was to use the meth-
ods and materials commonly employed in microfluidic fabrication,
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but at scales compatible with classical culture systems such as petri-
dishes and multiwells. This renders the bioreactors more amenable
to use by biologists and enables the use of cell densities comparable
with classic systems as well as the use of conventional assaying tech-
niques. In most cases, the cell culture chambers are thus made out
of PDMS (Polydimethylsiloxane), using soft-moulding with micro-
or mini-machined masters, or what we call “Soft Milli-molding”.
A “system on a plate” Multi Compartmental Modular Bioreactor
(MCmB) was developed using this technology. The MCmB is a mod-
ular chamber for high throughput multi compartmental bioreactor
experiments. It is designed to be used in a wide range of applica-
tions and with various cell types. A precise stimulus application is
also very important to better understand the correlation between
physical variables and pathologies allowing a more accurate study
of the tissue physiology and pathologies. For this reason in these
thesis three additional stimulation chambers for vascular and articu-
lar cartilage stimulation respectively were also designed and tested.
The control system was developed to be user-friendly, flexible and
expandable to include new stimuli and was based on modular compo-
nents, including motors and sensors. Importantly a single software
interface was designed to allow data acquisition and monitoring of
several chambers in series or in parallel.
Using SUITE, high throughput experiments can be performed
in an in vivo-like simulated environment for a long time to simulate
different physiological or pathological scenarios or for toxicity testing
of cells, tissues or in-vitro organ models.
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Introduction
Cell culture is an essential tool in biological science, clinical science, and
biomedical studies. This approach is a fundamental step in preclinical
drug testing and for this reason it is of great interest to the pharmaceutical
industry to employ cheaper and more ethical systems which can supply
accurate and predictive information on the effects of chemicals on the
human body.
Since drug testing involves a large number of tests on identical cell
cultures, a single well culture is inadequate and costly both in time and
money. The “High Throughput Screening” (HTS), is a methodology for
scientific experimentation widely used in drug discovery, based on a brute-
force approach to collect a large amount of experimental data in less time
and using less animals. HTS is achieved nowadays using multi-well equip-
ment, to contain the cell cultures subject to treatment [1]. An automatic
machine collects data, usually with an optical system, during the treat-
ment. Collected data can vary widely in nature, for instance, concentra-
tions of physiological metabolites or proteins. The parallel nature of HTS
makes it possible to collect a large amount of data from a small number
of experiments and in a very short time. The multi-well system, however,
suffers from a significant problem that may affect the relevance of tests:
the environment discrepancy problem [2].
The environment discrepancy problem lies in the fact that the tis-
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sue grown in wells is only a brutal approximation of biological reality.
There are several relevant factors that are missing in this environment;
for instance the cells in the well are not subject to convective flow of
nutrients present in the physiological environment. Another meaningful
example is the lack of the typical pressure peaks, and the presence of con-
stant solute concentrations, unlike in biological systems where gradients
of concentration are the basis of most important processes. In [3] it is
discussed how the multi-well approach does not scale fully as expected
by an HTS system because the collected data are not directly usable in
drug testing. This seems to be a paradox since the multi-well has been
the core element of the HTS methodology. In the mean time, systems
and devices tools for maintaining cells and tissue in controlled physical
conditions or bioreactors have become important tools in drug testing or
tissue engineering in general. This particularly due to the growing inter-
est in tissue engineering and in-vitro testing. Moreover, it is now being
increasingly recognized that cells respond not only to their biochemical
[4, 5, 6], but also to their physical environment [7, 8, 9, 10], and both
are necessary to create a biomimetic environment. Noticeably none of
these innovative and more physiological cell culture systems is designed
for high throughput screening.
Another problem related with the actual drug testing and tissue en-
gineering experiments is the enormous number of animals that have to
be scarified every year. Animal Testing occurs regularly throughout the
European Union (EU) and it still plays a large role in research and drug
development around Europe. In Europe, biomedical testing still remains
the most widely used type of research for drug development. Toxicity
testing for drugs, foodstuffs, household chemicals and various other sub-
stances is performed in laboratories throughout Europe. Rats and mice
are the most commonly used animals while reptiles are the least com-
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monly used animals. Recent years have seen a surge in the use of zebrafish
and non-human primates. While ethical concerns regarding zebrafish are
low, those involving non-human primates are high. The aim within Eu-
rope has been to reduce the number of monkeys and similar animals used
for testing purposes. Although their likeness to humans has great value in
animal testing, this same likeness raises extreme ethical concerns regard-
ing their ability to feel pain and to experience suffering and psychological
distress[11, 12].
European statistics showed that France used 2.3 million animals in
2005 while Germany used 1.8 million animals in that same year for test-
ing purposes. Statistics for 2005 showed that Finland and Ireland both
decreased their use of animals. In contrast, Sweden, Spain and Greece all
increased their use of animals, either doubling or near-doubling their use.
Across all of Europe, there are approximately 12.1 million animal testing
experiments performed each year. While there is some debate regarding
the statistics of which country is the highest tester of animals, Britain is
thought to be the top user of animals with its use of nearly three million
animal experiments each year. France is a very close second and generates
a large amount of debate given that one of the major global cosmetics
company is based in France and still tests on animals.
Europe’s overall laboratory use of animals has actually increased very
recently by 3.2 percent. This contrasts with the fall in animal testing
over the last few decades. It’s also important to note that one of the
biggest animal testers from a global perspective is Huntingdon Life Sci-
ences (HLS), which is based in Europe. HLS kills approximately 75,000
animals each year.
A shown in Table 1 most of the animal experiments are done for
cosmetics and toxicology purpose. While the UK officially banned animal
testing on cosmetics in the late 1990s, Europe has been somewhat slower
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to implement a ban. A near total ban is, however, planned for 2009.
While most of the EU supports the ban, countries such as France have
voiced strong opposition to the ban, citing their belief that cosmetics
testing on animals are necessary for sufficient health and safety testing of
products.
Table 1: Use of animal tests for the year 2001 in UK.
Research Research
for human
medicine
and cosmet-
ics
Research for
veterinary
Toxicity
tests
Disease
studies
Didattic Other
30% 57% 1.40% 7% 2.70% 0.30% 0.60%
Reducing animal suffering as a whole requires the use of alternative
approaches to animal testing. While the scientific community gener-
ally supports the use of animals to further our knowledge of health and
medicine, they still acknowledge the need for alternatives to reduce ani-
mal suffering. This is accomplished through the use of several different
categories of alternatives, which are often described as the three “Rs” of
biomedical research. They are:
• Reduction in the number of animals needed in a test
• Replacement of an animal test by a non-animal test
• Refinement of an animal test to reduce or eliminate stress or
suffering
Reduction is probably one of the most promising areas in the sense
that a great deal of progress has been made over the last decade. To
reduce animal testing, researchers use techniques that allow them to ob-
tain a level of information that is sufficient but requires fewer animals.
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Conversely, researchers may be able to employ a method that allows them
to obtain more information from the same number of animals. The end
result is that animal use is maximized and more efficient, leading to fewer
animals being used and therefore, fewer animals suffering from any pain
or distress that occurs from the experiment. There are numerous ways
that researchers can reduce the number of animals used or obtain more
information from the same number of animals that an experiment would
typically require for success. There are currently modified test methods
that are essentially traditional models that have been advanced to pro-
vide comparable results with fewer animals. For example, newer versions
of the Draize test can reduce the use of animals and additionally, can re-
duce the potential distress as well1. Many companies now perform more
than one test on the same animal, which allows them to use fewer ani-
mals overall. Some companies are also using human volunteers instead of
animals to test for skin irritation, which further reduces the number of
animals used in testing.
Testing certain substances on cellular models first can rule out the use
of animals if results are not favorable. In addition, the use of computer
models, databases and similar sources of information can provide the his-
tory of a substance and its use as well as offering preliminary information
on the safety of a formula.
Tissue cultures are also an extremely useful method for reducing the
number of animals used in laboratory experimentation. By utilizing ac-
tive cell cultures, companies can dramatically reduce the number of ani-
mals used while still obtaining comparable levels of information from the
method.
In Europe, alternative testing methods are scientifically validated by
1The Draize test is used to assess toxicity of various chemicals and products
through application of the product to the animal’s skin or eyes.
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the European Center for the Validation of Alternative Methods (EC-
VAM), an official body appointed for this purpose by the European Union.
Validation by ECVAM means that these methods can be used across the
different industries that test chemicals for safety purposes (chemicals,
food, pharmaceuticals, etc). Validation is the process by which scientists
and regulators establish whether a method is reliable and relevant for a
specific purpose.
To work out how to mimic a complex biological response outside a
living organism is a tremendous scientific challenge, and requires a rev-
olution in current in-vitro culture methods. Validating an alternative
method and proving it is safe also takes time To improve in vitro culture
conditions, the conventional models used in flasks or microwell plates
need to be re-evaluated and modified and transferred to a more realis-
tic representation of the physiological environment through the use of
bioreactors.
The design of a cell culture bioreactor requires a basic understanding
of both chemical reactor design and cell biology. First, engineers must
understand the effects of reaction rates and stoichiometry, mass transfer,
heat transfer, and turbulence and mixing on product distribution, reactor
productivity and size, and operational characteristics. These phenomena
need to be expressed in accurate but tractable models that can be used for
design and optimization calculations. Most bioreactors are cumbersome
and only provide a few cues such as flow or strain, allowing limited control
and flexibility. The aim of this work is to design and realize a single system
which can be used to provide a physiological environment to cells on a 3D
tissue engineered construct, on a cover slips or directly on tissue pieces
and to enable in-vivo physio-pathological phenomena to be simulated in
vitro, thus avoiding the use of animal experiments.
Thus, in this thesis, firstly the currently used methods were analysed
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and their pros and cons were assessed to exploit their advantages and sur-
pass their disadvantages. The most common method for culturing cells
is in cell culture incubators. These are large and cumbersome and all
mechanical stimuli are absent. They are nevertheless used ubiquitously
and their results quoted as “standards” of in-vitro protocols. Owing to
this dynamic culture methods have been proposed, and several systems
are currently available commercially. Amongst these are low shear perfu-
sion system [13, 14], stirred tank bioreactors [15], airlift bioreactors [16],
hollow fiber perfused systems [17, 18], rotary cell culture systems [19].
The main advantages of these systems with respect to an incuba-
tor are the introduction of fluid-dynamics; the cells are subject to shear
stresses, which in several cases are known to stimulate growth, and posi-
tively influence cell function. Most of them do however require the sup-
port of an incubator for pH and temperature control. A second genera-
tion of bioreactors has most recently been realized, these are systems for
tissue engineering which provide a high degree of oxygenation through
fibers or membranes, allowing adequate oxygen partial pressure with 3D
constructs. Finally, the third generation comprises micro-fluidic systems
in which small Reynolds number laminar flows are easily established.
These also include microfabricated systems such as the perfused microar-
ray bioreactor [20] and the micro cell culture chamber assay [21].
Third generation systems have one main drawback as far as tissue
engineering applications are concerned; they are small. This implies that
they cannot be used for culturing large numbers of volumes of cells or
tissue, and in a closed loop system, fluid sampling and analysis can be
difficult. Furthermore, in microfabricated systems, surface and edge ef-
fects are amplified whereas physiological cell-cell interactions are under-
represented
The key elements of a bioreactor are the cell culture chamber and the
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environmental control system, and together they form an experimental
platform on which a variety of experiments can be carried out. To offer a
vaild substitute for classical in-vitro experiments, an bioreactor platform
should should have the following characteristics:
• A culture cell chamber whose design permits a reconstruction
of the fluid-dynamic conditions during operation
• A control system able to adjust all the environmental variables
in order to simulate the phisyological reality
• A set of various culture chamber each one with a dedicated design
in order to easily mimic the different compartments of an organism
• A storing and viewing system where the user can easily interact
with the bioreactor system and where all the experimental data are
collected and stored
To obtain the flexibility and use of new materials and fabrication
methods of third generation bioreactors, combined with the control of es-
sential operating parameters such as shear stress, flow rates, pressure, pH,
temperature, O2 concentration as well as the liberty of being stand-alone,
we designed and realized a new concept in cell culture which offers plat-
form of bespoke physical and topological environments has been designed
and realized.
One of the main features the platform is the culture chambers; their
ease of fabrication renders them highly flexible and simple to modify
or remodel, and the low cost of manufacturing renders them disposable
and compatible with high throughput systems. A further characteristic
which is unique with respect to other systems reported in the literature is
the principle on which the environmental control system is based and the
simple software interface. In this thesis the bioreactor system is described
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starting from its design philosophy, its construction and its control. A
report on preliminary results of validation tests obtained with different
cell types and tissues is also presented.
A generic platform or SUITE (Supervising Unit for In-vitro TEsting)
for cell, tissue and organ culture composed of two main components: a
universal control unit and an array of bioreactor chambers is presented,
through which high throughput experiments can be performed in an in
vivo-like simulated environment for a long time (more than a week). In
this work it is describe how a new concept of cell culture bioreactor was
developed by integrating different technologies and research fields. The
data extracted using this new cell culture approach is more predictive of
the in vivo response with respect to the multi-well approach, particularly
for drug related studies.
This new system is a complete cell culture suite composed of:
• A custom made electronic control block that acquires signals
from sensors, such as a pH-meter, thermocouple, flow sensor, pres-
sure sensor and sends these signals to a PC through an I/O card
• A mixing chamber to allows the addition of oxygen or carbon
oxide to the culture media so as to have the desired value of pH
and oxygen concentration; it is also the location of the pH sensor
• A peristaltic pump to recreate the flow conditions of the tissue
under examination
• A heater to heat the media culture to 37 C
• One or more cell culture chambers
• A freestanding pressure generator to be used in classic CO2 in-
cubator experiments
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In this work Bioreactors are proposed as alternative in-vitro HTS
system to overcomes the limits due to the environment discrepancy prob-
lem. More relevant and more predictive data from experiments can be
obtained as a result of the capability of this innovative system to better
simulate a physiological environment than the classic static cell culture
protocols. The system is an innovative platform able to perform High
throughput experiment in a more physiological like environments. With
this platform it is possible to perform experiments using cell culture or
tissues with a consequent reduction of required animals, the experiments
done with the SUITE are organized as a High Throughput experiment,
and the data collected by a main supervision system which can also im-
pose control variables on multiple bioreactors running in parallel. With
this parallel and distributed approach a pathology can be simulated in
one bioreactor and the other used as a control reference. The system
is modular and a various chambers can be plugged together in order to
mimic the physiological district organization. With the SUITE is possible
to do multi compartmental experiments for drug testing or stimulation
experiments where the influence of the environmental variables on tissue
physiology is investigated. These two apparently opposite approaches
can be merged together using this platform in a more realistic experi-
ments where the multi-compartmental approach can be fused together
with the cell stimulation. With this new testing approach it is possible
for example to investigate how drug efficiency is influenced by physiolog-
ical environmental variables such us blood pH, vascular pressure, tissue
oxygen concentration etc.
This system can be defined as a virtual mouses set, where all the an-
imals are clones (tissues or cells coming from the same animal or donor
can be used in different bioreactor) and where by changing the drug con-
centration or the control variables a pathologies can simulate and data
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collected in parallel and autonomously.
This work was organized in two main parts, the first part was oriented
to designing and realizing the control and stimulation systems (Environ-
mental control and P.GIO) with the dedicated software and firmware.
The second part of the work was oriented to the design and realization of
innovative bioreactor chambers to be used as districts or organs simula-
tors to be plugged together in different configurations. Merging together
these two parts an innovative platform able to perform high throughput
experiments in a condition less aﬄicted by the environmental discrep-
ancy problem was realized.with this system is possible to do experiments
requiring a lower number of animals, with the possibility of using not
only cell cultures but also human or animal tissue, and with the option
of applying physical stimuli to the samples.
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Chapter 1
Environmental Control
In order to realize an innovative High throughput machine able to perform
experiments in a more physiological way than the classic multi well ap-
proach, the first step was to define and develop the environmental control
unit of the SUITE system.
The environmental control unit is the core of the system and is where
all the environmental variables are collected by various sensors placed
along the system connections and units. In this section it is discussed not
only the electronic part of the system but the entire control unit and also
the software and algorithm organization.
The aim of this system is to adjust the temperature, pH, pressure,
gas flow and dissolved oxygen percentage of the culture medium. The
control apparatus is consequently composed not only of the electronic
and electro-valves unit, but also of the mixing chamber, the peristaltic
pump, the heater unit and the control software.
In order to realize a real High throughput system, the entire design
process was driven by the necessity of a system able to perform experi-
ments in parallel, with an autonomous control and with a user friendly
interface that easily allows the researcher to change the controlled vari-
ables in order to mimic different pathologies.
Another aim of this design process is the data storage approach. All
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the data collected by the system using the XML data format [22] for
storing and organizing application data, in order to allow an easily inter-
operability among different programs for further processing of generated
data.
1.1 Materials and Methods
The SUITE platform is a complex system, in this section are described
all the generic parts required to control the system and to create the
required cellular environments. The dedicate bioreactor chambers used
in the SUITE system are described in the following sections.
1.1.1 The Bioreactor Hardware
The SUITE platform consists of the following parts:
• Cell culture chamber
• Mixing chamber
• Heating system
• Peristaltic pump
• Electronic circuit and electro-valve box
• PC
The Mixing Chamber
The mixing chamber (Figure 1.1) is connected in series with the cell
culture chambers and serves for pH and oxygen regulation as well as to
remove air bubbles; essentially the medium is perfused with gas according
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to the measured pH. The medium is inserted and removed in this chamber
through a needle with the flow imposed by the peristaltic pump.
pH regulation is performed by inserting two different gases in the
mixing chamber: Carbon dioxide and Air (not O2 because of flammability
risks). The culture medium contains bicarbonate buffer and its pH can
be closely regulated through diffusion of gases; in particular the diffusion
of O2 (Air) tends to raise the pH, while CO2 tends to lower it [23].
The mixing chamber is made with a plastic autoclavable bottle with
a screw cap. The cap is drilled and four silicone tubes are inserted and
sealed with PDMS (polydimethlysiloxane, an elastomeric polymer also
used for the fabrication of bioreactors). Two of these tubes are for the
medium flow and the other two for insertion and removal of gases. The
tubes present different lengths and just the gas inlet and the medium ex-
traction tubes are long enough to reach the bottom of the mixing cham-
ber. The other two tubes (medium insertion and gas removal) are just
few millimeters long (over the internal part of the cap), this allows visual
observation of the medium as the drops fall down the inlet tube. Drop
formation is useful not only for a system check but also to increase the
gas exchange processes. The gas outlet tube is shorter than the inlet in
order to prevent medium foam being collected by the outlet tube and
consequently removed from the mixing chamber and down to the cells.
Most pH probes are very sensitive to convective flow of the medium,
therefore, the bottom of the mixing chamber is designed in order to mini-
mize flow disturbance near the sensor. The bottom of the chamber where
the pH probe tip is inserted is cone-shaped. Media mixing is located over
the cone surface and in the probe tip zone the medium is mixed only
by diffusion and the pH measurement is consequently very low in noise
(Figure 1.1.b).
The gas inlet and outlet tubes of the mixing chamber are both con-
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nected to syringe filters in order to keep the internal volume sterile and
to prevent contamination coming from the gases. A syringe needle is
connected to the outlet tube, and its high flow resistance ensures a con-
stant pressure difference between the inlet and outlet. The outlet needle
can be easily replaced and its diameter can be chosen in order to adjust
the outlet flow resistance, so changing the correlation between the inlet
flow and the internal pressure of the mixing chamber. The inlet tube is
equipped with a one way valves in order to prevent the medium going
into the control unit in case of system failure.
Figure 1.1: a) The mixing chamber filled with medium and with the pH
meter placed in. b) The pH meter tip (blue) in the mixing chamber’s
dedicated notch.
The bioreactor mixing chamber allows also the insertion of Oxygen
sensors that may be lodged through a dedicated cap with a different
diameter hole. Alternatively a chamber equipped with oxygen sensor can
be connected in series to the main mixing chamber.
It was decided not to realize a single mixing chamber equipped with
both pH and Oxygen sensors because the O2 probe is an optional sensor
and it is preferable to have a small main mixing chamber to minimize
media volumes.
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The Electronic Circuit and Electro-Valves Unit
This part of the system is the heart of the bioreactor control unit. In this
unit there are the electronic circuits for the sensors, for communication
with the PC and for the actuation of the electro-valves, the pressure
regulator and the electro-valves. The sensors plugged or inserted in this
unit are (Figure 1.2):
• 2 temperature sensors (ntc thermistor [24])
• 1 gas flux sensor (AWM 3000[25]) (internal)
• 1 Pressure sensor (Phidgets 1115 - Pressure Sensor [26]) (internal)
• 1 pH sensor (Hamilton Biotrode pH probe [27])
• 1 Environmental Humidity and temperature sensor (1125 - Humid-
ity/Temperature Sensor [28])
The main component of the electronic control box is an usb I/O board
(1018 - PhidgetInterfaceKit 8/8/8 [29]) where all the analog sensors are
connected. This I/O interface has 8 Digital in, 8 digital out and 8 analog
in connections; this interface board is CMOS standard and the analog
channels acquisition range is consequently 0-5V with 12 bit resolution.
The digital channels are used to control the frontal status LEDs and to
actuate, through a dedicated relay board, the gas electro-valves.
The pressure, environmental temperature and humidity sensors are
directly plugged to the Phidget I/O board because they are directly com-
patible with it. For the flux sensor a simple signal adjusting circuit was
required in order to convert the flux sensor signal to the Phidget 0-5V
standard.
The two temperature sensors are read through a dedicated Phidgets
component (1121 - Voltage Divider [30]) and connected to the Phidgets
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Figure 1.2: The bioreactor external sensors: the two temperature sensors
probe, the environmental temperature and humidity sensor and the pH
meter.
board through a resistive sensor. These conversion units act as a voltage
divider where the base resistance can be adjusted through a trimmer in
order to fit the connected sensors working resistance.
The pH and the Oxygen sensors are connected to two separated 4-
20mA [31] reader units designed by Phidgets to read pH meter probes
but usable in raw values mode to read all the sensors with the 4-20mA
standard BNC current loop connection [32] (figure 1.4.b).
The electronic control box is connected to the CO2 and O2 lab connec-
tions through two dedicated pressure regulators equipped with a humidity
removal filter. The connection with the electronic box is done with two
quick plug connectors on the back side of the control box. Inside the
bioreactor control unit the two gas lines are connected to the electro
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valves through other two pressure regulators in order to prevent damage
of the system in case of failure of the lab regulators. The two electro valve
outputs are connected to the pressure regulator through a T connector.
In order to ensure CO2 and O2 mixing and also to reduce flow vibra-
tion introduced in the gas circuit by the pressure regulator and electro
valve components an expansion chamber is inserted (gas mixer). The ex-
pansion chamber is where the pressure is measured and this chamber is
connected in series to the pressure regulator. The outlet of the expansion
chamber is connected to the flux sensor that is the last component before
the gas outlet quick connector. 1.3.
Figure 1.3: Schematic connections of the pressure and gas regulation
system.
The electro-valves are used to select the gas that is injected in the
mixing chambers and are connected to a pressure regulator SMC ITV0000
series [33] used to control the pressure inside the cell culture chamber.
The electro-valves are powered at 24v AC and controlled by a Phidgets
relays board [34].
The pressure regulator is powered at 24V DC and is controlled by a
0-10V DC analog signal made through a serial to PWM (Pulse Width
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Modulation) generator chip (Pololu Micro dual serial motor controller
[35]).
A commercial USB to serial adapter was used to generate the RS232
control signal. The PWM generator is mounted on a dedicated board
designed for the purpose (Serial to PWM board). The serial to PWM
board is a circuit able to control the Pololu chip and to generate two
Analog signals in the range of 0-10V with a low ripple and with an on
board feedback system that allows the system to have a real feedback of
the analog generated signal. In the Serial to PWM board a reset circuit
that can be activated by the control library 1.1.2 in case of serial commu-
nication problem (Figure 1.4) rising up one of the I/O digital channels is
implemented.
Figure 1.4: a) The Serial to PWM board plugged to the USB RS232
converter and b) the Phidgets pH readers.
The two pH readers, the I/O Phidgets board and the usb to serial
converter are all connected to an USB hub placed on top of the control box
and suitable also for USB data stick or other USB peripheral connection.
The USB hub is powered by the control box power supply, this prevents
over charge the USB computer ports and also to prevents electric failures
of the system which may damage the connected computer. A dedicated
220V AC unit is also connected to the USB hub through an USB relays
Phidgets board [36] allow the user to control four separated 220V sockets.
20
1.1 Materials and Methods Environmental Control
One of these 220V socket is used to power up the heater described in the
next section 1.1.1. All the sockets are connected to ground and protected
by a 3 Ampere fast fuse. The other sockets are usually used to connect
the peristaltic pump and other equipments used during the bioreactor
experiments.
This allows complete disconnection of all the bioreactor experiment
components by the electrical network in case of failure. This safety rou-
tine is implemented through a classic “watch dog” routine in the control
library.
Figure 1.5: The Bioreactor control unit, the heating box and the 220V
sockets unit during an experiment.
The Phidgets components were used to realize the control unit because
these boards and sensors are very stable, resistant and with a well written
driver and library package. The Phidgets libraries are compatible with
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all the latest programming standards and languages such as C++, .NET,
Matlab, Labview etc.
Heating Hox
The bioreactor heating system consists of a Plexiglas box where the mix-
ing chambers and at most two modular culture chambers are inserted
(Figure: 1.6.a). Distilled water heated by an electric 220V powered AC
heater[37] is agitated using a bubble maker placed on the bottom of the
heating box and connected to lab air line1. The bath and chambers
temperatures are controlled by the two water proof temperature sensors
placed directly near the mixing chamber.
The heating unit is not directly in contact with the water, but is
placed inside a dedicated cooper support that prevents electric risk by a
direct connection to the ground 1.6.b. The cooper unit is also designed
in order to increase the heater exchange surface, the system takes at
most 10 minutes to warm the entire water volume (≈400 mL) from 17 to
37◦C[38, 39, 40]. The thermal coupling between cooper unit and heater is
obtained through a silicone thermal gel, this gel is inserted in the internal
part of the cooper unit and has no contact with the bath water. The
used cartridge heater, a low power heater, was chosen in order to ensure
a low thermal flow near the mixing in order to prevent over heating or
non-uniform thermal distribution in the mixing chamber medium. The
heater also has an internal temperature safety limit of 80◦C that prevent
any damage of the system in case of controller failure.
Culture chambers can be also heated independently using dedicated
resistive heaters [41] placed directly under the MCmB trays. The resistive
heaters are controlled by an electronic unit through a 24V PWM power
regulator [42].
1The air line is split before the environmental control box inlet.
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The heating box is equipped with a dedicated MCmB chambers tray
which enables facile assembly of a bioreactor experiment under a laminar
flow hood, without risk of contamination. The mounting tray is designed
to fit perfectly the heating box only in one position in order to prevent
risk of failure in the assembly phase. The tray system include also a pH
Meter holder to prevent breakage of the very thin pH Meter tip during
the bioreactor chamber procedures (sampling, cell insertion and removal
etc).
Figure 1.6: The heating box and other bioreactor components during an
experiment setup.
Computer
The computer is plugged to the electronic control box through a USB ca-
ble and the signal is split by the previous mentioned USB hub. A netbook
computer is used to control the whole system. Atom based boards for em-
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bedded systems are widely available and will substitute the computer in
the appliance.
Peristaltic Pump
To control the nutrient flow and the shear stress, it is necessary to regulate
the speed of the peristaltic pump used to perfuse the nutrients inside the
bioreactor, this control is operated by a dedicated connection between
the pump and the electronic box, and is monitored in feedback mode
through an appropriate control pin of the pump connected to the Digital
I/O board. The peristaltic pump is 220V powered and is connected to
the 220V sockets unit in order to allow an easily disconnection in case of
failure.
Figure 1.7: A) The Control box with all the sensors plugged in and the
heating box during an experiment. B) Detail of the mixing chamber in the
heating box with the pH meter tip and the temperature sensors. C) The
pH meter insertion phase.
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1.1.2 The Control System
A High Throughput bioreactor experiment employs many bioreactors
with different cell culture chambers. A pathology can be simulated in
one of the Bioreactors, and the others used for a control reference; the
bioreactors environmental variables can be set in order to simulate one or
more pathologies and observe the influence of this different environment
on the physiology of the tissue function during an experiment. In order to
deal with parallel management of multiple bioreactors a distributed pro-
gramming framework for robotics has been used. The framework is called
Robotics4.NET [43], and it has been developed to help programming the
control system of a robot.
The framework architecture has been inspired by the human nervous
system, and features the communication infrastructure required to con-
nect the central system to the peripheral. Peripheral “organs” are called
roblets and communicates with the central system, named body map, us-
ing XML messages. Communication is disconnected, and it is unreliable
(it uses the UDP protocol), thus roblets have to continuously inform the
body map about their state. The disconnected nature of the communi-
cation implies that a local crash does not imply a global crash. In fact
each of these elements can be restarted without need for a global restart;
this is an important aspect because if one unit of an experiment fails
other units can continue functioning without need for aborting the whole
experiment.
A program based on Robotics4.Net is composed of three ingredients.
• Brain: The core of the control system
• Bodymap: A sort of black board used to send and receive messages
• Roblets: The appendix of the system, like the parts of the nervous
system. They read data from the environment and convert the
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Brain signals into actions
In this case each of the bioreactor systems is composed of the elec-
tronic box connected to a netbook computer and it is perceived as a roblet
(figure 1.8). Each Bioreactor (roblet) communicates through the network
protocol with the supervision program installed on another remote com-
puter hosting the Bodymap. Because the connections among the roblets
and the bodymap are based on a datagram-oriented protocol the brain
can be powered off and restarted afterwards without affecting the activity
of roblets.
Figure 1.8: Schematic flowchart of the entire Bioreactor system; in
green are the electronic control units and connections, in red the culture
chambers and the medium circuit, the gas connections and apparatus are
represented in blue and the light red is the heating box unit that contains
part of the system.
This is a fundamental feature of this control architecture, each biore-
actor is able to control it environment autonomously and it requires the
connection with the supervision software (interface) just to receive the
target values and to show the collected and stored data.
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In a bioreactor system it is necessary to control many parameters: the
amount of nutrients flowing in the cell culture chamber, the hydrostatic
pressure inside the system, the flow generated shear stress on the cell
culture, the flow of gas, the temperature flux generated by the heating
system and the pH of the medium. These parameters are established
using a graphical interface and sent to the roblets running on the biore-
actors.
Since Ethernet is a communication bus, the graphical application used
to control an experiment can receive UDP packets from several units run-
ning in parallel. This is very important in the context of HTS method-
ology [44]. The network also allows connections through the Internet,
allowing remote monitoring of experiments, an important feature since
experiments run for several days [43].
Each bioreactor roblet runs an instance of the bioreactor control li-
brary (BioreactorControl.dll)1.1.2 developed for the purpose using F#
[45, 46], a functional programming language based on ML and developed
by Don Syme et al at Microsoft ResearchTM .
Data collected during the experiments is stored by the roblets on the
hosting computers as XML files that can be directly opened with any
spread sheet application supporting this format at the end of the exper-
iment. This feature is implemented using the .NET XML serialization
ability, allowing to directly write on a text file the state messages sent by
the roblet to the bodymap.
Bioreactor control library
The Bioreactor Control library is developed in F# .NET and compiled as
a dedicated library in order to maintain the control system independent
of the roblet architecture. This hierarchical architecture is safer than a
classic direct control approach, because the roblet and the control library
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library are developed and maintained separately. With a control library
independent of the roblet architecture it is possible to compile a direct
control console interface that was used during the preliminary library
debug phase and allow a direct check in case of hardware failure.
With a separated .NET library one can also choose to change the
control architecture without completely re-design of the hardware control
system. For example, it is possible to move to other control frameworks
without need to re design the control algorithms and vice-versa.
The bioreactor control library defines the sensor reading units and the
control strategies. Each sensor is designed not only as a reader, but as
an active part of the system capable to influence the actuation strategy.
The implemented sensor units are:
• pH sensor and gas selection unit
• pressure sensor and regulator unit
• temperature sensor and heater unit
Other sensors such as the environmental temperature and humidity
probe are designed as reading unit and they do not implement an actua-
tion behavior.
pH control strategy
As mentioned in [47], the pH is more complex to control than other pa-
rameters because of the delays between gas infusion and ionic dissociation,
for this reason in order to control the pH in the medium a dedicated con-
trol adaptive algorithm, based on a step strategy was developed. This
control algorithm is a high priority service running on the pH Sensor unit
of the bioreactor control library.
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The pH response to the diffusion of CO2 and air is very difficult to
predict, because it strongly depends on the environmental variables of the
particular experiment such cell type, temperature, volume of medium,
type of medium, hydrostatic pressure etc. Therefore rather than using a
mathematical model [48] of the CO2 and air diffusion in water, a function
defined by an algorithm was used.
Before designing a complex and not linear algorithm a formal model
of the algorithm using the Abstract State Machines (ASM) formalism
[49] was defined. Using ASM any algorithm can be described in a formal
mathematical system. It is a very effective approach for specifying the
algorithm and study its properties.
The system continuously inserts air in the mixing chamber through
an appropriate needle (blue zone in figure 1.9); when the pH goes over
the safety threshold (selected by the user through the control interface)
the control inserts a known CO2 impulse (red zone in figure 1.9), in the
mixing chamber, and waits a Delay Time. In this way a known amount
of CO2 is inserted in the mixing chamber and the control wait the CO2
dissolution and reaction time before evaluate the effect of this operation.
If the pH returns under the safety threshold the pH control routine is
stopped, otherwise after the Delay Time has passed, the control inserts a
new impulse of CO2 and waits for the Delay Time.
The Delay Time is constant, the CO2 spray amount (Spray Time) is
adjusted at every step in a manner dependent on the value of pH and the
derivative of pH with time 2.
The pH control strategy includes a safety logic test used to evaluate
whether the pH is decreasing or not; in the case of a negative derivative,
if the pH value is under the safety positive threshold (green zone in figure
2The derivate is calculated on a time span of 2 second because of the CO2
dissolution time.
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1.9, the control does not insert CO2 because it is possible to assume that
the last CO2 spray was sufficient and the pH can return under the thresh-
old in a short time; this test prevents an excessive fall in pH, because the
CO2 spray causes a large drop in pH but with a substantial delay.
Figure 1.9: pH control algorithm working zone.
Equation 1.1 describes how the Spray Time is calculated by the biore-
actor control library. The Spray Time to use is an increment of a default
spray time (AverageSprayTime) calculated adding an amount propor-
tional to the difference between the pH value and the selected target
value (pH*) and also an amount proportional to the pH derivate 2.
SprayT ime = AverageSprayT ime+A(pH − pH∗) +B(∆pH
∆t
) (1.1)
The multiplicative constants A and B are selected by the user through
the user interface and depended on the medium and volume, the user
can also choose the margin span through the pH margin variable of the
interface.
With a formal model based on ASM [50] the constants for a water
environment were predicted, but they are very sensitive to the physi-
cal conditions of the experiment (volume and type of medium, pressure,
temperature). Consequently the ASM predicted constants were used as
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default values that are suggested by the configuration interface. During
the experiment, these constants can be adjusted in order to match the
pH control parameter with the experimental set up. The code below is
the pH control algorithm.
let controlloph = seq {
while (true) do
if (this.DeltapH < 0.) &&
(this.PhValue < (this.targetValue + this.Range)) then
yield 0.
else
while(this.PhValue > (this.targetValue-this.Range)) &&
(this.controlState = InterfaceState.Auto) && ((this.DeltapH >= 0.)||
(this.PhValue >(this.targetValue + 2.*this.Range))) do
this.SetGas <- GasType.CO2
this.spraytime <- this.averagespray +
(float(this.avalue)*(this.PhValue-this.targetValue)) +
(float(this.bvalue)*(this.DeltapH))
yield this.spraytime
this.SetGas <- GasType.Air
this.waitingtime <- this.averagewait
yield this.waitingtime
yield 0.
}
As shown in the pH control algorithm F# code 1.1.2 the seq construct
was exploited to let the compiler generate a finite state automa that
performs the computation defined in the body and pausing and saving
the state of the computation whenever the yield expression is reached.
In the control library the pH control sequence is triggered by the pH
sensor event handler and it is active only if the control state is set to
Auto, otherwise the routine will return 0 that is considered as a timer
stop. The pH sensors require a temperature compensation that in the
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control library is obtained through the two temperature sensors inserted
in the heater box, the temperature sensor used as pH compensator can
be selected throught the user interface.
Pressure and gas flow control
The pressure in the mixing chamber is obtained through a needle placed
on the outlet tube in order to have a high flow resistance on the outlet
tube.
The pressure is controlled through the serial to PWM board that
generates the analog 0-10V control signal for the pressure regulator. Note
that the system does not use a calibration function that converts the
digital value sent to the serial port to the pressure regulator obtained
pressure.
Typically the pressure regulators are designed to be used in a closed
system and the imposed pressure is guaranteed for a static environment.
In the case of an open system with flow the pressure read-out is not linear
and there may be large errors between the real pressure and the read-out
1.10. In this case the mixing chamber has an outlet connection and the
system is always subject to flow, it is consequently impossible to use the
data sheet pressure regulator correlation factors.
For this reason use a ramp approach has been followed; the control
library use the pressure sensor to read the mixing chamber pressure and
increases or decreases the PWM signal in order to reach the target pres-
sure. In this case the pressure regulator under flow dis-alignment issue
can be adjusted, and the system can be actuated in a flow control strategy
in which the the flux sensor instead of the pressure is used as feedback.
The pressure in the mixing chamber is obtained with a flow resistance
imposed by a needle, with this ramp approach the outlet needle diameter
can be changed in order to change the flow rate/pressure ratio without
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needing to re calibrate the system.
Figure 1.10: Pressure regulator characteristic at different flow rates.
The iteration approach is incremental it is not necessary to send more
than one step per time, the ramp speed can be chosen through the user in-
terface in order to change the pressure adjustment and reactivity speed.
The user can also choose the pressure threshold that is used to calcu-
late the margin around the target pressure where the pressure control is
stopped and the pressure attained is considered acceptable.
All the control variables and the flux or pressure control strategy
can also be selected through the user interface during an already started
experiment.
The control routine also implements a safety control test that rises
up an exception in case the pressure regulator is unable to reach the
target pressure, this can occur for example if the outlet needle diameter
is too large and the flux imposed by the pressure regulator is unable to
pressurize the mixing chamber at the requested value1.1.2. The routine
below reports the code for the safety control test.
let DoControl (value:float) (target:float) (range:float) =
if (value < target-range) && (this.State = InterfaceState.Auto) then
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if not(this.pwm = 127uy) then
this.pwm <- this.pwm + 1uy
pwmset this.pwm
else
this.timer.Stop()
this.pwm <- 0uy
this.Pressuretrigger(new StatusEventArgs(EventType.targetpressure_fluxtohigh))
else if (value > target+range)&& (this.State = InterfaceState.Auto) then
if not(this.pwm = 0uy) then
this.pwm <- this.pwm - 1uy
pwmset this.pwm
else
this.timer.Stop()
this.pwm <- 0uy
this.Pressuretrigger(new StatusEventArgs(EventType.targetpressure_fluxtolow))
else
this.timer.Stop()
The GUI Software
The Graphical User Interface is developed in C# and is based on a multi-
tab structure;the GUI is used to read data from the bioreactors and to
setup the experimental variables of each module. The user interface also
serves as a tool for sensor calibration, in order to perform the sensor cal-
ibration with the same software used for bioreactor control. The user
has control over the experiments, including a manual overdrive, though
the autonomous control software running on the roblet avoids commands
that could damage the system or the experiment. When the User Inter-
face is open, it seeks for connected bioreactors; when one is found, the
GUI switches in the view mode figure 1.11(a). In this section the data
pertaining to each bioreactor can be viewed by selecting its menu and
experimental settings can be changed through the configuration tab.
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The Bioreactor control GUI has a set of default variables stored in
the system registry during the installation, all the changes to this vari-
able such as calibration or control parameter are stored on the Windows
registry and are saved as new working values. The installation default
values can be easily restored with a dedicated button1.11(b).
Figure 1.11: The bioreactor control user interface in the view mode (a)
and in the config mode (b).
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1.2 Environmental Control Test
The Environmental control system was tested in order to ensure its time
stability and also to calculate and verify the accuracy and resolution of
the sensors and electronic acquisition units. In order to verify the sys-
tem stability, a 48h experiment was performed. A mixing chamber filled
with 5 ml of fresh medium was placed in the heating box, plugged to
the peristaltic pump and the experiment started. The target values for
this experiment where: pH 7.4, Temp 37◦C and pressure 30 mmHg. No
cells where used in these preliminary experiments because cell cultures
do not significantly influence the maintenance of the environmental vari-
ables. With this experiment the capability of the system to maintain
the target environmental variables without problem for long periods was
demonstrated. When the experiment starts, the control chooses the gas
to insert in order to keep the pH near the target value, with a toler-
ance chosen by the user (in this case 0.04 pH units), the first 10 minutes
of experiment show an excursion of 0.2 pH units around the target pH
values because the controller has to adjust the CO2 Insertion Time and
the Waiting Time1.1.2 in order to fit the experimental setup3. After the
starting phase, the pH excursion is reduced to a range of ±0.1 pH unit
around the target value that is impossible to remove due to the non linear
and large delay time of the pH regulation process. This experiment en-
ables calculation of the experimental resolution of the pH control system
; the pH reading resolution is of 0.01 pH unit and the target value can be
chosen with a resolution of 0.1 pH unit, with a control tolerance down to
0.1 pH unit.
Unlike the pH controller, the pressure control system does not show
any adjusting phase during startup. When the experiment starts the
3Medium type and volume, chosen pressure, target pH and other experimen-
tal variables which influence the pH control routine.
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system is able to rapidly reach the imposed target pressure. The pres-
sure reading resolution is of 0.1 mmHg and the target pressure can be
chosen with steps of 1 mmHg with a tolerance (used as controller acti-
vation threshold) down to 1 mmHg. Due to the complicated gas circuit
and to the problem related with the inability of the pressure regulator to
work with high accuracy in case of continuous flow, the target pressure
is maintained with an oscillation around the target value of ±1 mmHg
that is enough to ensure a stable cell culture stimulation. The silicone
tube connections and the presence of an air volume in the mixing cham-
ber4 help to smooth these pressure oscillation acting as a low pass filter.
As described in the pressure controller code section 1.1.2 the pressure
regulator use a ramp approach to be controlled, the ramp speed can be
chosen in the range 1-10 samples per second, higher ramp speeds imply a
faster pressure controller reaction but they could introduce oscillations in
the system. The default ramp speed is set to 3 steps per second and can
be be adjusted by the user depending on the experimental setup (needle
dimension, mixing chamber volume, etc).
The target temperature is reached after 15 min since the experiment
starts due to the low power of the cartridge heater and to the safety
cartridge temperature limit imposed at 80◦C. After the warming phase
the temperature is kept around the target value with an oscillation that
is dependent only on the temperature tolerance imposed by the user. The
temperature reading resolution is of 0.05◦C and the target value can be
chosen with step of 0.05◦C and with a tolerance down to 0.1◦C. The
temperature control tolerance could be lower but the minimum level was
fixed to 0.1◦C in order to prevent fast switching of the cartridge heater
4The mixing chamber has an internal volume of 12mL but is filled with 5 ml
of medium, the 7 mL of air helps to smooth the pressure oscillations working as
a capacitor.
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that could damage it.
After 48h of experiment, before the control routine was halted, some
failure simulations where made. In order to investigate the stability of the
system in case of failure of the lab gas lines the main air and CO2 valves
where alternatively closed. When the CO2 is missing, the system is unable
to keep the pH under the target values and the pH values slowly rise up
as consequence of the air insertion. The system pressure is maintained
but with higher oscillations around the target value due to the pressure
falling down when the CO2 gas is selected. In case of air line failure the
system presents the same pressure instability problem but the pH fall
down very fast due to the higher diffusion of CO2 in water than O2. In
both cases the system do not stop its control of the other variables such
us temperature, pump speed etc and data collection is still guaranteed.
If the broken gas line is repaired the system works to reach the selected
target values again.
A network failure was also simulated. As previously described in sec-
tion 1.1.2 the control software is split between a netbook or embedded
board that acts on the system through various peripherals and a super-
visor that is used to setup the experimental targets and to show the col-
lected data. In case of network disconnection, the system does not present
any changes because the entire control system is not network dependent,
and the BioreactorControlLibrary is hosted by the roblet running on the
netbook. Without network connection is not possible to change the tar-
get values or observe the bioreactor data from a remote station in real
time. In this case, using a netbook, the bioreactor control is still guaran-
teed through the netbook monitor, in case of a system equipped with an
embedded board a computer with a bioreactor GUI installed on it can be
connected to the environmental control box in order to interact with it.
The bioreactor system is designed not only to control the environ-
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mental variables but also to impose stimulations to the cell cultures, in
order to verify the environment stability during a pressure stimulation
experiment the system was tested using a pressure profile as target value.
The first experiment was to test the pressure regulation response speed,
and it was a profile where three different pressures where imposed (30,
90 and 120 mmHg). As shown in figure 1.12 the system instantly reaches
the imposed pressure and the gas flux changes to maintain the required
pressure. The flux also depends on the needle used as gas outlet resis-
tance5 (described in section 1.1.1), the pH is controlled independently
of the selected pressure, but the oscillations around the target value are
influenced by the changes of the gas flow rate.
Figure 1.12: Pressure maintaining test, a profile of three pressure is
imposed (30, 90 and 120 mmHg).
As shown in figure 1.12 the error on the pressure value is independent
of the pressure level and is a consequence of the electronic noise and of
the pressure regulator inaccuracy. The lowest pressure that the system is
5For these experiments a syringe needle with a diameter of 21 Gauge was
used (internal diameter of 0.495mm).
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able to maintain depends on the mixing chamber outlet needle diameter
and also on the limits of the pressure regulator hardware. The tests
demonstrate that a target pressure lower than 15 mmHg results in an
unstable pressure control due to the inability of the pressure regulator to
maintain very low pressures6. In these experimental conditions, the gas
flow rate is very low and the inserted CO2 amount is not enough to keep
the pH at the desired value, this results in a very high pH oscillation.
To obtain very low pressure levels, the system has to be controlled in
flux mode and the mixing chamber outlet opened (without a needle), in
this configuration the pressure in the mixing chamber can be regulated in
the range 0 - 30 mmHg and the flux is enough to ensure stability of the pH
control . In case of flux control the system works switching on and off the
pressure regulators, and the gas mixer and mixing chamber air volume
are used as capacitors to smooth the switching oscillations. In this case
the pressure is not a target variable and its stability is not guaranteed,
the system works only in order to keep the flux and pH stable.
Another pressure control test was conducted in order to demonstrate
the system capability to generate a pressure profile used for cell stimu-
lation. As described in [51], in order to investigate the retinal glaucoma
disease, rat retinas are placed in bioreactor chambers and stimulated with
cyclic pressure profiles. In this case a stimulation path with a base level
of 30 mmHg and seven steps of 120 mmHg was defined.
As shown in figure 1.13 the system is able to generate pressure profiles
and to keep the pH in acceptable ranges also in case of continuous flux
or pressure changes.
The pH control algorithm was tested for a pH perturbation due to ex-
6The pressure regulator data sheet indicates a pressure regulation range of
7.5 - 750 mmHg in zero flow conditions. In flow conditions the pressure range is
reduced.
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Figure 1.13: Pressure control test for pressure profile generation. The
requested path was made of seven pressure steps at 120 mmHg with a base
line of 30 mmHg.
ternal stimuli. The mixing chamber was filled with 5mL of fresh medium
and after the pH stabilization phase (3 minutes after the beginning of the
experiment), 0.5mL of acid solution with pH 4 was injected through one
of the mixing chamber medium tubes and the system reaction observed.
When the pH reached the new stable point, a new external stimulus was
imposed by injecting 0.5mL of basic solution with pH 10. In both cases
the controller is able to adjust the pH value inserting Air or CO2 with
impulse times dependent on the pH error. As shown in figure 1.14 the
pH adjustment time in case of acid injection requires longer times than in
case of base injection, this is due to the lower oxygen diffusion time than
CO2. The controller is consequently faster in decreasing than increasing
the pH.
As demonstrated by these tests, the Environmental control box is
able to maintain the bioreactor cultures in the environmental conditions
chosen by the user also in case of external perturbation or variable target
values. The system is also able to impose variable stimulation and it can
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Figure 1.14: pH control tests, an acid and base insertion is done in
order to test the pH controller capability to react to external stimuli.
be used as a long term cell culture stimulator.
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P.GIO Pressure Generator of
In-vivO environments
The environmental control is a complex array of sensors, transducers and
actuators able to control different variables of the bioreactor environment.
During this work a ”light” version of the environment control system was
also developed. With this “lighter” system the environmental variables
(5% CO2 atmosphere, humidity, tempertaure and sterility) are main-
tained using a classic CO2 incubator. The P.GIO (Pressure Generator
of In-vivO environments) system is an innovative free standing unit able
to control stepper or DC motor in order to generate controlled pressures
or micro movements. As described in figure 2.1 P.GIO is a component of
the SUITE platform and can be used as autonomous motor control, as
environmental control box “slave” actuator or in connection with a PC
for a direct user interaction. The P.GIO DC motor control capability can
be used to impose hydrostatic pressure stimuli on cell cultures through
dedicated stimulation chambers described in the next sections 5, as vis-
cous material extrusor in micro-fabrication processes or as drug dispenser
in connection with the Environmental control box. The stepper motor
control capabilities can be used for the generation of squeeze pressures
for cell stiumlation as described in 5.1 or as micro positioning system.
The P.GIO system was designed in order to be easy to use, stable
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Figure 2.1: P.GIO features and connections schema.
and autonomous. With this system is possible to design a wide range
of experiments where pressure stimulations, micro movements, polymers
extrusion or drug tests are studied on cell cultures with or without the
environmental control “supervision”.
2.1 Material and Methods
2.1.1 The P.GIO Hardware
P.GIO is an all inclusive and standalone unit able to control DC or stepper
motors, it is equipped with an LCD display [52] (16 characters per 2
lines) and the user interaction is provided by a 2 axis joystick with one
button. The motors are plugged in the front side of the unit through
two DB9 connectors and only one motor can be controlled at any one
time. The motor type selection is done through a switch placed on the
top of the unit where the status LEDs are also located. The unit is
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powered at 220V AC and is equipped with an internal stabilized power
supply board described in section 2.1.1. The P.GIO unit is controlled
through a micro controller board based on an Atmel micro controller and
programmed in a programming language close to C (described in section
2.1.1). In case of connection with the environmental control unit, the
system can be controlled through the USB connection located on the back
of the unit and the experimental variables chosen through the bioreactor
supervising GUI. The USB connection is used also for firmware upgrades
of the micro controller programming GUI. The system box is completely
made of plastic to allow easy cleaning of the system and the power unit
is connected to ground and protected through a fast fuse.
Figure 2.2: The P.GIO unit with the SQPR chamber plugged in.
The two motors unit are based on two dedicated motor drivers: the
L298 H-Bridge for the DC motor and the Easy Driver controller for the
stepper motor both described in section 2.1.1.
The core of the system is the interface board which is designed to
connect all parts of the P.GIO system and to adjust and filter the sig-
nals coming from the sensors and going to the motor drivers or to the
display. In addition the pressure sensor, the joystick, the status leds, the
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motor switch selector and the auxiliary connector are all plugged into the
interface board.
The pressure sensor is the same used in the environmental control
hardware [26] and is used here in the hydro static pressure working mode
as pressure feedback. The pressure sensor is powered with a 5V stabilized
line from the power supply unit 2.1.1.
Arduino ontrol board
The control board used for the P.GIO system is “Arduino” [53]. Arduino
is an open-source electronics prototyping platform based on flexible and
easy-to-use hardware and software. It is intended for artists, designers,
hobbyists, and anyone interested in creating interactive objects or envi-
ronments.
Arduino is based on the ATmega168 [54] micro-controller. It has 14
digital input/output pins (of which 6 can be used as PWM outputs), 6
analog inputs, a 16 MHz crystal oscillator, a USB connection, a power
jack, an ICSP header, and a reset button. It contains everything needed
to support the micro-controller2.3.
We decided to use Arduino for this project because this platform since
it is cheap, ready to use and backed by a large developers community that
continuously releases bug fixes and code snippets.
The complexity of the P.GIO system required all the the digital in-
put/output pins of the Arduino board to be controlled (7 are required
just to control the display). In order to enlarge the number of available
digital pins we changed the default Arduino configuration converting two
analog pins into digital ones. This configuration change is allowed by the
Arduino firmware, it requires an explicit declaration in the configuration
part of the firmware and it can not be changed during the run time.
46
2.1 Material and Methods P.GIO
Figure 2.3: The P.GIO box with all his components.
The power supply board
The P.GIO system requires different power supply voltages, a stabilized
5V supply is required for the Arduino board, the Phidgets pressure sensors
and the display, the DC and stepper motors required 12V supply with
high current capabilities and a stabilized ±12V supply is required for the
auxiliary port where a signal processing electronic unit could be plugged
2.3. The motor supply voltage is usually 12V but could also be changed
in case of use of a different motor or actuation unit.
In order to realize an all in one solution that completely supplies the
P.GIO hardware a dedicated power supply board has been designed. The
P.GIO power supply board is based on a double secondary transformer
plugged to a diode bridge with a current capability of 6A. The vari-
ous voltages are obtained through 4 dedicated voltage regulators. The
+12V is obtained using a 7812[55] voltage regulator and the -12V using a
7912[56] voltage regulator. The +5V stabilized power supply is obtained
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limiting the already stabilized +12V line with a 7805[57] voltage regu-
lator. All the different voltages are stabilized with a set of electrolytic
capacitors of 100µF and 100pF, in the case of the 5V line, a ceramic
capacitor of 10ρF is also used to ensure a very low ripple signal to avoid
electronic noise into the Arduino board or in the pressure sensor. The
+12V with high current capabilities line, is obtained through a LM338[58]
a voltage regulator able to drain until 5A. The LM338 is mounted using a
dedicated adjustable feedback resistor in order to allow a voltage adjust-
ment in case of motor changes. The high current 12V supply is stabilized
using a bigger electrolytic capacitor of 450µF.
Figure 2.4: Power supply board schematic.
The P.GIO interface board
The P.GIO interface board is the routing unit of the system; it is equipped
with a large number of connectors and with the two motor drivers 2.5.
The interface board is a PCB designed during this work and industrially
printed in order to ensure a high quality and stable product. This in-
terface is designed in order to prevent assembly error and only one way
connectors are used. In the interface board, the signals coming form the
Arduino board are routed to the various system components. One of
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the various interface connections that requires a detailed description is
the motor selector switch connection. This selector switches the signals
coming from the pins Analog 0 and 11 of the Arduino board between
the two motor drivers, consequently only one motor driver per time can
be controlled by the system. When a motor driver is selected, the other
one is disconnected by the system and its control pins are floating. The
LCD display is connected to the Arduino control pins through a dedi-
cated 16 pin connector of the Interface Board. This connector routes the
seven display control pins to Arduino digital pins 4 to 10 and to the back
light power supply and contrast adjustment unit located on the interface
board.
The Joystick is connected to the interface board through a 4 pin
connector and the button and position signals coming from the joystick
are routed to the digital pin 13 and analog pin 5 of the Arduino board.
A reset button placed on the rear panel of the P.GIO system is also
connected through the Interface Board, and is used in case of failure or
after the firmware upgrades.
Figure 2.5: The P.GIO interface board equipped with the motor drivers
during the assembly phase.
1Used in this case as digital pins.
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Motor drivers
As previously described, the P.GIO system is able to control stepper or
DC motors. Only one type of motor per time can be plugged to the
system and the motor selection is done through a dedicated switch. The
stepper and DC motors requires two different control strategies and power
managements and these two different control approaches are managed by
two separate motor drivers. Both these drivers are powered by the High
current power line and the supply voltage is usually regulated to 12V.
Stepper motor driver Easydriver v3.0
The EasyDriver is a stepper motor driver able to drive up to about 750mA
per phase of a bi-polar stepper motor. It is a chopper micro-stepping
driver based on the Allegro A3967 driver chip[59]. It is permanently set
to use 8 step microstepping mode which allows a control resolution 8 times
higher than that of a single step mode.2 The EasyDriver is equipped with
a trimmer that allows the current per phase to be adjusted from about
150mA to 750mA. It can take a maximum motor drive voltage of around
30V, and includes on-board 5V regulation for the internal logic, so only
one supply is necessary.
Due to the easy driver current capabilities, two low power stepper
motors could also be connected to the P.GIO system in a parallel control
strategy in order to run two stimulation experiments in parallel. For the
two motor parallel connection a 1 to 2 DB9 adapter is required.
DC motor driver L298
The L298 is an integrated monolithic circuit in a 15-lead Multiwatt and
2In the microstepping control mode, the motor phases are powered at different
voltages and not using a ON/OFF strategy, in this way is possible to divide each
motor step in 8 sub steps positions, increasing the motor resolutionby 8.
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Figure 2.6: a) The easy driver connection scheme and b) the EasyDriver
V3 board.
PowerSO20 packages. It is a high voltage, high current dual full-bridge
driver designed to accept standard TTL logic levels and drive inductive
loads such as relays, solenoids, DC and stepping motors. Two enable
inputs are provided to enable or disable the device independently of the
input signals. An additional supply input is provided so that the logic
works at a lower voltage. In the P.GIO system, the L298 driver is used
to control the DC motor through two dedicated signals coming from the
motor selector switch. The l298 driver is able to control contemporary
two DC motor, but here is used to control only one motor. The driver
input pin 1 and 2 are connected through the motor switch to two Ar-
duino digital pins and are used to select the state of the motor (forward,
backward or brake). The motor speed is chosen through a PWM signal
generated by the Arduino board on pin 11 and directly connected to the
L298 enable 1 pin through the Interface Board. The DC motor control
system requires three pins and when the stepper motor routine is chosen
(only two Arduino pins are required for stepper routine) the Arduino dig-
ital pin 11 is set to low level in order to disable the L298 power circuit
(no PWM signal on pin 11 is generated in stepper control mode). The
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L298 power pin is connected to the high current line and the logic power
pin is connected to the 5 Volt stabilized line both provided by the power
supply board2.1.1.
2.1.2 The P.GIO Control Software
The P.GIO firmware was developed in order to allow high usability of this
stimulation system, the software is written in the Arduino language (very
similar to C), and is based on two separate control and programming
parts: The DC motor and the stepper motor control routine. When the
system is turned on, the user is invited to select the experiment type. The
user interface does not ask if the user is interested in a stepper or DC
experiment, the different type of pluggable chambers are shown in the
menu and the software knows which motor is required for each chamber.
When the experiment is chose, the user is invited to insert the control
variables and the experiment targets typical of the selected experiment.
After the programming phase the experiment starts and can be stopped
using the joystick button. The experiments can be stopped and the target
variables changed, but is not possible to change the experiment type
without resetting the P.GIO.
Stepper motor control routine
To control the stepper motor, the software has to generate a set of pulses
on the easy driver speed pin (analog 0) and choose the direction using
the direction pin (analog 1)3. The pulse frequency is proportional to the
obtained motor speed and the stepper motor direction depends by the
direction pin status. The Stepper motor routine is a cycle where the step
3The speed and direction pins are Arduino’s analog pins used in digital mode
as previously described.
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pin is raised with a frequency proportional to the requested motor speed
and where each step is counted incrementing a variable used to trace the
stepper motor position. The stepper stimulations are usually cyclic and
they are implemented comparing the motor position counter with the cy-
cle length variable. When the motor reaches the start or the end of the
cycle position (position is egual to 0 or to cycle length), the motor direc-
tion is inverted and the speed changed. In the case of the SQPR Chamber
stimulation 5.1 the stepper motor pushes a piston in a chamber where a
cell culture is inserted. The piston’s speed of approach speed has to be
very fast in order to generate a pressure on the cell culture, likewise the
piston has to be lifted up very slowly in order to avoid generating negative
pressure in the chamber. In this case the cycle length is chosen during the
programming phase and stored as a variable. During the “push and lift”
phases two different speeds, calculated using the variables stored during
the programing phase, are used. The stepper motor routine is imple-
mented using a while cycle that can be interrupted pushing the joystick
button. In case of experiment interruption, the software activates a spe-
cial routine that brings the piston/stepper motor to the ”Home” position
in order to allow a re-start of the experiment without requiring a new
system calibration. The home position is chosen during the calibration
routine of the programming phase and is based on a routine that uses the
stepper motor to measure the piston/motor range of motion. The home
position is not coincident with the upper or lower limit of the stimulation
cycle but it is chosen in order to allow chamber assembly.
The stepper motor routine can also be controlled through the serial
USB connection of the P.GIO system. In this case the experimental
variables can be selected and programmed through the bioreactor GUI
and after the experiment starts the P.GIO system controls the motor
actuation procedure autonomously. The USB connection can be used also
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to stop and start the experiment and allow changing of the frequency and
the range of the stimulation over the time. With this system plugged into
the Environmental Control unit the SUITE system becomes a complete
platform for long term complex cell stimulation.
DC motor control routine
The DC motor routine is based on the generation of a PWM signal used
to control the motor speed and the direction pins. In the DC routine the
pins required for the direction management are two, one more than in
the stepper motor because of the possibility to move the motor forward,
backward or brake it. Forward and backward movements are chosen alter-
nating which pin is set to high and which is set to low, the brake mode is
obtained raising up both the direction pins which acts like an electromag-
netic brake. The brake routine is very useful to actuate a fine control of
the motor position and is used in the VSC (Vascular Stimulation Cham-
ber)2.2.1 experiments. The DC motor routine is based on a while cycle
where the pressure sensor is continuously read in order to know the pres-
sure generated by the system and the motor moved in order to keep the
chamber pressure constant. As described in the next section, the P.GIO
DC motor mode is used to compress or decompress a syringe pump that
generates a hydrostatic pressure in a bioreactor chamber. The routine
is not a simple motor on off approach, the system changes the motor
speed during the approaching phase in order to allow a fine positioning
of the piston. During the pushing phase the pressure is constantly read
and compared with the target pressure, the compressing motor speed is
constant (approaching speed) it was chosen during the firmware testing
phase and it is dependent on the mechanical properties of the system
(gear ratio, motor maximum torque etc). When the chamber pressure
is 20 mmHg lower than the target one, the speed is increased to 30%
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(proximity speed) for 300ms after that the motor is braked. This strategy
was experimentaly developed considering the mechanical property of the
syringe actuator and it is designed in order to allow a position reaching
using the system’s inertia. With this approach the inertia provided by
the increase of the speed near the target point allows the system to reach
the target during the braking phase. If the system were be actuated by
just stopping the movement and braking the motor in a pressure thresh-
old around the target, the system would oscillate around the target due
to the starting and stopping phase. The increase of the speed before the
target allows the breaking phase to be used as a fine positioning strat-
egy. Owing to the complex circuit and the presence of biological samples
during experiments, pressure drops are quite likely. For this reason the
system continuously controls the chamber pressure even in the braking
phase and if the pressure falls 5 mmHg below the target pressure the
system applies a 300ms pulse at the proximity speed and brakes the mo-
tor again. This strategy has demonstrated to be the best solution to
perform micro movements of the piston which help to keep the pressure
chamber stable during the time. In case of tube disconnection, a failure
routine is implemented through the continuous check of a micro switch
placed at the end of the syringe actuator. If the safety switch is pushed
the system retracts the piston for 1s at the approaching speed and goes
into failure mode. If the system is in failure mode a user interaction is
required and the system can be re activated pushing the joystick button
and positioning the piston on a new starting point. The failure mode is
implemented in order to prevent of motor or mechanical parts in case of
tube disconnection.
The DC motor part of the firmware also includes a serial control mode
in which the motor movements are controlled through the USB serial
communication. This routine is used in case of connection of the P.GIO
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system with the Environmental control box. We decided to design the
P.GIO system as a slave of the Environmental Control system, in order
to use it as an actuator and to do all the calculations and the feedback in
the control roblet. The value read by the P.GIO pressure and auxiliary
sensors is continuously sent to the master through the serial connection
and the system has a while cycle that reads the serial incoming data
(motor speed, direction and duration of the action) and actuates the
system moving the motor. This connection allows the system to be used
as an external pressure generator of the SUITE system that can be used
for example secondary pressure generator or as a drug dispenser or as a
extrusor for polymers and viscous materials such as alginate or agarose
[60].
2.2 P.GIO Controller Tests and Results
The P.GIO system was tested for both the control strategies and rou-
tine, in order to check both the hardware connections and motor control
drivers.
2.2.1 DC motor tests and results
The P.GIO system was tested for the DC motor control part using the
syringe pressure generator system. In this configuration it is possible
to generate hydrostatic pressure in a closed chamber and it is used to
pressurize bioreactor chambers or as an extrusion or dispensing system.
The system consists of a commercial syringe inserted in a linear ac-
tuator that compresses the syringe in order to pressurize a chamber con-
nected to the syringe outlet. The linear actuator is moved through a DC
motor with an embedded encoder (not used in this experiment). The
pressure feedback is obtained using a T connector to split the syringe
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outlet to the chamber and to the P.GIO pressure sensor as described in
figure 2.7. For the system tests we used a bioreactor mixing chamber
previously described 1.1.1 filled with 5 ml of medium. The system was
programmed to maintain different pressures inside the chamber (20, 80,
130, 500, 1000 and 1300 mmHg) for 24h, at the end of the experiments the
system was switched off and the chamber pressure tested using the En-
vironmental Control System1.1.1 as reference4. The tests demonstrated
that the P.GIO hydrostatic pressure generator system is able to maintain
pressures up to 1300 mmHg for 24h without external intervention. This
system therefore be used as hydrostatic pressure generator for bioreac-
tor chambers and can be used as lighter version of the Environmental
Control system. With this system a pressurized cell culture environment
can be run in a laboratory without a piped gas supply as a stand-alone
application or as pressure generator apparatus of the SUITE system.
The pressure generator system can also be used as a drug dispenser to
be connected to the Environmental Control unit, and controlled through
the Bioreactor interface. The system can be controlled in order to insert
precise amounts of drug in the bioreactor circuit during the experiment
to automate drug testing protocols.
In addition this system can be used as a pressure generator system
for polymer extrusion and can be plugged to a CAD/CAM system for
scaffold fabrication.
2.2.2 Stepper motor tests and results
The stepper motor P.GIO control capabilities were tested using the SQPR
bioreactor chamber described in section 5.1. This chamber actuates a
piston through a linear stepper motor with a resolution of 16.7 µm per
4The environmental control pressure sensor tube was plugged in parallel to
the P.GIO sensor.
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Figure 2.7: The P.GIO system connected to the hydrostatic pressure
generator.
step[61]. The stimulation given by this innovative bioreactor chamber
is a cycle of compression and decompression where the compression and
decompression phases have two different speeds and where the period of
the stimulation cycle has to be very accurate.
The system was tested for this control routine at three different stim-
ulation speeds (1, 2, 5 sec. of cycle duration) in order to check the sta-
bility and accuracy of the system during the time. The SQPR chamber
equipped with the linear stepper motor was placed in a 37◦C, 5% CO2
incubator in order to test the system in the real working conditions, and
plugged to the P.GIO control unit through the dedicated cable. In order
to verify the stability of the system, the piston action range was set to
2mm5 and the action range was measured using the SQPR chamber base
5The SQPR piston goes through a cycle where the distance between the
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as reference. After 24h the SQPR was stopped and the piston action
range checked in order to identify misalignments. A misalignment of the
action range could mean that the stepper motor skips some steps during
the run with a consequent shift of the action range particularly in long
time experiments.
The stepper motor tests do not shown any action range misalignment
demonstrating that the system does not skip any steps during the exper-
iments and that the control routines are stable over time. This system
can be used as innovative cell stimulation system, independently or in
connection with the Environmental Control system, creating a complete
high throughput stimulation bioreactor SUITE.
lowest and the upper points can be changed.
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Chapter 3
MCmB (Multi Compartmental
modular Bioreactor) chamber
design
The microwell (MW) plate has become a standard in cell culture. The
plates are available in a variety of formats (6-1536 wells), although for
most general cell culture and tissue engineering applications, 12, 24, 48
and 96 well formats appear to be most common [62]. However, the com-
plexity of the physiological environment is not replicated in petri dishes
or microplates. All cells are exquisitely sensitive to their micro environ-
ment which is rich with cues from other cells, and from mechanical stimuli
due to flow, perfusion and movement. Microwells do not offer any form
of dynamic chemical or physical stimulus to cells, such as concentration
gradients, flow, pressure or mechanical stress. This is a major limitation
in experiments investigating cellular responses in vitro since the complex
interplay of mechanical and biochemical factors is absent [63]. Most re-
searchers and industry now accept that classical in vitro experiments offer
poor predictive value or mechanistic understanding, and there is a shift
to new technologies, generally in the form of bioreactors. A large number
of bioreactor systems for cell culture have been designed and described.
They range from commercial bioreactors which apply laminar flow [64],
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membrane systems [65], rotating vessel systems [66] to purpose designed
devices for specific tissues such as blood vessels [67], heart valves [68] and
livers [69]. In most cases, the bioreactors described are custom designed
for specific requirements and necessitate the use of particular seeding
methods or scaffolds with narrow dimensional and design specifications.
Size-wise they can be large scale bioartificial livers with several billions of
cells and several milliliters of fluid [70] down to microfluidic systems with
a few hundred microliters of medium [71]. In fact microfluidic microfab-
ricated bioreactors which enable the culture of different cell types in a
shear stress controlled environments [72], are highly popular, but remain
very much a niche research tool. In a micro-bioreactor, the cell culture
surface is generally around 0.5-0.8 m2m [71] and this tiny surface is seeded
with a few thousand cells. Such a small number of cells, organized on a
tiny surface can be only a rough approximation of an organ and cannot
meaningfully predict in-vivo physiology or pathophysiology [3]. Another
problem encountered in micro-bioreactors is the so-called ”edge effect”.
In a micro-scaled surface, the percentage of area close to the edge of the
system is higher than in a millimeter-sized surface. A large fraction of
the cell population will therefore be found in a peripheral zone of the sys-
tem. Cell cultures in the edge zone are usually organized differently and
have higher cytoskeletal tensions [73], and they may also have different
viability or activity [74]. The edge effect is consequently a problem that
can directly affect the results obtained in micro cell culture systems as
demonstrated Lundholt in [75].
Furthermore, most microfluidic bioreactors are fabricated using PDMS
(polydimethylsiloxane) or other elastomeric polymers, which are known
to adsorb small hydrophobic molecules [76]. In a microfluidic circuit, the
surface to volume ratio is high and PDMS adsorption can lead to nu-
trient or ligand depletion so giving rise to experimental artifacts such as
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increased metabolic consumption rates. Finally, microsystems and micro-
bioreactors are difficult to use and assemble and the seeding and filling
processes are quite complicated. This could lead to increased experimen-
tal failure and decreased reliability, and limits their usefulness and scope
and also puts them out of reach of many cell culture experiments which
could benefit from added dynamic stimuli. In fact, for alternative tools
to become acceptable as cell culture standards, the transition from wells
has to be as smooth as possible. Only then will biologists and technicians
adopt and adapt to new culture methods. For this reason, a “system on
a plate” Multi Compartmental Modular Bioreactor (MCmB) was devel-
oped with dimensions of the order of a few millimeters, which enables
microwell protocols to be transferred directly to the bioreactor modules.
The main design criteria for bioreactors are based on maximizing mass
transport between the cells and the culture medium and on the applica-
tion of mechanical, electrical, chemical or other stimuli.
Given that hepatocytes present a major challenge in cell culture [77,
78], and are probably the ’limiting’ cell in an in-vitro system, the MCmB
was designed using hepatocytes as a reference cell type. Hepatocytes are
known to rapidly loose phenotypic expression in-vitro due to the absence
of an adequately equipped micro-environment, and they are a particular
focus of attention in bioreactor development [79]. As the main orchestra-
tors of endogenous and exogenous metabolism in mammals, hepatocytes
are extremely sensitive to oxygen concentration, with high metabolic de-
mands [80, 81]. One of the main engineering issues in bioreactors for
in vitro liver models is therefore the balance between high mass transfer
and low wall shear stress to cells. Several reports describe the effects of
flow and shear stress on hepatocyte cultures; [82, 20, 83, 72]. Moreover,
many investigators have shown that the viability of hepatocyte cultures
under high shear is usually lower than that of static controls, indicating
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that the cells are under conditions of stress [84]. Hepatocytes are there-
fore very sensitive to shear, and according to [85] hepatocyte function
is compromised at wall shear stresses greater than 0.03 Pa. To realize a
generic bioreactor system, a modular chamber with shape and dimensions
similar to the 24 MW was designed. The new bioreactor unit is called
the Multi Compartmental modular Bioreactor (MCmB) and it consists
of a cell culture chamber made of PDMS (polydi-methylsiloxane), a bio-
compatible silicone polymer. By plugging together different chambers in
different configurations (series or parallel) it is possible to mimic different
metabolic pathways in order to investigate and test multi-compartmental
biological models in vitro without having to design dedicated equip-
ment or culture chambers, but just by connecting together a set of pre-
fabricated chambers. The MCmB stems from a previous Multi Com-
partmental Bioreactor (MCB), in which the metabolic circuit has a fixed
topology [86, 87]. To mimic salient features of the glucose consumption
pathway, the MCB system was designed with four chambers representing
the pancreas, the liver and 2 target organs respectively. The chambers
were connected by channels, and the circuit dimensions were calculated
using allometric laws [88]. The MCmB is a further evolution of the MCB
system, and allows any tissue or organ model to be simulated simply by
connecting the modular chambers in a desired configuration. The biore-
actor design process started with the analysis of the oxygen concentration
and with the assessment of the minimum concentration allowed near the
cell surface, using hepatocytes as a reference. Subsequently a fluid dy-
namic model of the MCmB chamber was developed in order to investigate
the shear stress and to estimate the optimal chamber size to obtain both
adequate oxygen diffusion and low shear stress near the cell surface.
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3.1 Material and methods
3.1.1 Mass transport and flow modeling
The first model of the MCmB (MCmB 1.0) was based on the dimensions
of the classic 24 MW so as to directly compare static and dynamic cell
cultures in equal sized chambers. The MCmB 1.0 was designed to allow
the use of 12 mm glass or plastic cover slips, commonly used for cell
culture, or different types of scaffolds. It is also possible to place a slice of
tissue, pre-grown cell construct or pellets directly on the cell culture zone.
A FEM (Finite Element Modeling) model of the cell culture chambers
was developed in order to study the oxygen concentration and the shear
stress at the cell surface. Cosmos Floworks, a Solidworks1TMextension
that allows fluid-dynamic FEM analysis and Comsol Multiphysics2 were
used for this purpose. In both the fluid dynamic and mass transport
models the following system constants were used: viscosity=10−3Pa s,
fluid density =1000 kg/m3, medium flow rate in the range between 60
and 1000 µL/min, pressure= 1 atmosphere or 760 mmHg, temperature=
37◦C and no slip boundary conditions. Water was chosen as a reference
fluid, so that the actual values of shear stress on the walls will depend
linearly on the density and viscosity of the culture medium used. Initial
considerations were focused on a flow rate of 180 µL/min for the sake of
comparison with a previous test in the MCB system [86, 87]
In order to study the fluid dynamics of the modular bioreactor a
parametric model was developed in which the effect of changes in height
on flow parameters (flow speed, shear stress and stream lines) could be
observed. As shown in figure 3.1, the first model had a base height H
which varied between 3 and 9 mm, and a 13 mm diameter base with a
1Dassault Systmes SolidWorks Corp. Concord, MA, USA.
2COMSOL AB, Stockholm, Sweden.
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modelled 160 µm thick 13 mm in diameter cover slip placed on the bottom
of the bioreactor. The distance between the roof and the 1 mm diameter
inlet and outlet tubes was fixed at 3 mm, and the FEM model was solved
for different heights (H) between the tubes and the cell culture surface:
3, 4, 6, and 9 mm
Figure 3.1: The FEM model geometry for the first modular bioreactor
chamber. H is the variable height in the range 3-9 mm.
Oxygen concentration analysis
A steady state model of oxygen diffusion in the McmB chamber was de-
veloped, in order to investigate if the cells were adequately supplied with
oxygen during the experiments. Michaelis-Menten (MM) kinetics were
used to model oxygen consumption and Ficks laws to model oxygen dif-
fusion in water. In the bioreactor circuit, which is described in a previous
section 1, air rather than O2 is used for safety purposes. The O2 concen-
tration C[O2 ] in the medium just below the gas-liquid interface is directly
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dependent on the O2 partial pressure in air, typically 20% or 159 mmHg,
through Henry’s law C[O2 ] can be calculated using tabulated values of
the Henry constant:
P [O2] = K[O2] ·C[O2] (3.1)
With K[O2 ] = 932.4 Atm/mol/L and P[O2 ] = 0.2 Atm (20%), below
the gas-liquid interface C[O2 ] = 214 µmol = 0.214 mol/m
3. In the
presence of oxygen consuming cells, the O2 concentration will decrease as
a function of distance from the interface and the metabolic requirements
of the cells. The steady state flux of O2 in the bioreactor chamber is due
to cellular oxygen consumption at the base. The oxygen consumption
rate, per unit volume is given by the MM equation:
δC
δt
=
V m ·C
Km+ C
(3.2)
C is the oxygen concentration in mol/m3, Vm is the maximum vol-
umetric consumption rate in mol/m3, and Km is the MM constant in
mol/m3.
The flux at the base of the chamber where the cells lie is:
JC = −DδC
δx
· V m ·C
Km+ C
· 1
cells number
(3.3)
Where JC is the O2 mass flow at the cell surface,
δC
δx is the O2 concen-
tration gradient at the cell surface calculated along the axis perpendic-
ular to the cell culture layer, D is the O2 diffusion coefficient (in water)
D = 3 · 10−9m2/s @ 37◦C, and Vmax is the maximum consumption rate
in m2/s.
The kinetic model was calculated for a medium flow rate of 180 µL,
for a comparison with the MCB result, and a cell monolayer of 1.13 cm23
312 mm cover slip area.
67
3.1 Material and methods MCmB chamber design
surface area with 5 x 105 cells, which represents typical cell numbers
observed 48h after seeding HepG2 cells on a 3D scaffold [89].
In order to choose the height of the bioreactor, a minimum oxygen
concentration of the medium at the cell surface was fixed; Cmin= 0.04
mol/m3. Below this concentration it is assumed that cell function is
compromised. In fact typical oxygen concentrations in the liver are of the
order of 0.04 - 0.15 mol/m3 (4-15%), while 0.021 mol/m3 (2%) is known
to inhibit mitosis in hepatocytes [90]. Using the data in [91], Vmax =
0.048 nmol/s for 1 million cells, giving a value of 0.024 nmol/s for 5 x 105
cells (Vmax(5 x 105 )), and Km = 0.5 mmHg.
Figure 3.2 illustrates that the O2 concentration in the MCmB is al-
ways higher than the minimal threshold, and falls rapidly at the edge of
the chamber near the outlet. Increasing bioreactor height from 3 to 9
mm, the oxygen concentration decreases rapidly but cell survival is al-
ways guaranteed in the central region of the chamber. Above H=9 mm
however, at the bottom of the chamber the oxygen concentration is con-
stantly below the Cmin threshold of 0.04 mol/m3. The maximum oxygen
s at the base are 0.17, 0.12, 0.10 and 0.007 mol/m3 for H= 3,4,6, and 9
mm respectively.
Fluid dynamic model
To investigate the fluid-dynamics of the modular bioreactor, a parametric
model similar to the mass-transfer model was developed. The height H
was varied to determine its influence on the shear stress generated at the
cell surface, assuming again that the cells are seeded on a 12 mm, 160
µm thick cover slip placed in the bioreactor. Table 3.1 summarizes the
results, showing how the shear stress at the cells surface decreases rapidly
with increasing H. However the laminarity of the flow is compromised by
increasing the height of the bioreactors. This is a consequence of the
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Figure 3.2: Theoretical oxygen concentration profile across the bioreac-
tor chamber for different heights H, calculated using Michaelis Menten
kinetics and a flow rate of 180 µL/min. The minimal concentration
threshold of 0.04 mol/m3 is indicated by the solid line.
separation of flow stream lines caused by the difference in height between
the inlet tube and the base.
After evaluating the results from the fluid dynamic and mass trans-
port modeling, a Modular Bioreactor chamber with tubes placed 6 mm
over the cell surface (H) was realized. A distance of at least 1 mm between
the wall of the tube and the top of the chamber is necessary to ensure me-
chanical stability of the tube/chamber junction. Since standard silicone
tubing with an inner diameter of 1 mm has an outer diameter of 3 mm,
the total height of the chamber is 10 mm. This is the best compromise
between shear stress, flow, oxygen diffusion and mechanical feasibility.
Figure 3.3 shows the three dimensional FEM model of the H = 6 mm
MCmB with an internal diameter of 13 mm, sufficient to place a slice or
a scaffold of 12 mm in diameter. This bioreactor has a peak shear stress
value of 6.85 X 10−6 Paand a velocity peak of 10−6m/s near the center
of the base.
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Height (H)
Shear
Stress Peak
(Pa) @180
µL/min
Shear stress pro-
file (log Pa)
Velocity
Peak
(m/s) @180
µL/min
Velocity vector Stream Line
3mm 3.21710−5 4.42910−6
Parallel to the
cell surface
Parallel to the
cell culture
4mm 1.19510−5 1.66510−6
Parallel to the
cell surface
Parallel to the
cell culture
6mm 6.85610−6 9.88710−7
Slightly sloped
Nearly paral-
lel to the cell
culture
9mm 8.74710−7 1.38910−7
Sloped
High impact
angle on the cell
culture surface
Table 3.1: Fluid Dynamic FEM model results for a fixed flow rate of
180 µL/min for the first MCmB model as a function of height H.
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Figure 3.3: FEM model of the H=6 mm MCmB 1.0. a)Velocity and
b)shear stress. The analysis takes into account a 160 µm thick glass
cover slip placed on the base of the chamber.
3.1.2 Chamber Fabrication
A first prototype of the bioreactor chamber (MCmB 1.0) was fabricated
using “milli-molding” in order to investigate the performance of the sys-
tem. Milli-molding is similar to micromolding [92], in that PDMS is used
as a mold, but the master is machined using a mill or rapid prototyping
rather than lithographic methods, and the features of the mold are of
the order of tenths of millimeters, rather than microns. The chamber is
composed of two separate parts which are plugged together through a
friction fit system. In the friction fit system two complementary geome-
tries form a seal when brought together thus avoiding the use of o-rings or
additional parts [93]. PDMS 4 is used to fabricate the chambers. Along
with the friction fit system, the use of PDMS , which is self adhesive
and deformable, ensures that the seal is watertight. The two parts of
the chamber (figure 3.4)are made by casting and curing PDMS accord-
ing to the manufacturer’s instructions on aluminum masters purposely
machined. Each master is made of two separate pieces which allow easy
removal of the chambers after polymerization.
4Sylgard 184, Dow Corning, Silverstar, Italy.
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Figure 3.4: The two parts of the MCmB 1.0 chamber. The top part
(left) has two holes for the 3 mm silicone tubes insertion, on the bottom
part (right) is possible to see the fit system.
Turbulence Tests
The first prototype of the MCmB 1.0 cell culture chamber had severe
problems with the build-up of air bubbles during the initial phases in
which the bioreactor is filled with medium. This resulted in the formation
of a bubble of air at the top of the chamber (Figure 3.5.a) which disturbed
the flow profile, causing turbulence and more importantly unpredictable
values of shear stress. In order to evaluate the effects of the bubble
induced turbulence, a small drop or blob of alginate was introduced in the
chamber as a turbulence sensor. An alginate blob is easily disaggregated
under turbulent or high impact flow, and for this reason is a good indicator
of the presence of altered flow profiles. Moreover, cross-linked alginate at
the concentrations used here has approximately the same elastic modulus
as the liver (≈10kPa), [94, 95].
The alginate blobs are made placing 166 µL of 2% sodium alginate5
dissolved in MEM5 on top of a glass cover slip in the chamber and cross
5Sigma, Milan, Italy.
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Figure 3.5: a) Bubble formed at the top of the first MCmB 1.0 chamber
, and B) alginate drop used for turbulence tests placed on the bottom half
of the chamber.
linking in-situ with 104 µL of 0.1 M CaCl2 (Figure 3.5.b). The volume
of the blob was chosen in order to form a thin uniform coating of the
glass cover slip, without interfering with the inlet tube. A peristaltic
pump 6 was attached to the inlet, and keeping the flow rate constant
at 180 µL/min, the consistency of the alginate blob after 24 hours in
the MCmB 1.0 @ 37◦Cwas analyzed. The alginate drop was completely
disaggregated, showing that the bubble induced a turbulent environment.
180 µL/min was chosed in order to test the MCmB prototype in the
experiemtnal conditions described in the MCB works [86, 87].
3.1.3 Design Improvements: MCmB 2.0
In order to eliminate bubble entrapment and turbulence in the bioreactor
chamber, a second prototype (MCmB 2.0) of the modular bioreactor was
designed. The new bioreactor is slightly larger in diameter (15 mm) to
enable 13 or 14 mm slides to be easily inserted and its top surface is
sloped along and perpendicular to the axis of flow, so that bubbles are
6Ismatec, Glattbrugg, Switzerland.
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collected and conveyed to the outlet tube (Figure 3.6.a). Furthermore,
the diameter of the outlet tube was increased to 2 mm to facilitate the
removal of bubbles. This also reduces the impact angle on the cell culture
surface and the recirculation near the outlet wall as shown in table 3.2.
The final height of the MCmB 2.0 is 11 mm at the inlet side and 13 mm at
the outlet side, with the tubes positioned respectively at H=9 and H=10
mm from the cell surface (Figure 3.6.b).
Figure 3.6: a) dimensions of the new chamber, b) three dimensional
representation of the sloped roof and ridged base, c) MCmB 2.0 Velocity
profile, showing stream lines and d) Shear Stress at the base.
Through FEM modeling a tenfold decrease in fluid velocity and shear
stress on the cell surface with respect to MCmB 1.0 was observed with the
introduction of the sloping roof and the increased outlet tube diameter.
The MCmB 2.0 is 3 mm higher than MCmB 1.0, the increase in the
height of the new chamber design was chosen because this allows a further
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reduction in shear stress in comparison with MCmB 1.0 (6 mm in height)
while maintaining the oxygen concentration over the 4% threshold.
Flow rate (µL/min) 180 300
Shear Stress Peak (Pa) 4.295 · 10−6 6.456 · 10−6
Shear stress profile (log Pa)
Velocity Peak (m
s
) 5.939?10−7 9.04810−7
Velocity vector
Parallel to the cell surface Parallel to the cell surface
Stream Line
Parallel to the cell culture Parallel to the cell culture
Table 3.2: Fluid Dynamic FEM model results for the MCmB 2.0 at two
different flow rates, the average height (H) of the MCmB 2.0 is 9.5 mm.
The base of the bioreactor chamber was also modified to ensure easy
removal and support of coverslips, since the slides and thin substrates tend
to stick to the flat silicone base. The three small rectangular oxygenation
ridges, shown in figure 3.6.b, provide support and also allow medium
to flow under the support, supplying nutrients to the lower surface of
tissue slices or scaffolds. Without the oxygenation ridges the removal of
75
3.1 Material and methods MCmB chamber design
cover slips by the bioreactor bottom could be very complicated due to the
adhesion the thin cover slips to the silicone bottom of the chamber. Two
different types of bases, with or without oxygenation ridges, were realized.
The bottom with ridges is useful for coverslips or scaffold experiment but
is not suitable in case of use with little pieces of tissue or gel seeded with
cells because the tissue pieces can fall down the ridges or the gel may
stick between the ridges.
3.1.4 Modular Mould Design
The first prototypes of the MCmB bioreactors were made using two alu-
minum moulds one for the top and one for the bottom part of the cham-
ber. Both the MCmB moulds where composed of two parts, an internal
shape that is the core of the chamber design and an external frame that
is the mould wall. The external dimension of the two chamber parts are
exactly the same in order to provide a perfect fit and consequently a good
sealing effect. The aluminum moulds where not suitable for a long term
bioreactor production, because the aluminum is easily damaged during
the mould cleaning process and oxidize very fast in presence of oxygen
and high temperatures. PDMS polymerization is very sensitive to metal
oxides that can block the polymer cross-linking process. Moreover, re-
moval of the PDMS parts was difficult and required the use of sharp
instruments. Therefore a new mould was realised that can be used for
long term, for the production of a high number of bioreactors and that
do not present any problem of oxidation or wear during the cleaning pro-
cess. The new mould is a modular mould made of a frame system and
a set of three different inserts, all the parts that are in contact with the
silicone are made of stainless steel AISI 316L in order to prevent polymer
cross linking problems due to metal oxidation processes. With the modu-
lar mould is possible to fabricate six bioreactor parts in parallel, and it is
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consequently possible to produce 2 complete chambers (2 tops, 2 bottoms
with or without oxygenation ridges) or other combinations. The modular
mould frame is made of two specular parts (except for the tube hole posi-
tions and dimensions) that assembled together form the external wall of
the six bioreactor parts, these parts require a high dimensional tolerance
especially in the coupling surfaces. The high tolerance is required in order
to allow a perfect coupling of the two parts to prevent any leakage of the
liquid silicone polymer during the casting phase and also to prevent the
formation of ridges in proximity of the coupling surface in the bioreactors
obtained. The internal part of the chambers is made using the three in-
serts that are fixed on a dedicated mounting base made of aluminum (it
is not in contact with the silicone) and allows a perfect insert alignment.
All these parts are described in detail in figure 3.7 where the dimensions
are also indicated .
In particular it is important to highlight the sloped roof of the top
part modular insert. The top part of the insert presents two different
inclinations of the roof, the top is sloped 7◦ degree along the inlet outlet
axis because in this direction a high slope is not required to move the
bubble due to the force imposed by the flow of medium. Perpendicular
to the direction of flow a higher slope is required (14◦ degree) in order to
ensure bubbles are collected on the upper part of the roof. The top and
bottom inserts have two complementary geometries at the base, these ge-
ometries embody the snap/friction fit system of the bioreactor chambers
previously described 3.1.2. The snap fit system consists of a male female
geometry step shaped with dimensions of 3 X 3 X 3 mm (shown in figure
3.7.a.1), the total contact/sealing surface is consequently 9 mm even if
the bioreactor wall width is only 6 mm. This large contact surface due to
the self adhesive properties of PDMS ensures a perfect sealing effect that
prevents any leakage of the system and works also as a self alignment
77
3.1 Material and methods MCmB chamber design
system [93]. The bioreactor internal cavities do not present any sharp
angle and all the edges are rounded so as to avoid any discontinuities
which may damage the chambers during extraction.
Figure 3.7: Design of the modular mould. a) Bioreactor top part design
, b) bioreactor bottom part design (the bottom is shown with (2) or without
(3) oxygenation ridges), c) Lateral and d) top views of a modular mould
frame.
As shown in figure 3.7 all the bioreactor mould parts are polished in
order to facilitate the PDMS extraction phase and also to ensure com-
plete transparency of the chambers. Transparency is a very important
factor because due to the optical properties of the PDMS is possible to
observe cell cultures under microscope without requiring bioreactor dis-
assembly. This aspect is very important because one of the main reasons
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why biologists hesitate to migrate from multiwell technology is that most
bioreactors do not allow optical observation of cell cultures under a micro-
scope during the experiments. Another advantage of the modular mould
is in the tube insertion procedure. With the first prototype mould, the
tubes where manually integrated after the curing phase using some drops
of silicone polymer as glue. In these conditions the coupling between
the chamber top parts and the tubes was very fiddly and tube alignment
was not perfect. This approach also required another curing process with
an increase in bioreactor production time. With the modular mould the
tubes are inserted directly in the two frame parts and are integrated into
the top part of the chamber due to the high tolerance of the holes which
prevents any misalignments. Before the polymer casting stainless steel
wires of 1 and 2 mm (the inlet and outlet tube of MCmB 2.0 have differ-
ent diameters) are inserted in the tubes in order to prevent the cavities
being occluded with polymer and also to perfectly align the tubes with
the higher and lower parts of the top roof. The tube alignment is ob-
tained through two holes (1 and 2 mm in diameter) made on the higher
and lower part of the top roof as shown in figure 3.7.a.3.
3.2 MCmB 2.0 design validation
3.2.1 Oxygen Consumption and Shear stress in
the MCmB 2.0
Figure 3.9 shows the oxygen concentration in the two bioreactor designs;
for a given flow rate, the mean value is slightly lower in the new MCmB
2.0 design. As far as oxygen consumption is concerned, the difference
between the two chambers is the value of H (6 mm in MCmB 1.0 and 9
mm in MCmB 2.0) and their respective volumes 1.32 and 1.94 mL. The
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Figure 3.8: Modular mould fabrication and testing. In a) and b) the
bottom ridges obtained from the milling process are shown, in c) the mould
ready for the silicone casting in d) bioreactor extraction after the curing
and cooling phase.
MCmB 2.0 chamber has a larger volume (47% more) so the total amount
of oxygen available is greater. Therefore, despite the greater distance
between the tubes and the cell surface in the new chamber the minimal
oxygen concentration is still guaranteed except at the outer edge of the
base closest to the outlet. It should be noted that the number of cells used
in the model was more than twice that used in the experiments (decribed
in the MCmB validation section 4), and that the oxygen concentration
is highly dependent on the flow rate and metabolic requirements of the
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cells.
Figure 3.9: a) Oxygen concentration in the MCmB 1.0 for a flow rate of
180 l/min and MCmB 2.0 for a flow rate of 180 and 300 µL/min and b)
Oxygen concentration in the MCmB 2.0 for different flow rates between
60 and 500 µL/min.
The Graetz number which is a dimensionless number indicating the
ratio between the characteristic diffusion time and the convection time
respectively perpendicular and parallel to the direction of flow was also
characterized.
Gr =
D
L
Re ·Sc (3.4)
In the Graetz number equation, D is the internal diameter in round
tubes or hydraulic diameter in arbitrary cross-section ducts, L is the
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length of the conduct that in the MCmB case is 15 mm (internal diam-
eter of the chamber). Re and Sc are respectively the Reynolds7 and the
Schmidt number8. In the MCmB 2.0 The Graetz number calculated near
the outlet hole through the chamber FEM model is greater than 100 even
for low flow rates (60 µL/min) showing that the fraction of oxygen con-
sumed per reactor is insignificant and so downstream chambers do not
suffer from any input oxygen depletion. This is a very important aspect
of the MCmB 2.0 chambers because its demonstrate the capability of this
bioreactor to be used as modular system.
Using the FEM model empirical equations were established allowing
to calculate the wall shear stress and peak fluid velocity at the cell surface
as a function of flow rate.
Shear(Pa) = Flow (µL/min) · 1.8 · 10−8 + 1.1 · 10−6 (3.5)
FlowSpeed (
m
s
) = Flow (µL/min) · 2.6 · 10−9 + 1.3 · 10−7 (3.6)
Therefore the wall shear stress at 180 and 300 µL/min is respec-
tively 4.3410−6 and 6.510−6 Paand the peak flow velocity is 5.9810−7 and
9.110−7m/s.
3.2.2 Bubble and Turbulence Testing
As shown in Tables 3.2, the MCmB 2.0 has lower values of shear stress,
and the stream lines are parallel to the base of the chamber, even though
7the Reynolds number Re is a dimensionless number that gives a measure of
the ratio between inertial forces and viscous forces.
8Schmidt number is a dimensionless number defined as the ratio of momentum
diffusivity (viscosity) and mass diffusivity.
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its height (H) is 3 mm greater than MCmB 1.0. The MCmB 2.0 was bub-
ble free, as the sloped roof and the position and respective diameters of
the inlet and outlet tubes forced bubbles to be conveyed out of the cham-
bers. In the turbulence tests carried out with the alginate blob, the gel
showed no signs of wear even after 48 hours under a flow of 500 µL/min.
At a flow rate of 1000 µL/min the alginate gel showed signs of disaggre-
gation after 24 hours, due to the direct high impact of fluid on the base of
the chamber as well as the high wall shear. The alginate blob turbulence
test is not only a simple method for investigating turbulent, high impact,
or disturbed flow in the system, but can also be used to create a cell
culture environment more similar to the in-vivo liver environment. As
shown in [86, 87], coating the cells in an alginate or collagen gel increases
hepatocyte viability and phenotypic stability during the culture.
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Chapter 4
MCmB 2.0 Cell Testing
The MCmB 2.0 is a modular chamber for high throughput multi compart-
mental bioreactor experiments. It is designed to be used in a wide range
of applications and with various cell types. For this reason this innovative
chamber was tested with different cell types and experimental procedures
in order to validate the MCmB 2.0 for generic cell culture testing. The
first test performed on the MCmB 2.0 was aimed at demonstrating the ca-
pability of the chamber to maintain the vitality and function of one of the
most important yet most delicate cells in the human body: hepatocytes.
With the hepatocyte tests the mass transport and fluid dynamic FEM
models previously described3.1.1 were validated. In fact, through these
experiments we verified that the oxygen concentration in the MCmB
chamber allows hepatocyte survival and showed that their vitality is shear
stress dependent. The second set of tests was focused on establishing an
in-vitro liver model in the McmB 2.0, in which different chambers are
plugged in series and parallel in order to simulate a human liver. The
third test served to demonstrate that the MCmB 2.0 can be used to study
other cell types in a flow system. The MCmB 2.0 was used to investigate
the behavior of condrocyte cultures, in monolayers and in scaffolds, under
different levels of shear stress.
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4.1 Validation of Shear Stress and Oxy-
gen Concentration Models
Hepatocytes present a major challenge in cell culture [77, 78], and are
probably the “limiting” cell in an in-vitro system, the MCmB 2.0 was de-
signed using hepatocytes as a reference cell type. Hepatocytes are known
to rapidly loose phenotypic expression in-vitro due to the absence of an
adequately equipped micro-environment. Hepatocytes are extremely sen-
sitive to oxygen concentration, with high metabolic demands. For this
reason a series of experiments were conducted on hepatocytes to evaluate
the effective oxygen diffusion and the effects of shear stress in the MCmB
2.0 .
4.1.1 Material and Methods
Primary rat hepatocytes were used to test the performance of the MCmB
2.0 bioreactor at various flow rates. Hepatocyes were isolated from adult
male Wistar rats weighing between 250 and 300 g as described in [96, 97].
Isolated cells were assessed for vitality by trypan blue1 exclusion2, and
then seeded on glass cover slips (2x105 cells per sample) pre-treated with
0.1 mL collagen extracted from rat tails according to standard procedures
[98], placed in 24-MW plates and left at 37◦Cand 5% CO2.
About 5 hours after seeding, the medium was removed and replaced
with FBS-free William’s E complete medium. The following day, the
hepatocyte seeded coverslips were placed into the MCmB 2.0 chambers
and coated with 250 µL collagen gel prepared by mixing ice-cold colla-
gen solution and acetic acid 0.2 N (to a final collagen concentration of
1All cell culture reagents were purchased from Sigma, unless otherwise spec-
ified.
2Vitality routinely greater than 90%.
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about 1.1 mg/mL). The collagen coating used in these experiments has a
Young’s modulus similar to the alginate blob used to evaluate the turbu-
lence in the chamber [99]. It also provides an adhesive roof to the cells,
and shields the cells from the effects of direct flow.
MCmB Assembly
Prior to assembly the bioreactors with hepatocyte seeded and collagen
coated slides were left in the incubator for 40 minutes to allow the collagen
to set. The MCmB system was then assembled by connecting 2 chambers
in series to a peristaltic pump and the mixing chamber. Finally, the
system was filled with 10 mL FBS-free complete William’s E, and run for
up to 24 hours. The first experiment was run at a flow rate of 180 µL/min.
At 2, 4, 6 and 24 hours a 100 µL sample of medium was withdrawn for
analysis of rat albumin. A second set of experiments was carried out at
various flow rates (60-100-180-250-300-500-1000 µL/min) to determine
cell viability as a function of flow rate. The bioreactors were run for
24 hours after which the cover slips were removed and assessed for cell
viability. Control experiments with cells from the same rat liver were
run using glass slides seeded with the same number of cells, coated with
collagen and placed in 10 mL petri dish plate multiwell3.
Viability and Albumin Testing
Albumin, which is an important marker of hepatic function, was mea-
sured using a commercial ELISA kit4, according to the manufacturer’s
instructions. Rat albumin production is expressed as total quantities of
albumin per seeded cells. Each experiment was repeated at least three
3BD Biosciences, Milan, Italy.
4Bethyl Laboratories, Montgomery , TX, USA.
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times, and comparisons were only made between cells extracted from the
same liver.
The viability kit used was CellTiter-BlueTM Cell Viability Assay5, a
resazurin-based fluorescent compound metabolized by mitochondrial cy-
tosolic and microsomial enzymes to resorufin which can be detected with
a fluorimeter6 at 573 ηm. Viability was assessed both in control static
cultures and in the MCmB 2.0, and the results are expressed as ratio
between hepatocyte viability in dynamic and static conditions after 24
hours. The static control was a hepatocyte seeded and alginate coated
cover slip placed in a bioreactor base filled with medium and left open
in order to allow oxygen exchange without medium flow. Each experi-
ment was repeated at least three times, and comparisons were only made
between cells extracted from the same liver.
4.1.2 Cell viability and albumin production re-
sults
Figure 4.1.a illustrates the viability ratio between the MCmB dynamic
culture at different flow rates and a static control. The figure shows that
below 180 µL/min the viability is compromised, this could be due to the
lower oxygen concentration at the bottom of the bioreactor chamber for
these low flow rates (shown in figure 3.9.b). For flow rates in the range
between 180 to 500 µL/min the viability is very close to the control and
the viability peaks at 300 µL/min, this could be due to the high oxygen
concentration as demonstrated in figure 3.9.b. A further increase in flow
rates above about 500 µL/min causes a significant reduction in viability.
At higher flow rates, despite the increased availability of oxygen, the cells
5Promega Madison WI USA.
6FLUOstar Omega, BMG Labtech, Offemburg, Germany.
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suffer, and this is due to the high shear and impact angle of flow on the
collagen coating and cells. Figure 4.1.b shows the albumin production af-
ter 24 hours in the MCmB for different flow rates in the range 100 - 1000
µL/min, and the static control. Albumin in the bioreactor chamber, is
slightly up regulated except for the 1000 µL/min flow rate, where the cells
are damaged by the shear stress as previously discussed. These results
are confirmed by several reports describing dynamic hepatocyte cultures
[70, 20, 85] where the albumin production is maintained at control levels
even in the presence of shear. We have suggested that this induction is
due to two factors: the circulation of medium which provides a sustainable
supply of nutrients, as well as efficient removal of metabolic products, and
the mechanical stimulus due to the presence of a low velocity porous or
percolative interstitial-like flow which is established through the collagen
coating [89]. In fact, in the human liver, hepatocytes are never subject to
direct or tangential flow; they receive nutrients through a rich capillary
network and consequently only through interstitial flow driven by concen-
tration and pressure gradients [100, 101]. Not surprisingly a large number
of reports on liver bioreactors use co-cultures of hepatocytes with non-
parenchymal cells, typically fibroblasts [85, 102, 84]. These supporting
cells not only provide heterotypic signals, but they also secrete collagen
which likely forms a protective coating over the cells shielding them from
direct fluid flow.
4.2 In-vitro Liver Model in the MCmB
Bioreactor
Hepatocytes, like all cells, are dramatically affected by the physical and
chemical nature of their micro-environment. This is one of the reasons
why in vitro cell culture experiments are so difficult to compare from lab-
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Figure 4.1: a) Hepatocyte viability, expressed as the ratio between via-
bility in the MCmB 2.0 and a bioreactor static cultures after 24 hours at
different flow rates and b) Rat albumin production after 24 hours in the
MCmB 2.0 and in the control. ∗p < 0.05
oratory to laboratory. The hepatic cell habitat comprises 3 main features,
or cues, which are known to influence cell behavior; the biochemistry, the
architecture and the supply of nutrients to meet the metabolic demands of
the cells. With this experiment we investigated 2 of the main cues which
are known to influence hepatocyte function, a 3D topology and convec-
tive flow. Several investigators have shown that cell culture in 3D rep-
resents a more physiologically relevant environment. However the extent
to which this influences hepatocyte function with respect to the provi-
sion of oxygen and other nutrients is unclear. Moreover, the relationship
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between the topological features of a scaffold and hepatic function have
not been studied in depth [89]. Hepatocyte function on three-dimensional
micro-fabricated polymer scaffolds realized with the Pressure Activated
Microsyringe (PAM) [103, 104, 105] was tested in static and dynamic
conditions. Hepatocyte cell density, glucose consumption, and albumin
secretion rate were measured daily over a week.
4.2.1 Material and methods
Since primary hepatocytes rapidly lose liver morphology and differen-
tiated functions in vitro, in this study we used the HepG2 cell line as
an alternative model cell. HepG2 cells maintain the main synthetic and
endogenous functions of primary hepatocytes, as well some exogenous
metabolic functions [106]. The cells were grown in Eagle minimal essen-
tial medium (EMEM, 1 gL glucose) supplemented with 5% foetal bovine
serum, 1% non-essential amino acids, 1% EMEM vitamins, 2 mmol L-
glutamine, 100 Unit/mL penicillin and 100 µg/mL streptomycin)7 in a
humidified incubator at 37◦C, 5% CO28. The cells were all used at the
same passage (no. 22 after receipt) and passaged using 0.05% trypsin
with 0.02% EDTA in PBS. Cells were seeded (105 cells/c2m) on the films
or scaffolds using 2 mL of complete medium per well. After 24 hours, the
structures were moved to a new microwell plate to eliminate interference
from non-adherent cells. Both scaffolds and films were coated with an
alginate film consisting of 250 µL 1% sodium alginate dissolved in serum-
free medium, cross-linked with 50 µL 1% CaCl2
9. Excess alginate was
removed with a pipette. The resulting film had a thickness of a few tens
7All reagents from Eurolone, Milan, Italy, unless otherwise specified.
8Heraeus SpA, Milan, Italy.
9Sigma-Aldrich, Milan,Italy.
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of microns as measured by an optical profilometer10, having a nominal
resolution of 1 µm. The profilometer uses a small laser spot (0.7 mm X
0.5 mm) which is reflected off a surface. Displacements were calibrated
using an uncoated glass slide as a reference. The coating was not uniform
and flat as observed by an optical microscope, and this was also reflected
in the scatter of the profilometer readings across the slide (40 - 100 µm).
At the low alginate concentrations used, the diffusion coefficient of oxy-
gen and of small solutes is similar to water [107, 108]. Finally, 2 mL
fresh medium was added to each well to begin the experiment. Cells were
maintained on the structures for a week and cell counting and medium
collection was performed daily. The experiment was performed in trip-
licate using 21 structures (3 series of seven bioreactors ran in parallel
through a multi way peristaltic pump) three samples were removed for
counting per day, and the culture medium was changed every third day
(figure 4.2). Medium was perfused through the chambers at a flow rate
of 250 µL/min.
Figure 4.2: In vitro liver experiments organization; every day a chamber
from each series is unplugged and analyzed. The three series of seven
bioreactors are connected as separated circuits to the peristaltic pump.
In addition up to 200 µL of media (50 µL per assay) was withdrawn for
10Opto NCDT, model ILD1400-10, UK.
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analysis at fixed intervals. All cell culture experiments were carried out in
the same incubator. The cells adhered on the structures were trypsinised
and counted using a Burker chamber. Cell viability was evaluated using
tryptan blue exclusion, and this was always greater than 95%. Because
the 3D scaffolds are composed of 3 layers of hexagons, the “true” area
available for cell adhesion is difficult to estimate. Therefore we use the
term “nominal area” to refer to the effective surface area which the scaf-
fold or film occupies in the well or bioreactor. Cell densities are expressed
as the total numbers of cells counted divided by the nominal 2D-surface
area of the samples. The PAM scaffolds have a nominal surface area of
0.8 c2mand a large percentage of this is free space of the pores, while the
spin-coated films have an area of 1.33 c2m.
Albumin production, was measured as previously described 4.1.1, glu-
cose consumption was quantified using a commercial enzymatic kit 11. In
order to compare data from different experiments with different cell num-
bers and media volumes the glucose and albumin data are expressed as
quantities consumed or produced per cell per day.
4.2.2 Results of In-vitro Liver Experiments
Before testing the different hepatocyte costructs in the MCmB a com-
parison between 2D films and 3D scaffolds in static culture was done.
The cell density was higher on the scaffolds than on films particularly
from day 4 onwards (ANCOVA12, p < 0.01). The cells on the 2D films
consumed a higher quantity of glucose than 3D scaffolds in the first two
days. After this period, the glucose consumption per cell was constant
and similar to that of the 3D scaffolds. Albumin is one of the functional
11Megazyme International Poncarale, Italy.
12Analysis of covariance (ANCOVA), Matlab Statistics Toolbox, The Math-
Works Inc.
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marker proteins of the liver. Human albumin was produced in similar
quantities by 3D scaffolds and 2D films during the experiment.
In the bioreactors, the cell density increased smoothly over time and
density values were similar to those in static conditions. Glucose con-
sumption was higher in the MCmB with a constant consumption rate
of 7.6±0.1 ηg/(cell/day) (p=0.0001 ANCOVA) with respect to the 3D
scaffold in static conditions (5.2±0.2 ηg/(cell/day), p=0.001, ANCOVA)
(figure 4.3.a). Therefore the cell energy requirements are greater in the
bioreactor, and glucose is used as a substrate. This may be due to an
upregulation of liverspecific synthetic function in the bioreactor.
As shown in figure 4.3.b a large increase in albumin production per
cell was observed in dynamic culture, particularly in the first 2 days;
albumin production was 10 times higher in the MCmB than in static
conditions and then decreased progressively maintaining a value 4/5 times
greater than in static culture. In fact, the average albumin production
in the bioreactor over the 7 days was 3.12±0.43 ηg/(cell/day), compared
with 0.65±0.16 ηg/(cell/day) (p=0.02, ANCOVA) in the static conditions
scaffolds . To ensure that the increased albumin production was not due
to the increased volume of medium in the bioreactor, a final experiment
was performed using 3D scaffolds cultured in 50 mm Petri dishes in which
the total medium volume was 10 mL. The albumin production rate was
0.50±0.14 ηg/(cell/day) over the 2 day period of analysis, indicating that
the volume of medium does not influence the secretion rate of this protein
in static conditions.
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Figure 4.3: (a) Cell density (defined as cellnumber
nominalarea(c2m)
for PLGA scaf-
folds in the bioreactor and in static conditions and (b) Albumin produc-
tion rate in static and dynamic conditions for PLGA 3-D scaffolds (in
both case n=3 per data point).
4.3 MCmB Bioreactor Tests with Skele-
tal and Epithelial Tissue Cells
Articular chondrocytes are well known to respond to mechanical forces in
the native tissue by synthesizing matrix components (e.g. collagen II and
proteoglycans). This ability is rapidly lost in monolayer culture due to cell
de-differentiation resulting in a more ’fibroblastic’ phenotype in which the
cells do not synthesize the matrix components found in native cartilage
[109]. For example, collagen I is synthesized by chondrocytes instead of
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collagen II and little aggrecan, the main proteoglycan of native tissue, is
produced. Therefore early passage cells (P1) maintain more chondrocyte
features than later passaged cell (e.g. P4). In these experiments the
effect of flow rate on passage number was determined in extended culture
in monolayer to see if the cellular response to shear stress was changed
with passage number.
4.3.1 Materials and methods
Cartilage cells (chondrocytes) were isolated from bovine metacarpopha-
langeal joints and cultured as described in [110]. Human oral fibroblasts
were isolated from biopsies of oral tissues obtained with consent under
appropriate ethical approval from patients undergoing oral surgery pro-
cedures 13. Rat osteosarcoma cell lines ROS 17/2.8 were a commercial
frozen cell line.
For experiments using monolayer cultures the Condrocyte, fibroblasts
and ROS experimental protocol was the same. 500 x 103 cells were seeded
onto Petri dishes with 5 collagen-coated glass 12 mm coverslips and left
for 48-72 h for the cells to attach and become confluent. In the expansion
phase DMEM medium added with 10% FCS and 10µL/mLof FGS was
used. When at confluence the cell cultures were examined microscopically
and photographed. Two coverslips were placed in individual bioreactor
culture chambers to form the test groups and two more coverslips placed
in open MCmB 2.0 chambers (only the bottom part of the chamber was
used) to form the control group. The bioreactor was connected up to
the mixing chamber and the peristaltic pump and placed in an incubator
(37◦C, 5% CO2 atmosphere). The two bioreactor circuits were filled with
10 mL of DMEM medium added with 5% FCS and no FGS [111] in or-
13School of Clinical Dentistry, Sheffield, Uk.
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der to promote the matrix prodution phase instead of the expansion one.
The cells were either left without perfusion (static bioreactor culture con-
trol) or perfused with culture medium in the bioreactor chambers for 24h
(perfused cultures). At the end of the incubation time the coverslips were
removed from the MCmB and transferred into small culture dishes and
covered in medium to check cell morphology and viability by microscopy
and by quantitative measurement of reduction of the vital dye Alamar
Blue14 as described in[112].
Figure 4.4: Assembly of two flow experiments in MCmB 2.0 bioreactor.
In this experiment two MCmB kits were used, in order to run in parallel
two experiments with different flow rates.
3D cartilage constructs of bovine articular chondrocytes were pre-
pared by culturing the cells on scaffolds of polyglycolic acid (PGA) as
described in [110]. Bovine articular chondrocytes at P2 were seeded onto
PGA scaffolds (5x2 mm, 4 · 106 cellsscaffold). The resultant chondrocyte scaf-
fold construct was incubated on an orbital shaker for a total of 14 or 21
14Invitrogen.
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days to allow initiation of chondrocyte differentiation and extracellular
matrix deposition. Constructs were either transferred to the bioreactor
chambers (1 construct per chamber) or kept under static conditions in the
same volume of medium used for the bioreactor circuit (10 mL). After
incubation, the constructs were removed and the level of cell activity was
measured. The constructs were then analyzed for matrix production by
quantifying the levels of sulphated glycosaminoglycans (GAGs) in both
constructs and culture media. GAG quantification is a measure of the
amount of one of the main cartilage matrix components, proteoglycan.
3D constructs of human fibroblasts were formed by culturing the cells
at passage 3 on the commercial collagen support Alloderm c©15. Con-
structs were transferred to the bioreactor chambers (one per chamber) and
perfused with appropriate medium (10 mL) for 24h or kept under static
conditions in the same volume of medium used for the bioreactor. Proteo-
glycan production was determined by measurement of the glycosamino-
glycan content of the tissue constructs and media using dimethylmethy-
lene blue as described in [113]. The constructs in the bioreactor were
perfused with medium at a flow rate of 110 µL/min. After incubation,
the constructs were removed and the level of cell activity was measured
using Alamar Blue dye, a resazurin-based fluorescent compound metab-
olized by mitochondrial cytosolic and microsomial enzymes to resorufin
which can be detected with a fluorimeter at 573 nm.
152009 LifeCell Corporation.
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4.3.2 Effect of bioreactor conditions on mono-
layer cell cultures
Effect of flow rate on bovine chondrocytes at different pas-
sage number
Table 4.1 shows micrographs of condrocyte mono-layers at different pas-
sages before and after 24 hours in the MCmB 2.0 compared with their
static counterparts. P1 cells do not show any signs of damage after 24h
at 110 µL/min, the cells are morphologically similar to the static control
but it is possible to observe a reduced deposition of ECM products on the
coverslips (background of the picture has a higher contrast). This could
be due to the effect of flow which continuously removes the ECM pro-
duced by the cells. Therefore in these conditions cells are stimulated to
increase their matrix productivity because they do not reach steady state
concentrations in the vicinity of the cells. At 290 µL/min P1 cells show
signs of damage, the number of rounded dead cells is high and adhered
cells are more elongated and spread.
For the P4 cells culture, signs of damage are evident even at 100
µL/min. Increasing the passage number, chondrocytes de-differentiate to
a more fibroblastic phenotype. The condrocyte de-differentiation process
can be also observed by a comparing the morphlogy of P1 and P4 con-
trols. P4 cells show a more spread shape with a preferential direction
of elongation. As is well known, fibroblast are not able to support shear
stress and for this reason chondrocyte cultures with high passage numbers
are damaged by flow as demonstrated by these experiments.
As shown in figure 4.5 a and b, for a flow rate of 110 µL/min the
viability of P1 chondrocytes was around 20% higher than the controls.
The wall shear stress on the cell surface at this flow rate is in the order
of 3.510−6 Pawith a flow average residency time of 20 minutes. In the
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Table 4.1: Effect of flow rate at different passages in the MCmB 2.0 on
the cellular morphology of monolayer cultures of bovine chondrocytes.
P1 static control P1 after 24h @ 110µL/min P1 after 24h @ 290µL/min
P4 static control P4 after 24h @ 110µL/min P4 after 24h @ 290µL/min
in-vivo environment articular cartilage is mechanically stimulated by the
movement of synovial fluid over the surface of the tissue. This stimulus
is critical for maintaining the unique mechanical properties of cartilage.
In the MCmB 2.0 chambers this process is mimicked through flow me-
diated shear stress. The continuous removal of ECM products results in
a higher metabolic demand because the cells are induced to upregulate
ECM production with a consequent increase in mitocondrial activity.
For flow rates higher than 200 µL/min P1 cells also show signs of
damage and detached dead cells could be observed. P4 chondrocytes at
295 µL/min clearly show a large degree of cell damage and in this case
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Figure 4.5: Normalized viability of chondrocyte cultures after 24h in
MCmB 2.0 at different flow rates. Graphs a and b show how the flow
rate influences cell viability and how fibroblast cultures with high passage
number are unable to support shear stress.
the viability is less that than 50% of the controls.
Effect of increasing flow rate on human oral fibroblasts
Due to the low chamber volume, the MCmB 2.0 system does not require
a high number of cells, and it is consequently possible to use human
tissues extracted during surgery or biopsy. In this experiment oral mucosa
tissue extracted during implantation procedures were used as a source of
human fibroblasts. The MCmB 2.0 was used to test the effects of flow
rate and shear stress on human oral fibroblasts in order to investigate
the difference between of chondrocytes and fibroblasts when exposed to
shear stress. Fibroblasts at the same passage number were used for these
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experiments. Perfusion rates up to 195 µL/min had no apparent effect
on fibroblast morphology (Table 4.2). Higher perfusion rates caused the
fibroblasts to round up and detach from the glass coverslips. Changes in
fibroblast morphology were reflected by greatly reduced changes in cell
activity that were more marked than those observed in P1 chondrocytes
cultures at the highest flow rate.
Table 4.2: Effect of flow rate in the MCmB on the cellular morphology
of monolayer cultures of human fibroblasts.
Static Static
110µL/min 195µL/min
295µL/min 400µL/min
Figure 4.6 compares the viability at different flow rates for P1, P4
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chondrocyte and fibroblast cultures. The P4 chondrocyte curve is more
similar to the fibroblast curve than to the P1 because of the phenotype de-
differentiation effect. P1 chondrocyte cultures are stimulated to increase
viability and ECM turnover by the gentle laminar flow and shear stress
at 110 µL/min. On the other hand P4 chondrocytes and fibroblasts do
not support this level of stimulation.
Figure 4.6: Viability comparison at different flow rates for different
cell types. The Chondrocyte culture with low passage number are able to
support shear stress and have increased viability at 110 µL/min, while
high passage number chondrocytes and fibroblasts are not able to support
shear stress induced stimulation.
4.3.3 Effect of increasing flow rate on monolayer
cultures of a ROS osteoblastic cell line
Preliminary observations indicate that incubating the ROS cells at low
flow rates (110 µL/min and 195 µL/min) had a stimulatory effect. The
microscopy analyses did not show any morphological changes due to the
flow.
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Figure 4.7: Effect of flow rate on viability of monolayer cultures of ROS
osteoblasts.
4.3.4 Effect of bioreactor conditions on 3D cul-
tures
A set of experiments with 3D constructs of different cell types was per-
formed in order to investigate the differences between mono-layers and 3D
cultures when exposed to shear stress stimulation in the MCmB 2.0. As
shown in figure 4.8 the 14-day chondrocyte constructs incubated in the
bioreactor had a higher cellular activity compared to the static controls.
These stimulated constructs also demonstrate a 45-60% increase in the
total amount of GAGs dissolved in the constructs with a similar increase
in their proteoglycan content.
The stimulated construct was also shown to have increased levels of
GAG in the medium (double that of controls), indicating an upregulation
of the matrix synthesis rate (Table 4.3). These results indicate that the
bioreactor significantly enhanced matrix synthesis over the static control.
Mechanical stimulation is known to enhance matrix production, and as
mentioned previously, the flow conditions in the bioreactor are capable of
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Figure 4.8: Effect of a 72h culture period in the bioreactor on construct
cellular activity normalised to construct wet weight at a perfusion rate of
110 µL/min.
reproducing this stimulus. In summary, chondrocytes are stimulated to
matrix production by flow in the MCmB 2.0. The mechanical stimulation
and continuous removal and dilution of cellular products helps to maintain
the chondrocyte culture in the matrix production phase, as a result the
cells have a higher viability and show a considerable increase in matrix
production rate.
In contrast, after incubating the 21-day construct in the bioreactor
there were no significant changes in cell activity (Figure 4.8) or an in-
creased accumulation of GAGs into the construct matrix. However, a
small increase in GAGs is detected in the medium compared to the static
control (Table 4.3). This would suggest that there was some increase in
GAG synthesis but not in incorporation into the extracellular matrix of
the construct and this could be due to the “age” of the construct. These
experiments show that the 14-day construct cells are in a more active
phase and their metabolic activity can be driven to the matrix produc-
tion, whereas the 21-day construct seems to be in a quiescent phase in
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which the matrix levels are established and the cells are in a sort of steady
state of ECM production. These experiments suggest that chondrocyte
matrix production can be induced and stimulated by gentle flow and shear
but only for ”young” (14 day) constructs made with low passage cells (P1)
that do not suffered from the the chondrocyte de-differentiation process.
Table 4.3: Effect of 72h bioreactor culture at a perfusion rate of 110
µL/min on proteoglycan accumulation in 14 and 21 day cartilage con-
structs.
GAGs in
medium
µg/mL
GAGs (% of
matrix dry
weight)
Total GAGs in
each construct
µg
Construct wet
weight µg
Static control 1.95±0.25 15.75±2.12 219.05±42.22 18300±2923
14 Day construct 4.25±0.25 24.75±3.95 363.05±10.15 15100±2100
21 Day construct 4.9±0.6 16.55±0.15 214.65±1.85 16450±250
The construct experiments were also performed with fibroblast cul-
tures in order to investigate if a 3D organization can enable fibroblast
cultures to withstand shear stress. The experiment was conducted in-
serting a 14-day fibroblast construct in the bioreactor and stimulating it
with a flow rate of 110 µL/min for 72h. The results showed that even in
3D culture, fibroblasts are unable to support shear stress and cell viability
is reduced to 26±1.1% in comparison with static controls.
These experiments demonstrate that the MCmB 2.0 chamber is not
only a modular bioreactor for the construction of in-vitro organ models
for metabolic and toxicity studies, but can also be used as a cell culture
stimulation unit, in which experiments can be designed with different
types of stimuli applied to connected cultures, allowing investigation of
tissue and organ physiopathology in an more in-vivo-like environment.
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Figure 4.9: Effect of 72h bioreactor culture at a perfusion rate of 110
µL/min on proteoglycan medium and matrix accumulation in 14 and 21
day cartilage constructs.
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Chapter 5
Stimulus Specific Chambers
Design and Realization
5.1 SQPR SQueeze PRessure stimula-
tion Chamber
Articular cartilage serves as the load-bearing material of joints, with ex-
cellent friction, lubrication and wear resistance characteristics [114]. It
is a white, dense, connective tissue, from 1 to 5 mm thick, that covers
the bony articulating ends inside the joint. It consists of two phases, a
solid organic matrix (50% mass by dry weight collagen fibrils and 20-30%
mass by dry weight proteoglycan macromolecules)[115] [116] [117] and a
mobile interstitial fluid phase (predominately water) [118]. In humans,
chondrocytes contribute only about 1% of tissue volume [119] and main-
tain this matrix, synthesizing and secreting extracellular matrix, to bal-
ance extracellular degradation and matrix turnover. The biomechanical
properties of articular cartilage are dependent on the integrity of the col-
lagen network and on maintenance of a high proteoglycan content within
the matrix. Expression of the genes for aggrecan and link protein, two
major components of the aggregates of protepglycans, can be modulated
by mechanical forces [120, 121, 122, 123, 124] as well as chemical stimuli
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(growth factors and cytokines). Diseases of hyaline cartilage represent
one of the major health problems especially in industrialized countries
with high life expectancy [125]. Due to its avascular nature, cartilage
exhibits a very limited capacity to regenerate and to repair. Moreover, it
has been stated that the natural response of articular cartilage to injury
is variable and, at best, unsatisfactory. The clinical need for improved
treatment options for the numerous patients with cartilage injuries has
motivated tissue engineering studies aimed at the in vitro generation of
cartilage replacement tissues (or implants) using chondrocyte-seeded scaf-
folds [126, 127, 128, 129]. The normal loading environment of chondro-
cytes involves a combination of intermittent cyclical fluid pressurization.
Under normal conditions, chondrocytes are able to balance their synthetic
and catabolic activities to maintain the integrity of articular cartilage in
vivo. In order to restore aspects of the articular physiologic environment
in vitro an innovative stimulation chamber was developed.
5.1.1 Material and methods
In this section the simulation and design of an innovative cell culture stim-
ulation chamber is described. The SPQR (SQueeze PRessure) bioreactor
chamber is designed to impose a cyclic hydrodynamic pressure that repli-
cates the physiological environment of the joint on different types of cell
cultures or tissues slices. One of the most important features of the SPQR
chamber is the ability to generate a squeeze pressure without requiring
any contact with the samples. The SQPR chamber was designed through
analytic and FEM models in order to simulate the fluid-dynamics of the
chamber and to verify the squeeze pressure generation principle. After
model validation the chamber was designed, realized and tested together
with its control unit (P.GIO)2.
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Analytical and FEM analysis
The fluid dynamics inside the bioreactor can be described using the fluid
film lubrication theory. The introduction of a fluid film between two mov-
ing and rough surfaces provides a lubricating effect which substantially
reduces the coefficient of friction between them [130]. Such films are usu-
ally sufficiently thin such that viscous forces are large in comparison with
inertia forces, so that the latter may be neglected.
The fluid dynamics of the SQPR bioreator was simulated from an
analytical and numerical point of view. The analytical model does not
consider the presence of the external walls, for this reason a complete
FEM model is required in order to evaluate how the chamber walls influ-
ence squeeze pressure generation.
The analytical model stems from Reynolds equation which describes
fluid flow in a narrow gap with well defined dimensions and geometry. In
its most general form, the Reynolds equation has the following form:
∂
∂x
(
ρh3
µ
∂p
∂x
)
+
∂
∂y
(
ρh3
µ
∂p
∂y
)
= (5.1)
6(U1 − U2)∂(ρh)
∂x
+ 6ρh
∂
∂x
(U1 + U2) + 12
∂(ρh)
∂t
where x, y are mutually perpendicular coordinates within the fluid,
p is the local pressure within the film, ρ and µ are the density and ab-
solute viscosity of the lubricant, and h is the film thickness, and U1 and
U2 are the velocities of sliding of upper and lower surfaces respectively.
The physical significance of this equation is that the generation of hydro-
dynamic pressure within the film is a function of three terms the wedge,
stretch, and squeeze contributions to load support.
Pressure generation inside the bioreactor is based on the squeeze con-
tribution, which is due to normal approach of the surfaces, whether or
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not sliding motion occurs between them. The term squeeze films applies
to the case of an approaching surface (usually planar) which attempts to
displace a viscous liquid between them.
p(r)− pa = 3µV
h3
R2
(
1− r
2
R2
)
(5.2)
v =
3V r
h3
z(z − h) (5.3)
Figure 5.1: a)Pressure and b) Velocity analytical profiles.
Is possible to note that v is a function of three coordinates, r, h and
z, of which only h is time-dependent. This equation shows clearly that
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at any fixed h and radius r the velocity distribution is parabolic over the
cross-section of flow and its mean value at a fixed height increase linearly
with r. Shear stress at bottom (τw) site can be obtained from Newton’s
viscosity law from equation 5.3, fixing z=0
τw = −3µV r
h2
(5.4)
In order to simulate the hydrodynamics of the SQPR bioreactor the
commercial software COMSOL Multiphysics1 was used. The Axisymmet-
ric Incompressible Navier-Stokes for Newtonian flow (constant viscosity)
application mode was used to calculate the velocity field u, pressure dis-
tribution p and shear stress on the bottom wall.
Figure 5.2: SQPR FEM model scheme.
1COMSOL Multiphysics is a registered trademarks of COMSOL AB.
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The geometry, designed as in figure 5.2, represents the culture medium
filled domain, and it is characterized by a density of 1000 kg/m3 and
a viscosity of 0.02 Pa s. Predefined elements type Lagrange - P3 P2
was chosen. Boundary conditions are set as follows (referred to the wall
indexes of figure 5.2): (1) Symmetry boundary - Axial symmetry, (2-3-4-
5) Wall - No slip, (6) Outlet - Pressure with no viscous stress - P0=0 Pa,
(7-8) Wall - Moving/leaking wall - Uw=0, Vw= vel and (9-10) Continuity.
In our model vel is the piston velocity and it is equal to -0.0116 m/s
during the approaching phase and 0.002 m/s in the retraction phase.
Mapped mesh (594 elements) was obtained fixing the number of edge el-
ements on boundary 1-2-3-7 respectively to 9-42-12-4 linearly distributed
elements. A 3D model was also obtained by rotating the 2D geometry
around the z-axis and by extrusion of coupling variables p, u, v, and
K r ns. Models were implemented in COMSOL Multiphysics 3.4 and
solved with the UMFPACK direct solver (in a parametric mode with
parameter vel)2.
SQPR chamber design and realization
The main purpose of this design was to realize a bioreactor chamber able
to impose hydrodynamic pressure stimulation on cell cultures without
requiring complicated machines or protocols. For this reason the design
and realization process was driven by few key points:
• Easy and fast to use
• Contactless stimulation
• Allow long time stimulation protocols without requiring disassem-
bly and restarting the experiment
2Ran on a Macbook 5,1 (Intel COre 2 Duo, 2GHz CPU) running Mac OS X.
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• Allow easy sample collection during all the stimulation phases
• Possibility to use different types of tissues, constructs or cover slips
with different thickness in the chamber
• Allow adequate oxygenation
• Light, small and transparent
The design process was aimed at exactly replicating the FEM model
dimensions 5.2. The FEM piston was 14 mm in diameter and 10 mm
height, we decide to split the piston in two parts, the head and the shaft,
in order to simplify the bioreactor assembly and the cleaning phase. The
head is the real functional part and it was designed with the same diam-
eter as the FEM model (figure 5.3.b). The shaft diameter was reduced
to 6 mm (figure 5.3.e) in order to minimize the weight of the system and
the tolerance of this part was imposed to be very low (H7) in order to
obtain a perfect alignment and parallelism of the system.
The shaft was drilled on the top and threaded for the linear motor
coupling, a cavity was designed in the top part in order to allow a seeger
insertion used as excursion limit. The excursion limit is useful during
the assembly phase when the piston shaft is not coupled to the motor
and it can slide down and impact with the cell surface during the SQPR
experiment assembly.
The external part of the chamber is designed as a cylinder (figure
5.3.a) in order to reproduce the FEM dimensions, and have internal end
external diameters respectively of 18 mm and 25 mm. The external height
of the chamber is 65 mm but the internal cavity where the medium is
inserted is only 40 mm. The top part is necessarily thick to allow a
perfect linear motion of the piston inside the chamber and to ensure a
high parallelism of the piston and cell support surfaces. The piston shaft
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and the hole where it is inserted are both grinded and a H7 tolerance is
required.
The chamber external cylinder have a base larger than the body (50
mm), that fits on a quick snap fixing system designed on the SQPR hold-
ing frame. The internal diameter of the chamber is also grinded in order
to allow a perfect linearity of the wall. The high dimensional accuracy
of the internal cavity is critical factor due to the fact that the distance
between the piston head and the internal chamber wall is very important
in the hydrodynamic pressure generation principle (the presence of the
wall is the difference between the analytical and FEM model5.1.1).
The SQPR chamber has also two holes near the top of the internal
cavity to allow sample collection during the experiments. The cavity holes
are also important for medium oxygenation and they have a diameter of
4 mm in order to allow a perfect fit of the standard syringe and Luer-
Lock connectors. In fact, during the experiment the holes are closed
using syringe filters in order to prevent any contamination and allowing
incubator atmosphere to diffuse in the SQPR cavity.
The SQPR bottom is made of two parts, the base and the samples
brace. The base is an aluminum disc of 65 mm in diameter and 10 mm
thick (figure 5.3.f), it is an holder for the brace and it is not in contact with
the medium. The braces are various and they can be changed depending
by the used sample (fresh tissues, gels, cover slips etc), they are made
of Derlin, with a diameter of 18 mm and a height (H)3 of 12 mm. The
braces have two cavities with a diameter of 14.9 mm for the O-Ring
insertion that sealed the system preventing medium leakage from the
internal SQPR cavity (figure 5.3.c,d).
3(H) is the distance between the aluminum base and the surface where the
samples are placed.
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The braces are used as tissue supports, but they have to prevent the
piston impacting with the cell cultures during the “finding home” rou-
tine2.1.2. The impact is avoided through a 1.5 mm thick ring realized on
the brace top (figure 5.3.d), where the cultures are inserted, the different
braces present rings of various thickness in order to allow the insertion in
the culture cavity of different samples/constructs such as fresh tissues or
scaffolds.
Figure 5.3: The SQPR bioreactor parts: a) The Plexiglass chamber with
the stimulation cavity, b) The piston Derlin top part, c) The basic sample
bracer, d) The sample bracer with ring, e) The piston shaft and f) The
aluminum base (parts are not equally scaled).
The basic brace have no ring on the top surface, the other braces are:
• scaffold brace (ring height 2 mm)
• cover slips brace (ring height 1 mm)
• fresh tissue brace (ring height 3 mm)
• Gel construct brace (ring height 5 mm)
The aluminum base and the Derlin braces are coupled through a screw
threaded on the brace bottom. The SQPR bioreactor requires a frame
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system where the linear stepper motor is fixed and where the SQPR
chamber is inserted after sample insertion. The SQPR frame system has
to be light, easy to assembly and clean and has to allow easy sample
collection. The frame system is made of three Nylon plates assembled
together with screws and two columns used as a support to be placed in
the anterior part of the system in order to ensure stability of the frame
during the stimulation. The vertical plate of the frame is drilled and
threaded, the horizontal plates have holes with cavities for the insertion
of screws. The bottom horizontal plate has a small cavity to assist the
SQPR chamber alignment phase and it is equipped with the fast plug
holding system. The fast plug holding system is composed of two L-
shaped Derlin plates screwed on the bottom of the frame and where the
SQPR aluminum base has to be inserted. The tolerance between the
SQPR base and the L shaped holders is very low and this allows the
entire system to be solidly held together. The top vertical plate of the
frame is where the linear stepper motor is fixed, a 6 mm in diameter
hole at the center allow the motor shaft to be connected with the SQPR
piston shaft and two screws are used to fix the motor to the top frame.
The motor is protected from the humid incubator environment through
a case, coupled through a flat round gasket to the top part of the frame,
where the motor cable is inserted through a water proof connector (figure
5.4.b).
The two frontal columns are made of nylon and they are inserted in
the system only before starting the experiments. They are required to
prevent any deformation of the frame as consequence of the finding home
procedure where the motor pushes the piston to the base of the SQPR
chamber for 2 seconds (impacting with the brace ring). In fact if frame
deformation occurs during the finding home procedure, the piston align-
ment is compromised and the generated pressure will be uncharacterised.
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Figure 5.4: a) The SQPR stimulation unit assembled and b) The SQPR
bioreactor in its framework during setup of an experiment.
The frontal columns reduce the working space of the SQPR system but
sample collection and disassembly are still possible.
5.1.2 SQPR design and model validation
FEM models results
In this section a comparison between the analytical and FEM models
is presented in order to demonstrate the validity of the finite element
approach to solve the complex SQPR bioreactor fluid dynamics. The
analysis was performed for a piston approaching phase that stops 300 µm
(piston channel height) over the cell culture, with an approaching and
retraction speed respectively of -0.0116 and 0.002 m/s. Figure 5.5 shows
a comparison between the FEM and the analytical model of the SQPR
bioreactor environment. The difference in calculated pressure between
the two models is 7% (which corresponds to 89 Pa) (calculated at the
center of the chamber) during the approaching step and it is due to the
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over-pressure determined by the bioreator walls that are not considered
by the analytical model.
Figure 5.5.e shows the velocity field during the approaching phase.
The modulus of the velocity increases with the radial coordinate as in
the analytical model and present a parabolic profile in each section. The
differences in shear stress at the cell surface are shown in figure 5.5.c, 3D
plots of pressure distribution and shear stress in the channel are shown
in figure 5.5.b and d.
SQPR chamber preliminary tests
A set of preliminary tests oriented to verify the SQPR chamber assembly,
sealing and functionality was performed. The chamber was completely
disassembled and all its parts washed in ethanol in order to simulate
and identify any problem related with the classical sterilization process.
After rinsing all the bioreactor parts with PBS, the system was assembled,
connected with the linear motor and the SQPR cavity filled with 4 ml
of DMEM medium. The SQPR stepper motor was connected with the
P.GIO system and a squeeze pressure experiment started. During this
preliminary experiment the oxygenation holes were closed in order to
prevent medium evaporation and the medium level monitored every 6
hours for 2 days. During the experiments no medium reduction was
noted indicating that the chamber is correctly sealed, the piston range
was also monitored and after 48h no shifts were noted indicating that
the P.GIO system and the SQPR motor are able to support long term
experiments. All the calibration and free movement procedures were also
tested and sample insertion procedures were also simulated and found to
be essentially smooth and trouble-free.
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5.2 VSC Vascular Stimulation Chamber
Smoking, stress, lack of a suitable physical training, a fatty diet are all
determinant factors of setting in vascular diseases, and are the primary
causes of death in industrialized countries [131, 132]. Despite the large
quantity of studies on this subject the precise relationship between these
risk factors and the pathogenesis of these diseases is not completely un-
derstood at biochemical and mechanical level [133, 134, 135]. It is well-
known that the shear stress influences the physiology of vascular tracts,
but the difficulty of modulating the forces that act on them does not allow
the determination of precise quantitative effects [136]. This shortage of
knowledge affects the cure. Autologous vascular grafts are the only vas-
cular substitutes with long term patency [137]. This surgical technique is
limited by poor availability of donor sites. For this reason we designed and
realized a bioreactor able to reproduce the physio-pathological situations
of a vascular tract with an inner diameter of less than 6 mm.
This device has two possible applications:
• To engineer vascular conduits that can be used as grafts for the
cure of main diseases of vascular system, due to scarce mechanical
and biological properties of commercial grafts.
• To study the relationship between the different components of a
blood vessel at the biomechanical and biological level.
In a previous study, the vessel chamber was modeled through analyti-
cal and a finite element analyses in order to establish a working geometry
to mimic the physiological environment and to determinate the biore-
actor’s working window. The system was designed and realised in way
to be manageable, low volume, low cost and amenable to easy medium
sampling.
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The system has been tested in terms of fluid dynamic characteristics
in order to verify the correspondence with the models developed. More-
over its capacity to modulate the mechanical properties of the vascular
tract has been performed by subjecting porcine blood vessels to several
transmural pressures, simulating different physio-pathological states.
5.2.1 Material and methods
Analytical and FEM analyses
Many studies present in the literature have proposed vessel chambers for
vascular characterization [138, 139] without an adequate analytical and
finite element models, able to evaluate the correlation between physiolog-
ical stresses and those induced by the systems induced. The first step of
the analytic analysis of the bioreactor starts from a fluid-dynamic point
of view. The absence of turbulent flow in the bioreactor is validated by
the low Reynold’s number of the system. Combining Reynolds number,
friction Fanning parameter and Bernoulli’s equation, the hydraulic circuit
has been studied, evaluating the pressure drop along it. The mechanical
analytical model has been developed comparing the vessel placed in the
culture chamber with a pressurized elastic tube locked by a rigid flange
5.6
The vessel wall, of radius R, thickness h and elastic modulus E, reflects
the Hooke’s law, which, in a cylindrical coordinate system and in MKS
units, can be expressed as:
σzz =
E
1− υ2 (zz + υθθ) (5.5)
σθθ =
E
1− υ2 (θθ + υzz) (5.6)
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Whereas radial stress can be neglected using the thin wall approxi-
mation. Solving these equations with boundary conditions of constant
pressure inside the vessel, longitudinal stress equal to zero and negligible
shear stress, the final result is:
Wrr =
pR2
Eh
[1− e−kz(sin kz + cos kz)] (5.7)
The previous formula 5.7, where p is the pressure, shows how the ra-
dial displacement W varies as function of longitudinal coordinate: after
an initial transient, due to the stress shielding of the flange, the displace-
ment is close to Laplace’s law after a fixed distance from the inlet. The
parameter k depends on the geometry and on the mechanical properties
of the materials.
A FEM model developed with COMSOL Multiphysics4 allowed esti-
mation of strains, shear stresses, transmural pressure and flow inside the
vessel 5.7.
Vascual stimulation chamber realization
A bioreactor chamber have to be made of a biocompatible, easy to work,
low cost, sterilizable, and transparent material in order to allow the di-
rect analysis of experiments. It should also have small dimensions. A
bioreactor should be easy to use even for a non-specialised operator, and
its sterility should be conserved for a long time. For this reason, the ves-
sel chamber wasrealised by casting Poly-dimethylsilosane (PDMS)5. The
mould was made in aluminum according to the technical requirements
and the results of FEM modeling analysis. The cell chamber is composed
of two modular parts, easy to assemble with a water tight seal. The
4COMSOL Inc, Burlington,USA.
5Dow Corning, USA.
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PDMS is cast in the mould, cured in an oven at 60◦Cfor 4 hours and then
peeled off.
The vessel chamber is composed of:
• A top, in which silicone tubes are mechanically inserted and sealed
to connect to the perfusion system. These tubes allow insertion of
the connectors for the locking of the perfused vessel
• A bottom, which, once assembled with the top, creates small inter-
nal volume where the vessel is bathed in a culture medium
The vascular stimulation chamber has two inlet and two outlet con-
nections, two for the intra and two for the extra vessel medium circulation,
all these connections are fabricated by inserting standard Luer Lock con-
nectors into the silicone 5.8.a. To increase the seal of vessel chamber the
two parts are clamped between two Derlin plates and held with screws.
5.8.b.
The vascular stimulation chamber can be connected to the SUITE
platform for maintenance of the culture environment or used as a free
standing application in an incubator. In both case the transmural pres-
sure is achieved through the P.GIO 2 dedicated unit.
Vascular pressure generator design and realization
The Vascular pressure generator design is based on a classic syringe pump
used to compress a reservoir of medium connected in parallel to the intra
vascular medium circuit. The pressure generator is made by a sliding unit
where the syringe is placed and actuated. The sliding unit is actuated
through a 12 VDC motor equipped with an encoder used for the position
feedback. The sliding unit is equipped with a safety switch used to prevent
the complete compression of the syringe that avoids mechanical failure
and damage in case of tube breaks or disconnections.
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The pressure feedback is archived through the P.GIO pressure sensor
connected to the syringe through a T connector.
The pressure generator is used to compress air, the system is plugged
to the intra vascular circuit mixing chamber in order to impose a con-
trolled transmural pressure. The extra vascular circuit is kept at environ-
mental pressure through an open tube attached to a syringe filter5.9.
5.3 LFC Laminar Flow Chamber
A laminar flow chamber was specifically designed to enable cells to be sub-
ject to a large range of shear stresses. Several cardiovascular pathologies
are associated with altered patterns of flow and shear stress [140, 141].
The study of endothelial cell response to different flow conditions is there-
fore important for understanding and curing cardiovascular disease. Us-
ing finite element methods and imposing a number of design criteria such
as maximum volume and minimum area for cell culture, as well as the
range of shear stresses desired, we converged to a final design for the
chamber. Figure 5.10 shows the chamber design and the constant and
controlled velocity vector, in the cell culture zone. By changing the flow
rate of the fluid, constant and controlled shear stresses ranging from 410−2
to 9010−3 Pacan be applied to simulate aortic as well as capillary shears,
in physiological or pathological states. Equation 5.3 allows, the shear
stress (τ) on the cell layer to be calculated from the applied volume flow
rate (Q) with a medium viscosity (µ), cell chamber cross section (A) and
a distance between the center of the chamber and the cell monolayer (z).
τ = µ
Q
A ·Z
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The laminar flow bioreactor chamber is realized through a polydimethyl-
siloxane (PDMS) casting process on an aluminum mould (Figure 5.11.b).
The cell chamber is 198 mm long, 49 mm wide and 7 mm high (Figure
5.11.a).
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Figure 5.5: FEM results: Comparison between finite element model of
bioreactor (solid line) and analytic model of squeeze pressure (Pa) (a)
and shear stress (Pa) (c) generation during the approaching (blue) and
the retraction (red) phase; Surface plot of pressure (b) and shear stress
(d) distribution inside the channel and (e) Velocity field in the channel
during the approaching phase.
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Figure 5.6: Schematic diagram of the blood vessel placed in the culture
chamber.
Figure 5.7: Parametric analysis of the bioreactor system as function of
fluid velocity (0.0023 m/s; 0.023 m/s; 0.23 m/s): Reynolds number (sur-
face plot), circumferential stress (contour plot) and radial strain (arrow
plot) are shown. All values are in MKS units.
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Figure 5.8: a) CAD design of the vascular culture chamber and b) The
Vascular Stimulation chamber during the assembly phase.
Figure 5.9: VSC and P.GIO connections schema.
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Figure 5.10: FEM simulation of the laminar flow bioreactor chamber
with a medium flow speed of 0.05 m/s(12 mL/min).
Figure 5.11: (a) CAD design of the Laminar Flow chambers and (b)
the Laminar Flow Chamber mould.
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Chapter 6
Cell and Tissue Tests on Stimulus
Specific Chambers
The SUITE platform is a complete system for the maintenance of the
cell culture environment, and can apply different types of stimuli on cells.
The application of precise and well-controlled stimuli is important in or-
der to better understand the correlation between physical variables and
pathologies, and allows a more accurate study of tissue physiology and
pathologies. In this chapter tests on the three stimulation chambers are
described.
6.1 SQPR Squeeze Pressure Chamber
tests
The goal of this study was to test the hypothesis that contact-less me-
chanical stimulation of chondrocyte cultures, can promote differentiation
and enhance matrix production, compared to a static culture. For this
reason, bovine adult chondrocytes (BAC) were seeded in different con-
structs and subjected to a controlled, contact-less overpressure, using the
SQPR chambers 5.1 and the P.GIO 2.0 system 2. In order to simulate the
knee’s physiologic environment, the SQPR bioreactor was used to apply
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a cyclic pressure of 15 kPa with a frequency of 1 Hz. This stimulation
was chosen in order to mimic the intra-articular synovial fluid pressure
oscillations during continuous passive motion [114]. With this type of
stimulation the construct is subjected to localized overpressure and a low
shear stress at the same time as described in the section on SQPR design
5.1. The viability of the cells was examined before and after the stimu-
lation, to test the culture conditions, and the production of GAGs was
analyzed in order to evaluate how the applied stimulation influences cell
activity in terms of matrix production [127, 128].
6.1.1 Material and methods
Bovine articular chondrocytes where extracted using the same protocols
described in the MCmB 2.0 chondrocyte cellular tests section 4.3 and
used for construct seeding.
Constructs seeding and cultivation
During the validation tests, two different PGA scaffolds were used: 100%
PGA felt, 1 and 2 mm thick with a diameter of 5 mm and a density of
70 mg/c3m.
The two different constructs (1 and 2 mm thick) where seeded us-
ing the same procedure [142] but with different cell concentrations. The
scaffolds were previously sterilized by washing them with isopropanol for
15 min and rinsing several times with sterile PBS. The PGA was placed
in dishes and pre-wetted with FCS for 10-15 minutes and threaded onto
needles embedded in the spinner flask lead. Cells were inoculated adding
different amounts of cell suspension in order to obtain a cell density of
2.5×106 cells for the 1 mm thick scaffolds and 4×106 cells for the 2 mm
thick scaffolds. The culture flask was filled with 200 ml of complete
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medium, to completely cover the constructs. The cells were agitated at 50
rpm with a magnetic stir bar for 3 days in a 37◦C5% CO2 incubator [143].
After 3 days of agitation in incubator cell-polymer constructs were trans-
ferred to deeper Petri dishes (4 scaffold in each one), adding expansion
media (complete media + Fibroblasts Grow Factors FGF). The dishes
were left in a rotating shaker, which gently mix the media at 30 rpm.
After three days of orbital agitation the media was removed and replaced
with complete media (Dulbecco’s Modified Eagle’s Medium containing
10% v/v FCS, 10,000 units/ml penicillin, 10 mg/mL streptomycin, 10
mM HEPES, non-essential amminaacid and L-glutamine 2mM.) supple-
mented with 0.1% v/v 50 µg/mL Ascorbic Acid and 0.1% v/v 5 mg/mL
insulin1. Starting from here, the cells began matrix production. Medium
was completely replaced three times/week.
Experimental Protocol
The final purpose of this experiment was the validation of the SQPR
bioreactor chamber as a cell culture system able to stimulate chondro-
cytes culture in physiological like condition. Experiments on condrocytes
constructs where conducted applying a continuous pulsatile pressure for
24 or 48h. In order to simulate the joint environment all the experi-
ments where performed using a High Viscosity media (HV media) that
better approximates the characteristics of the synovial fluid (1-10 Pa · s)
[144, 145]. For this reason, 5% w/v of Dextran 500000MW was added to
the complete media, already supplied with 0.1% v/v 50 µg/mL Ascorbic
Acid and 0.1% v/v 5 mg/mL insulin2.
Cell viability was evaluated using the Alamar Blue assay 3, as pre-
1All cellular reagents and equipments purchased from Sigma-Aldrich UK.
2Sigma-Aldrich UK.
3Alamar Blue is a cell viability reagent from Invitrogen.
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viously described 4.1 in order to demonstrate the vitality of the culture
in the SQPR system. The stimuli mediated effects were investigated an-
alyzing the concentration of GAGs which is directly correlated with the
extent of matrix production. For this reason, total glycosaminoglycan
content was determined by analysis of papain-digested samples using the
dimethyl-methylene blue (DMB) spectrophotometric method [113].
An experimental protocol was planned and applied to all of the differ-
ent constructs in order to allow a future comparison between the different
approaches. The bioreactor was previously sterilized leaving all compo-
nents in a solution of 70% ethanol for 30 minutes. Then, one scaffold
was placed in each bioreactor (two experiments were performed in par-
allel) and one left in the 12-well plate as a static control; 4 mL of High
Viscosity media (HV) were added in each one, and both bioreactors were
placed in the 37◦C5% CO2 incubator. The Alamar Blue assay was per-
formed twice in all experiments: 24h before the stimulation, to assess the
initial cell activity, and then just after the stimulation, to evaluate if the
system permits normal growth and survival of the cultures. At the end
of the experiment, 0.5 mL of media were collected from the bioreactor
and from the control and used for GAGs assay. Immediately after the
end of the experiment, the Alamar Blue assay was made to check the cell
viability. Each construct experiment was carried out for a minimum of
three independent trials, and a statistical analysis was performed using
ANOVA.
6.1.2 Results
The cell experiments were carried out for 24 and 48h in the case of the 1
mm thick scaffolds and only for 24h in the case of the 2 mm one. All the
constructs were used within the one week after seeding. The experiments
were carried out in triplicate, using scaffolds 5,6 and 7 days post seeding,
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after which the statistical analysis was performed. Figure 6.1 shows the
normalized viability, with respect to controls, of the 1 mm thick scaffolds
after 24h and 48h of stimulation in comparison with the static control.
The viability of the stimulated construct is comparable with the static
control indicating that the HPC bioreactor environment is compatible
with cell survival and that the imposed pulsatile stimuli do not damage
the cell cultures.
Figure 6.1: Viability of chondrocyte constructs (1 and 2 mm thick) after
24 and 48 hours of stimulation in SQPR bioreactor. All the constructs
have a viability similar to the control, indicating that the SQPR stimula-
tion does not damage the cell culture. All data are normalised with respect
to the control.
The collected media samples were analyzed with the DMMB assay,
as previously described in section 4.3.1 and the results are shown in fig-
ure 6.2. The glycosaminoglycan concentration in the 24h and 48h 1 mm
stimulated scaffolds shows (figure 6.2.a) a relevant increase respectively
of 70% (4.73 mg/mL control and 8,08 mg/ml bioreactor) for the 24h
construct and 250% (6.40 mg/mL control and 16.66 mg/mL bioreactor)
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for the 48h one. The 2 mm thick constructs show a lower level of GAG
concentration (figure 6.2.b) in the medium but the control/bioreactor
difference after 24h of stimulation is higher than in the 1 mm scaffold
with an increase of 95% (1.96 mg/mL and 3.80 mg/mL bioreactor) in
the medium GAG concentration. This could be due the entrappment of
GAGs in the thicker scaffolds, such that their diffusion in the medium is
limited [146, 147]. These results demonstrate how the contact-less stimu-
lation imposed by the SQPR system is able to enhance ECM production
in chondrocyte constructs giving rise to a very high difference in the ECM
production speed. As shown in figure 6.2 the stimulated cultures present
a GAG production rate higher than the static control. Analysing the
1 mm scaffolds GAG production curves it is possible to note that after
24h the slope of the static control tends to decrease indicating that these
cultures gradually loose the ability to produce ECM. The 1 mm curves
in the bioreactor do not shown this change in the production rate after
24h of stimulation, indicating that the contact-less pressure induces the
constructs to maintain increased metabolic activity in order to maintain
a high rate of ECM production instead of lapsing into a quiescent phase.
6.2 VSC Vascular Stimualtion Chamber
tests
In this section the VSC tests are described. Porcine carotid arteries were
cultured for 24 hours varying the applied transmural pressure and the
flow rate. The mechanical properties of the vessel were tested before and
after the experiment in order to evaluate how this physical stimulus influ-
ences the remodeling of extracellular matrix and orientation of collagen
fibers. The results obtained have demonstrated that this device was able
to reproduce different physiological and pathological situations.
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Figure 6.2: Concentration of GAGs in medium in static controls and
SQPR stimulated constructs (1 (a) and 2 (b) mm thick) after 24 and 48
hours of cyclic contact-less stimulation.
6.2.1 Material and methods
Mechanical tests
The mechanical properties of vessels before and after culture in the VSC
bioreactor were measured using an isotonic transducer4, where the applied
force has a resolution of 1x10−3N. The system is connected to a pc for
the signal acquisition through a dedicated I/O board. Three specimens
for each case were tested and fixed to transducer with nylon suture wire.
During the stress-strain tests, the applied weights were changed every 3
minutes, and the elastic modulus of each sample was calculated using the
4Model 7006, UGO Basile Biological Research Apparatus, Comerio, Italy.
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final part of the curve.
Culture of vessels in the VSC bioreactor
The specimens analysed in this study were longitudinal and circumferen-
tial strips of porcine carotid artery with dimensions of 10 mm length, 2
mm width, and thickness around 1 mm. The porcine vessel was divided
in two parts; one used as control and placed in static condition, and one
placed in the VSC bioreactor. All the experiments were carried out within
24 hours from the vessel extraction.
The vessel was installed in the bioreactor under a laminar flow hood
in sterile conditions and locked to the connectors by clamp with a surgical
knot. After sealing and blocking with the dedicated Derlin frame 5.8.b
the VSC bioreactor extra vessel circuit was filled with DMEM Dulbecco
Modified Essential Medium supplemented with 30% (FBS) Fetal Bovine
Serum], 2% penicillin/streptomycin and 2% L-glutammina5.
The peristaltic pump was switched on in order to fill the vessel and
the entire circuit with media and the same culture medium was used
to perfuse the vessel filling the intra vascular mixing chamber. After
a preliminary check in order to detect any leakage or vessel clamping
problem, the VSC chamber was placed in an incubator at 37◦Cand 5%
CO2.
The medium flow rates (the two media circuits are separated but
have the same flow speed) were imposed to 0 or 10 mL/min in order to
investigate any shear stress related mechanical changes in vessel physiol-
ogy. Three different transmural pressures where applied (0, 60 and 120
mmHg) using the P.GIO hydrostatic pressure generator 5.2.1 in order to
simulate hypotensive, physiological and hypertensive conditions respec-
tively. The protocol was oriented to investigate any correlations between
5All reagents from Sigma, Italy.
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applied stimuli and changes in mechanical properties of the vessels all the
chosen pressure-shear combinations where tested. All the experiments
were carried out for 24 hours.
6.2.2 Results
As shown in figure 6.3.b and in table 6.1 shear stress stimulation results
in an increase of the longitudinal Young’s modulus, while the transmural
pressure has an opposite effect. The vessel stimulated with no pressure
and 10 mL/min flow rate shows a 40% (16.95 kPa)increase in Young’s
modulus with respect to the control (11.65 kPa). The reduction in the
pressure mediated circumferential Young’s modulus is attenuated by the
flow effect and the 10 mL/min 120 mmHg samples shown a circumferential
Young’s modulus that is only 30% (21.84 kPa) lower than the control
one (30.69 kPa). On the other hand the 0 mL/min 120 mmHg samples
have a greater reduction in circumferential Young’s modulus (80% (11.91
kPa)) lower than the control (73.84 kPa). The tangential post stimulation
Young’s moduli (figure 6.3.a) do not shown any relevant changes except
for the high pressure and flow rate experiments that demonstrate a 30%
(67.66 kPa) increase of the tangenzial Young’s modulus with respect to
the control (50.69 kPa).
This phenomenon could be explained taking into account that the cel-
lular component of the vascular wall is able to perceive changes of physical
stimuli and adapts the ECM organization by changing the collagen fiber
organization and orientation.
These experiments demonstrated the possibility of modulating the
mechanical properties of blood vessel walls in an in-vitro environment
by applying different stimuli. This innovative vessel stimulation chamber
can be used in connection with other chambers of the SUITE platform in
order to better investigate the pharmacology of anti-hypertensive drugs
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Table 6.1: Longitudinal young module and percentage increase post stim-
ulation in the VSC bioreactor.
mL
min
0 mmHg 60 mmHg 120 mmHg
kPa % kPa % kPa %
0 Bio. 15.81 -23.80 11.91 -83.87
Control 20.75 73.84
10 Bio. 16.95 +45.49 26.42 +34.93 21.84 -28.83
Control 11.65 19.58 30.69
and study how the presence of other tissues can interact with the stimuli
mediated collagen re-organization. The VSC bioreactor allows indepen-
dent application of the applied pressure and the flow rate, in order to
investigate how these parameters are correlated with vascular diseases. A
particular application where the VSC bioreactor can be used is the study
of the post stent implantation re-stenosis processes simulating physiologi-
cal conditions in-vitro and investigating how these influence the behavior
of the vessel wall.
6.3 LFC Laminar Flow Chamber tests
6.3.1 Materials and methods
The cells used for the laminar flow experiments were human umbilical
vein endothelial cells (HUVEC) [148, 149, 141]. They were placed in the
cell culture chambers, and in an incubator for 24 hours in order to ensure
their adhesion on the gelatin-treated PDMS base. After incubation the
cell culture chambers were plugged into the bioreactor system and 4 sets
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Figure 6.3: Normalized tangential (a) and longitudinal (b) young module
of vessels after 24h of stimulation in the VSC bioreactor.
of experiments at 4 different flow rates were ran for 24 hours. At the end
of each experiment the culture medium was analyzed for nitric oxide (NO)
and endothelin (EN-2)[150]. Nitric oxide and endothelin are respectively
a vasodilator and a powerful vasoconstrictive molecule. Cell morphology
and orientation were also assessed by calculating cell eccentricity.
6.3.2 Results
The vascular endothelium is a dynamic organ that responds to various
physical and humoral conditions, by producing several biologically active
substances, both vasoconstrictors and vasodilators, which control these
processes. Therefore to assess the ability of the laminar flow system to
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Figure 6.4: Histological section of a porcine carotid after 24h in the VSC
bioreactor.
maintain functional properties that cells possess in physiological condi-
tions the production of these important vasoactive factors were examined
in endothelial cells culture under different shear stress stimulation condi-
tions. The results are shown in Figure 6.5.a and b.
Even at shear stress values much lower than those typical of the in-
vivo environment, significant variations in ET-1 and NO concentrations
can be observed, as well as structural modifications induced by flow. As
reported in Figure 6.5.b, shear stress induces downregulation of ET-1 with
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Figure 6.5: (a) Nitric oxide production (µmol/106 cells) after 24 h in the
laminar flow bioreactor chambers with different shear stress and (b) En-
dothelin production (pg/106 cells) after 24 h in the laminar flow chamber
with different shear stress.
respect to static conditions. This result is in accordance with some litera-
ture reports [151, 152]. In particular, the decrease of ET-1 production has
been related to a reduction of synthesis of mRNA for ET-1 in HUVECs
[153]. NO concentrations on the other hand increased with shear stress
6.5.a, as generally reported in the literature [154, 155]. Flow also induced
structural reorganisation of endothelial cells, even at the low stresses used
here. Endothelial cells, which are known to respond strongly to flow
through the shear stress sensitive mechanoreceptors [156]. Changed their
morpohology becoming more elongated and aligning with the direction
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of flow. This well-known phenomenon which has been ascribed to the
reorganization of F-actin and microtubule networks, is activated through
mechanoreceptors. As can be observed in the micrographs of HUVEC
exposed to different levels of shear stress in figure 6.6, the cells are elon-
gated along flow lines, and this effect increases with the increasing shear
stress.
The culture do not show any type of cell membrane damage or forma-
tion of picnotic nuclei. In these experiment cells are used as environmental
sensors, where information relative to flow conditions are transduced into
secretion of proteins. Is possible to observe also a change in eccentricity
of endothelial cells, which respond to shear stress by orienting and elon-
gating along the direction of flow as observed in-vivo [141, 157, 158, 140].
Figure 6.6: Cell culture after 24 hours of treatment, we can observe how
the cells have an elliptical shape and are oriented with the medium flow
(indicated by the arrow).
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Conclusions
A new experimental bioreactor control framework, called SUITE (Su-
pervising Unit for In-vitro TEsting) was presented, through which high
throughput experiments can be performed in an in vivo-like simulated
environment for a long time. This thesis has described how by integrat-
ing different technologies and research fields a new concept of cell culture
bioreactor was designed. Bioreactors were used as alternative in-vitro
HTS systems to overcome the limits due to the environment discrepancy
problem. More relevant and more predictive data from experiments can
be obtained as a result of the capability of this innovative system to
better simulate a physiological environment than the classic static cell
culture protocols. The presented system is an innovative platform able
to perform High throughput experiments in more physiological like en-
vironments. With the SUITE (Supervising Unit for In-vitro TEsting)
platform it is possible to perform experiments using cell culture or tis-
sues with a consequent reduction of required animals. The experiments
performed with the SUITE are organized as a High Throughput experi-
ments, and the data is collected by a main supervision system which can
also impose control variables on multiple bioreactors running in parallel.
The SUITE system is composed of different parts described in this
work, the environmental control unit is the core of the system and is where
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all the environmental variables are collected by various sensors placed
along the system, the various cell culture chambers are the stimulation
zones of the system and in these the cell cultures are maintained and
stimulated.
The aim of the Environmental control unit is to adjust the tempera-
ture, pH, pressure, gas flow and dissolved oxygen percentage of the culture
medium. The control apparatus is consequently composed not only of the
electronic and control unit, but also of the mixing chamber, the peristaltic
pump, the heater unit and the control software. The entire high through-
put system design process was driven by the necessity of a system able
to perform experiments in parallel, with an autonomous control and with
a user friendly interface that easily allows the researcher to change the
controlled variables in order to mimic different pathologies.
A “light” version of the environment control system called P.GIO
(Pressure Generator of In-vivO environments) was also developed. With
this ”lighter” system the environmental variables (5% CO2 atmosphere,
humidity, tempertaure and sterility) are maintained using a classic CO2
incubator. The P.GIO system is an innovative free standing unit able to
control stepper or DC motors in order to generate controlled pressures
or micro movements. P.GIO is a component of the SUITE platform and
can be used as autonomous motor control, as environmental control box
”slave” actuator or in connection with a PC for a direct user interac-
tion. The P.GIO system was designed in order to be easy to use, stable
and autonomous. With this system is possible to design a wide range
of experiments where pressure stimulations, micro movements, polymers
extrusion or drug tests are imposed on cell cultures.
The Environmental control box test demonstrated that the system
is able to maintain bioreactor cultures in the environmental conditions
chosen by the user also in case of external perturbation or variable target
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values. The platform is also able to impose variable stimulation and it
can be used as a long term cell culture stimulator. In connection with
the P.GIO system the SUITE platform is able to impose complex stimu-
lations on cell cultures such as squeeze or transmural pressures allowing
the system to be used for the study of various tissues or organs diseases.
A ’system on a plate’ Multi Compartmental Modular Bioreactor (MCmB)
was also developed with appropriate dimensions in order to allow microw-
ell protocols to be transferred directly to the bioreactor technology. The
MCmB is a modular chamber for high throughput multi compartmental
bioreactor experiments. It is designed to be used in a wide range of ap-
plications and with various cell types. Given that hepatocytes present a
major challenge in cell culture the MCmB was designed using hepatocytes
as a reference cell type. For this reason this innovative chamber was pre-
liminary tested with hepatocytes and then with different cell types and
experimental procedures in order to validate the MCmB as a generic cell
culture system.
The first test performed on the MCmB was aimed at demonstrating
the capability of the chamber to maintain the vitality and function of
one of the most important yet most delicate cells in the human body:
hepatocytes. With the hepatocyte tests the mass transport and fluid
dynamic FEM models used for the design were also validated. In fact,
through these experiments we verified that the oxygen concentration in
the MCmB chamber allows hepatocyte survival and showed that their
vitality is shear stress dependent. The second set of tests was focused
on establishing an in-vitro liver model in the MCmB, in which different
chambers are plugged in series and parallel in order to simulate a human
liver. In the third test the MCmB was used to investigate the behavior
of condrocyte cultures, in monolayers and in scaffolds cultures, under
different levels of shear stress. These experiments demonstrate that the
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MCmB chamber is not only a modular bioreactor for the construction
of in-vitro organ models for metabolic and toxicity studies, but can also
be used as a cell culture stimulation unit, in which experiments can be
designed with different types of stimuli applied to connected cultures,
allowing investigation of tissue and organ physiopathology in an more
in-vivo-like environment.
A precise stimulus application is important in order to better under-
stand the correlation between physical variables and pathologies allowing
a more accurate study of the tissue physiology and pathologies. For this
reason three stimulation chambers were also designed and tested. The
SPQR (SQueeze PRessure) bioreactor chamber is a system designed to
impose on different type of cell cultures or tissues slices a cyclic hydrody-
namic pressure that replicate the joint physiological environment. One of
the most important features of the SPQR chamber is the ability to gener-
ate a squeeze pressure without any contact with the samples. This cham-
ber was tested using different cell types and support materials indicating
that the SQPR applied stimulation is able to enhance ECM production
and can be used as an in vitro system for cartilage regeneration studies.
A Vascular Stimulation Chamber (VSC) was also developed and tested,
with this chamber it is possible to impose various flow rates and transmu-
ral pressures on animal or human ex-vivo vessels in order to investigate
how these physical stimuli interact with the vessel wall re-organization
process. The VSC chamber tests demonstrated that with this innovative
system is possible to induce vessel wall re-organization and that a col-
lagen fiber orientation process is induced as consequence of applied flow
rate and transmural pressure. This chamber can consequently be used
as ex vivo system for the study of the post stent implantation re-stenosis
process.
In summary the SUITE platform has been demonstrated to be a valid
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system applicable to various tissue engineering experiments as an environ-
ment control or as a cell stimulator. Due to new European Community
directives, there is an urgent requirement for innovative systems that help
to reduce the number of animal required for drug testing. For this reason
the SUITE system is perfectly aligned with the scientific communities
needs.
The system has been tested with various scientific protocols during the
course of this thesis and is in use in various European labs, however the
debugging of such a complex system is a long process that will continue
in the next few months.
Finally we can affirm that the SUITE platform is a complete system
for cell, tissue and organ maintenance and stimulation that will help the
scientific community to establish more ethical and sustainable research
reducing the number of required animals and allowing the study of the
correlation between physical stimulation and physiological processes.
149
Conclusions
150
Appendix A
Appendix
In the following section a verbatim copy of the publications referred to as
numbers [159, 157, 89]
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ABSTRACT: A generic ‘‘system on a plate’’ modular multi-
compartmental bioreactor array which enables microwell
protocols to be transferred directly to the bioreactor mod-
ules, without redesign of cell culture experiments or pro-
tocols is described. The modular bioreactors are simple to
assemble and use and can be easily compared with standard
controls since cell numbers and medium volumes are quite
similar. Starting from fluid dynamic and mass transport
considerations, a modular bioreactor chamber was first
modeled and then fabricated using ‘‘milli-molding,’’ a tech-
nique adapted from soft lithography. After confirming that
the shear stress was extremely low in the system in the range
of useful flow rates, the bioreactor chambers were tested
using hepatocytes. The results show that the bioreactor
chambers can increase or maintain cell viability and function
when the flow rates are below 500mL/min, corresponding to
wall shear stresses of 105 Pa or less at the cell culture
surface.
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Introduction
The microwell (MW) plate has become a standard in cell
culture. The plates are available in a variety of formats
(6–1,536 wells), although for most general cell culture and
tissue engineering applications, 12-, 24-, 48-, and 96-well
formats appear to be the most common (Chen et al., 2009).
However, the complexity of the physiological environment
is not replicated in Petri dishes or microplates. All cells are
exquisitely sensitive to their microenvironment which is rich
with cues from other cells, and from mechanical stimuli due
to flow, perfusion, and movement. MWs do not offer any
form of dynamic chemical or physical stimulus to cells, such
as concentration gradients, flow, pressure, or mechanical
stress. This is a major limitation in experiments investigating
cellular responses in vitro since the complex interplay of
mechanical and biochemical factors is absent (Janmey
and McCulloch, 2007). Most researchers and industry
now accept that classical in vitro experiments offer poor
predictive value or mechanistic understanding, and there is
a shift to new technologies, generally in the form of
bioreactors.
A large number of bioreactor systems for cell culture have
been designed and described. They range from commercial
bioreactors which apply laminar flow (Fu et al., 2008),
membrane systems (Morelli et al., 2007), rotating vessel
systems (Martin et al., 2004) to purpose designed devices for
specific tissues such as blood vessels (Miyakawa et al., 2008),
heart valves (Dumont et al., 2002), and livers (Powers et al.,
2002a). In most cases, the bioreactors described are custom
designed for specific requirements and necessitate the use
of particular seeding methods or scaffolds with narrow
dimensional and design specifications. Sizewise they can be
large-scale bioartificial livers with several billions of cells and
several milliliters of fluid (De Bartolo et al., 2000) down to
microfluidic systems with a few hundred microliters
of medium (Baudoin et al., 2007). In fact, microfluidic
microfabricated bioreactors which enable the culture of
different cell types in a shear stress controlled environments
(Tanaka et al., 2006) are highly popular but remain very
much a niche research tool. In a microbioreactor, the cell
culture surface is generally around 0.5–0.8 mm2 (Baudoin
et al., 2007) and this tiny surface is seeded with a few
thousand cells. Such a small number of cells, organized on a
tiny surface can be only a rough approximation of an organ
and cannot meaningfully predict in vivo physiology or
pathophysiology (Tingley, 2006). Another problem encoun-
tered in microbioreactors is the so-called ‘‘edge effect.’’ In a
micro-scaled surface, the percentage of area close to the edge
of the system is higher than in a millimeter-sized surface. A
large fraction of the cell population will therefore be found
in a peripheral zone of the system. Cell cultures in the edge
zone are usually organized differently and have higherCorrespondence to: D. Mazzei
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cytoskeletal tensions (McBeath et al., 2004), and they may
also have different viability or activity (Francis and Palsson,
1997). The edge effect is consequently a problem that can
directly affect the results obtained in micro cell culture
systems as demonstrated in Lundholt et al. (2003).
Furthermore, most microfluidic bioreactors are fabricated
using polydimethylsiloxane (PDMS) or other elastomeric
polymers, which are known to adsorb small hydrophobic
molecules (Toepke and Beebe, 2006). In microfluidic
circuits, where the surface area to volume ratio is high,
surface adsorption can lead to nutrient or ligand depletion
so giving rise to experimental artifacts such as increased
metabolic consumption rates. Finally, microsystems and
microbioreactors are difficult to use and assemble, and the
seeding and filling processes are quite complicated. This
could lead to increased experimental failure and decreased
reliability and limits their usefulness and scope and also
puts them out of reach of many cell culture experiments
which could benefit from added dynamic stimuli. In fact,
for alternative tools to become acceptable as cell culture
standards, the transition from wells has to be as smooth
as possible. Only then will biologists and technicians
adopt and adapt to new culture methods. For this
reason, we have developed a ‘‘system on a plate’’ Multi-
Compartmental modular Bioreactor (MCmB) with dimen-
sions of the order of a few millimeters, which enables MW
protocols to be transferred directly to the bioreactor
modules.
The main design criteria for bioreactors are based on
maximizing mass transport between the cells and the culture
medium and on the application of mechanical, electrical,
chemical, or other stimuli. Given that hepatocytes present a
major challenge in cell culture (Coleman and Presnell, 2003;
Guillouzo, 1998) and are probably the ‘‘limiting’’ cell in an
in vitro system, the MCmB was designed using hepatocytes
as a reference cell type. Hepatocytes are known to rapidly
loose phenotypic expression in vitro due to the absence of
an adequately equipped microenvironment, and they are a
particular focus of attention in bioreactor development
(Nahmias et al., 2007).
As the main orchestrators of endogenous and exogenous
metabolism in mammals, hepatocytes are extremely
sensitive to oxygen concentration, with high metabolic
demands (Balis et al., 1999; Schumacker et al., 1993). One of
the main engineering issues in bioreactors for in vitro liver
models is therefore the balance between high mass transfer
and low wall shear stress to cells. Several reports describe the
effects of flow and shear stress on hepatocyte cultures (Mufti
and Shuler, 1995; Nakatsuka et al., 2006; Powers et al.,
2002b; Tanaka et al., 2006). Moreover, many investigators
have shown that the viability of hepatocyte cultures under
high shear is usually lower than that of static controls,
indicating that the cells are under conditions of stress (Park
et al., 2007). Hepatocytes are therefore very sensitive to
shear, and according to Tilles et al., (2001) hepatocyte
function is compromised at wall shear stresses greater than
0.03 Pa.
To realize a generic bioreactor system, a modular
chamber with shape and dimensions similar to the 24-
MW was designed. The new bioreactor unit is called the
Multi-Compartmental modular Bioreactor (MCmB), and it
consists of a cell culture chamber made of PDMS, a widely
available and reasonably priced biocompatible silicone
polymer with excellent self-sealing properties, transparency
and flexibility. For this reason, in systems, which have a
small surface to volume ratio with respect to microfluidic
circuits, its use can be highly advantageous. By plugging
together different chambers in different configurations
(series or parallel) it is possible to mimic different metabolic
pathways in order to investigate and test multi-compart-
mental biological models in vitro without having to design
dedicated equipment or culture chambers, but just by
connecting together a set of prefabricated chambers. The
MCmB stems from a previous multi-compartmental
bioreactor (MCB), in which the metabolic circuit has a
fixed topology (Guzzardi et al., 2009; Vozzi et al., 2009). To
mimic salient features of the glucose consumption pathway,
the MCB system was designed with four chambers
representing the pancreas, the liver, and the two target
organs, respectively. The chambers were connected by
channels, and the circuit dimensions were calculated using
allometric laws (West et al., 1997).
The MCmB is a further evolution of the MCB system and
allows any tissue or organ model to be simulated simply by
connecting the modular chambers in a desired configura-
tion. The bioreactor design process started with the analysis
of the oxygen concentration and with the assessment of the
minimum concentration allowed near the cell surface, using
hepatocytes as a reference. Subsequently, we developed a
fluid dynamic model of the MCmB chamber in order to
investigate the shear stress and to estimate the optimal
chamber size to obtain both adequate oxygen diffusion and
low shear stress near the cell surface. This article describes
the designing, modeling, and dimensioning of the bioreactor
chambers, their fabrication using precision machining and
‘‘milli-molding,’’ and testing of the bioreactors using rat
hepatocytes.
Materials and Methods
Mass Transport and Flow Modeling
The first model of the MCmB (MCmB 1.0) was based on the
dimensions of the classic 24-MW so as to directly compare
static and dynamic cell cultures in equal sized chambers. The
MCmB 1.0 was designed to allow the use of 12 mm glass or
plastic cover slips, commonly used for cell culture, or
different types of scaffolds. It is also possible to place a slice
of tissue, pregrown cell construct, or pellets directly on the
cell culture zone. A finite-element modeling (FEM) model of
the cell culture chambers was developed in order to study
the oxygen concentration and the shear stress at the
cell surface. Cosmos Floworks, a SolidworksTM (Dassault
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Syste`mes SolidWorks Corp., Concord, MA) extension
that allows fluid-dynamic FEM analysis and Comsol
Multiphysics (COMSOL AB, Stockholm, Sweden) were
used for this purpose. In both the fluid dynamic and mass
transport models we used the following system constants:
viscosity¼ 103 Pa s, fluid density¼ 1,000 kg/m3, medium
flow rate in the range between 60 and 1,000mL/min,
pressure¼ 1 atm or 760 mmHg, temperature¼ 378C, and
no slip boundary conditions. Water was chosen as a
reference fluid, so that the actual values of shear stress on the
walls will depend linearly on the density and viscosity of the
culture medium used. Initial considerations were focused on
a flow rate of 180mL/min for the sake of comparison with
our previous tests in the MCB system (Guzzardi et al., 2009;
Vozzi et al., 2009).
In order to study the fluid dynamics of the modular
bioreactor, we developed a parametric model in which the
effect of changes in height on flow parameters (flow speed,
shear stress, and stream lines) could be observed. As shown
in Figure 1, the first model had a base height H which varied
between 3 and 9 mm, and a 13-mm diameter base, with a 12-
mm diameter, 160mm thick cover slip placed on of the
bottom of the bioreactor. The distance between the roof
and the 1 mm diameter inlet and outlet tubes was fixed at
3 mm, and the FEM model was solved for different heights
between the tubes and the cell culture surface: 3, 4, 6, and
9 mm.
Oxygen Concentration Analysis
A steady-state model of oxygen diffusion in the MCmB
chamber was developed, in order to investigate if the cells
were adequately supplied with oxygen during the experi-
ments. We used Michaelis–Menten (MM) kinetics to model
oxygen consumption and Fick’s laws to model oxygen
diffusion in water.
In the bioreactor circuit, which is described in the
following section, air rather than O2 is used for safety
purposes. The O2 concentration (C[0]) in the medium just
below the gas–liquid interface is directly dependent on
the O2 partial pressure in air, typically 20% or 159 mmHg,
through Henry’s law and we can easily calculate C[0] using
tabulated values of the Henry constant:
PðO2Þ ¼ KðO2ÞC½O2
with KO2 ¼ 932.4 atm/(mol/L) and (PO2 )¼ 0.2 atm (20%),
C[O2] below the gas–liquid interface or C[0]¼
214mM¼ 0.214 mol/m3.
In the presence of oxygen-consuming cells, the O2
concentration will decrease as a function of distance from
the interface and the metabolic requirements of the cells.
The steady-state flux of O2 in the bioreactor chamber is due
to cellular oxygen consumption at the base. The oxygen
consumption rate per unit volume is given by the MM
equation:
dC
dt
¼ VmC
Km þ C
where C is the oxygen concentration in mol/m3, Vm is the
maximum volumetric consumption rate in mol/m3/s, and
Km is the MM constant in mol/m
3.
The flux at the base of the chamber where the cells lie are
Jc ¼ D @C
@x
¼ VmaxC
Km þ C
1
cell area
where Jc is the O2 mass flow at the cell surface, ð@C=@xÞ is
the O2 concentration gradient at the cell surface calculated
along the axis perpendicular to the cell culture layer, D is
the O2 diffusion coefficient (in water) D¼ 3 109 m2/s at
378C, and Vmax is the maximum consumption rate in mol/s.
The kinetic model was calculated for a medium flow rate
of 180mL/min, for a comparison with the MCB result, and a
cell monolayer of 1.33 cm2 surface area with 500,000 cells,
which represents typical cell numbers observed 48 h after
seeding HepG2 cells on a three-dimensional scaffold (Vinci
et al., 2009). In order to choose the height of the bioreactor,
we fixed a minimum oxygen concentration of the medium at
the cell surface; Cmin¼ 0.04 mol/m3. Below this concentra-
tion we assume that cell function is compromised. In fact,
typical oxygen concentrations in the liver are of the order
of 0.04–0.15 mol/m3 (4–15%), while 0.021 mol/m3 (2%) is
known to inhibit mitosis in hepatocytes (Smith and
Mooney, 2007).
Using the data in Patzer (2004), Vmax¼ 0.048 nmol/s for
1 million cells, giving a value of 0.024 nmol/s for 500,000
cells (Vmax(500,000)), and Km¼ 0.5 mmHg.
Figure 2 illustrates that the O2 concentration in the
MCmB is always higher than the minimal threshold and falls
rapidly at the edge of the chamber near the outlet. Increasing
bioreactor height from 3 to 9 mm, the oxygen concentration
decreases rapidly but cell survival is always guaranteed in the
central region of the chamber. Above H¼ 9 mm, however,
in the bottom of the chamber the oxygen concentration is
constantly below the Cmin threshold of 0.04 mol/m
3. The
maximum oxygen concentration at the base is 0.17, 0.12,
0.10, and 0.007 mol/m3 for H¼ 3, 4, 6, and 9 mm,
respectively.
Figure 1. The FEM model geometry for the first modular bioreactor chamber. H
is the variable height, (a) side view and (b) top view.
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Fluid Dynamic Model
To investigate the fluid dynamics of the modular bioreactor,
a parametric model similar to the mass-transfer model was
developed. The height H was varied to determine its
influence on the shear stress generated at the cell surface,
assuming again that the cells are seeded on a 12-mm,
160mm thick cover slip placed in the bioreactor.
Table I summarizes the results, showing how the
shear stress at the cells surface decreases rapidly with
increasing H. However, the laminarity of the flow is
compromised by increasing the height of the bioreactors.
This is a consequence of the separation of flow streamlines
caused by the difference in height between the inlet tube and
the base.
After evaluating the results from the fluid dynamic
and mass transport modeling, we choose to realize a
modular bioreactor chamber with tubes placed 6 mm over
the cell surface (H). A distance of at least 1 mm between the
wall of the tube and the top of the chamber is necessary to
ensure mechanical stability of the tube/chamber junction.
Since standard silicone tubing with an inner diameter of
1 mm has an outer diameter of 3 mm, the total height of the
chamber is 10 mm. This is the best compromise between
shear stress, flow, oxygen diffusion, and mechanical
feasibility.
Figure 3 shows the three-dimensional FEM model of the
H¼ 6 mm MCmB with an internal diameter of 13 mm,
sufficient to place a slice or a scaffold of 12 mm in diameter.
This bioreactor has a peak shear stress value of
6.85 106 Pa and a velocity peak of 106 m/s near the
center of the base.
Chamber Fabrication
A first prototype of the bioreactor chamber (MCmB 1.0) was
fabricated using ‘‘milli-molding’’ in order to investigate the
performance of the system. Milli-molding is similar to
micromolding (Xia and Whitesides, 1998), in that PDMS is
used as a mold, but the master is machined using a mill or
rapid prototyping rather than lithographic methods, and the
features of the mold are of the order of tenths of millimeters,
rather than microns.
The chamber is composed of two separate parts which are
plugged together through a friction fit system. In the friction
fit system two complementary geometries form a seal when
brought together thus avoiding the use of o-rings or
additional parts (Mazzei et al., Improved Bioreactor
Chamber, GB Patent Application No. 0814034.5). PDMS
(Sylgard 184, Dow Corning, Silverstar, Italy) is used to
fabricate the chambers. Along with the friction fit system,
the use of PDMS, which is self adhesive and deformable,
ensures that the seal is watertight.
The two parts of the chamber are made by casting and
curing PDMS as per the manufacturer’s instructions on
aluminum masters purposely machined in our workshop.
Each master is made of two separate pieces which allow easy
removal of the chambers after polymerization. The two parts
are held together using an aluminum frame with four screws
as shown in Figure 4a.
Turbulence Tests
The first prototype of the MCmB 1.0 cell culture chamber had
severe problems with the build-up of air bubbles during the
Figure 2. Theoretical oxygen concentration profile across the bioreactor chamber for different heights H, calculated using Michaelis–Menten kinetics and a flow rate of
180mL/min. The minimal concentration threshold of 0.04 mol/m3 is indicated by the solid line.
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Table I. Fluid dynamic FEM model results for a fixed flow rate of 180mL/min for the first MCmB model as a function of height H.
Height (H) 3 mm 4 mm 6 mm 9 mm
Shear stress peak
(Pa) at 180mL/min
3.217 105 1.195 105 6.856 106 8.747 107
Shear stress profile (log Pa)
Velocity peak (m/s)
at 180mL/min
4.429 106 1.665 106 9.887 107 1.389 107
Velocity vector
Stream line
Figure 3. FEMQ1 model of the H¼ 6 mm MCmB 1.0. a: Velocity and (b) shear stress. The analysis takes into account a 160-mm thick glass cover slip placed on the base of the
chamber.
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initial phases in which the bioreactor is filled with medium.
This resulted in the formation of a bubble of air at the top of the
chamber (Fig. 4a), which disturbed the flow profile, causing
turbulence and more importantly unpredictable values of shear
stress. In order to evaluate the effects of the bubble induced
turbulence, a small drop or blob of alginate was introduced in
the chamber as a ‘‘turbulence sensor.’’ An alginate blob is easily
disaggregated under turbulent or high impact flow, and for this
reason it is a good indicator of the presence of altered flow
profiles. Moreover, cross-linked alginate at the concentrations
used here has approximately the same elastic modulus as the
liver (	10 kPa) (Constantinides et al., 2008; Tirella et al.,
unpublished work). The alginate blobs are made placing
166mL of 2% sodium alginate (Sigma, Milan, Italy) dissolved
in MEM (Sigma) on top of a glass cover slip in the chamber
and cross-linking in situ with 104mL of 0.1 M CaCl2 (Fig. 4b).
The volume of the blob was chosen in order to form a thin
uniform coating of the glass cover slip, without interfering with
the inlet tube. A peristaltic pump (Ismatec, Glattbrugg,
Switzerland) was attached to the inlet, and keeping the flow
rate constant at 180mL/min, the consistency of the alginate
blob after 24 h in the MCmB 1.0 at 378C was analyzed.
The alginate drop was completely disaggregated, showing that
the bubble induced a turbulent environment.
Design Improvements: MCmB 2.0
In order to eliminate bubble entrapment and turbulence in
the bioreactor chamber, a second prototype (MCmB 2.0) of
the modular bioreactor was designed. The new bioreactor is
slightly larger in diameter (15 mm) to enable 13 or 14 mm
slides to be easily inserted and its top surface is sloped along
and perpendicular to the axis of flow, so that bubbles are
collected and conveyed to the outlet tube (Fig. 5a).
Figure 4. a: Bubble formed at the top of the first MCmB 1.0 chamber, and (b)
alginate drop used for turbulence tests placed on the bottom half of the chamber.
Figure 5. a: Dimensions of the new chamber, (b) three-dimensional representation of the sloped roof and ridged base, (c) MCmB 2.0 velocity profile, showing stream lines,
and (d) shear stress at the base.
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Furthermore, the diameter of the outlet tube was increased
to 2 mm to facilitate the removal of bubbles. This also
reduces the impact angle on the cell culture surface and the
recirculation near the outlet wall as shown in Table II. The
final height of the MCmB 2.0 is 11 mm at the inlet side and
13 mm at the outlet side, with the tubes positioned,
respectively, at H¼ 9 and 10 mm from the cell surface
(Fig. 5b).
Through FEM modeling a tenfold decrease in fluid
velocity and shear stress on the cell surface with respect to
MCmB 1.0 was observed with the introduction of the
sloping roof and the increased outlet tube diameter.
The MCmB 2.0 is 3 mm higher than MCmB 1.0, we
choose to increase the height of the new chamber design
because this allows a further reduction in shear stress in
comparison with MCmB 1.0 (6 mm in height) while
maintaining the oxygen concentration over the 4%
threshold.
Table II shows the velocity profile and the streamlines in
the MCmB 2.0.
The base of the bioreactor chamber was also modified to
ensure easy removal and support of coverslips, since the
slides and thin substrates tend to stick to the flat silicone
base. The three small rectangular ridges, shown in
Table II. Fluid dynamic FEM model results for the MCmB 2.0 at two different flow rates, the average height (H) of the MCmB 2.0 is 9.5 mm.
Flow rate (mL/min) 180 300
Shear stress peak (Pa) 4.295 106 6.456 106
Shear stress profile (log Pa)
Velocity peak (m/s) 5.939 107 9.048 107
Velocity vector
Stream line
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Figure 5b, provide support and also allow medium to flow
under the support, supplying nutrients to the lower surface
of tissue slices or scaffolds.
Control System
The bioreactor chambers are part of a complex gas and
fluid circuit, which enables individual chambers to be
connected in series or in parallel to mimic different
metabolic pathways. Experimental variables such as oxygen
concentration, pH, pressure, and medium flow rate through
the MCmB chambers can all be controlled through a
purposely designed electronic and software control system
(Mazzei et al., 2008). A series of MCmB chambers plugged
together in series and parallel are represented in Figure 6.
MediaQ2 are moved by a peristaltic pump through
to a mixing chamber, and to the MCmB chambers in a
closed-loop circuit. The mixing chamber acts as a medium
reservoir, a sampling port, a gas exchanger, and a flow
rectifier to convert peristaltic flow into a smooth flow. The
controlled injection of an appropriate combination of air
and CO2 through a dedicated algorithm enables the oxygen
concentration, pH, and pressure of the medium to be tightly
modulated. A microcontroller board is used to read the data
collected by a sensing unit placed in the mixing chamber.
The MCmB bioreactor can also be used in a classic cell
culture incubator, without need for the control unit. In this
case, the mixing chamber is equipped with a single gas inlet
with a 0.2mm syringe filter which allows gas exchange
without risk of contamination.
Cell Culture
All cell culture reagents were all purchased from Sigma,
unless otherwise specified. Primary rat hepatocytes were
used to test the performance of the MCmB 2.0 bioreactor
at various flow rates. Hepatocytes were isolated from
adult male Wistar rats weighing between 250 and 300 g as
described by Seglen (1979) and Papeleu et al. (2006).
Isolated cells were assessed for vitality by trypan blue
exclusion (vitality routinely greater than 90%), and then
seeded on glass cover slips (2 105 cells per sample)
pretreated with 0.1 mg/mL collagen extracted from rat tails
according to standard procedures (Rajan et al., 2006), placed
in 24-MW plates and left at 378C and 5% CO2. About 5 h
after seeding, the medium was removed and replaced with
FBS-free William’s E complete medium. The following day,
the hepatocyte seeded coverslips were placed into the
MCmB 2.0 chambers and coated with 250mL collagen
gel prepared by mixing ice-cold collagen solution and
acetic acid 0.2 N (to a final collagen concentration of about
1.1 mg/mL) and 10 M199. The collagen coating used in
these experiments has a Young’s modulus similar to the
alginate blob used to evaluate the turbulence in the chamber
(Wu et al., 2005). It also provides an adhesive roof to the
cells and shields the cells from the effects of direct flow.
MCmB Assembly
Prior to assembly the bioreactors with hepatocyte seeded
and collagen coated slides were left in the incubator for
40 min to allow the collagen to set. The MCmB system was
then assembled by connecting two chambers in series to a
peristaltic pump and the mixing chamber. Finally, the
system was filled with 10 mL FBS-free complete William’s E,
and run for up to 24 h. The first experiment was run at a flow
rate of 180mL/min. At 2, 4, 6, and 24 h a 100-mL sample of
medium was withdrawn for analysis of rat albumin. A
second set of experiments was carried out at various flow
rates (60–100–180–250–300–500–1,000mL/min) to deter-
mine cell viability as a function of flow rate. The bioreactors
were run for 24 h after which the cover slips were removed
and assessed for cell viability. Control experiments with cells
from the same rat liver were run using glass slides seeded
with the same number of cells, coated with collagen, and
placed in 10 mL Petri dish plate multiwell (BD Biosciences,
Milan, Italy).
Viability and Albumin Testing
Albumin
Albumin, which is an important marker of hepatic
function, was measured using a commercial ELISA kit
(Bethyl Laboratories, Montgomery, TX), according to the
manufacturer’s instructions. Rat albumin production is
expressed as total quantities of albumin per seeded cell.
Each experiment was repeated at least three times, and
comparisons were only made between cells extracted from
the same liver.
Viability
The viability kit used was CellTiter-BlueTM Cell Viability
Assay (Promega, Madison, WI), a resazurin-based fluor-
escent compound metabolized by mitochondrial cytosolic
Figure 6. Scheme of the bioreactor medium and gas flow circuit.
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and microsomal enzymes to resorufin which can be detected
with a fluorimeter (FLUOstar Omega, BMG Labtech,
Offemburg, Germany) at 573 nm. Viability was assessed
both in control static cultures and in the MCmB 2.0, and the
results are expressed as ratio between hepatocyte viability in
dynamic and static conditions after 24 h. The static control
was a hepatocyte seeded and alginate-coated cover slip
placed in a bioreactor base filled with medium and left open
in order to allow oxygen exchange without medium flow.
Each experiment was repeated at least three times, and
comparisons were only made between cells extracted from
the same liver.
Statistical Tests
Statistical analysis was performed using the Student’s t-test
when comparing between albumin production in static
(n¼ 3) and dynamic (n¼ 3) experiments; a P-value of less
than 0.05 was considered statistically significant. At least
three dynamic experiments and three static controls were
performed per flow rate for viability tests.
Results and Discussion
Oxygen Consumption and Shear Stress in the MCmB 2.0
Figure 7 shows the oxygen concentration in the two
bioreactor designs; for a given flow rate, the mean value is
slightly lower in the new MCmB 2.0 design. As far as oxygen
consumption is concerned, the difference between the two
chambers is the value of H (6 mm in MCmB 1.0 and 9 mm in
MCmB 2.0) and their respective volumes. The MCmB
2.0 chamber has a slightly larger volume so the total amount
of oxygen available is greater. Therefore, despite the greater
distance between the tubes and the cell surface in the
new chamber the minimal oxygen concentration is still
guaranteed except at the outer edge of the base closest to the
outlet. To minimize oxygen depletion at the edges, the
bioreactor could be placed on a low-frequency oscillator or
shaker. It should be noted however that the number of cells
used in the model was more than twice that used in the
experiments, and that the oxygen concentration is highly
dependent on the flow rate and metabolic requirements of
the cells.
We also characterized the Graetz number which is a
dimensionless number indicating the ratio between the
characteristic diffusion time and the convection time,
respectively, perpendicular and parallel to the direction of
flow. The Graetz number is greater than 100 even for low
flow rates (60mL/min) showing that the fraction of
oxygen consumed per reactor is insignificant and so
downstream chambers do not suffer from any input oxygen
depletion.
Using the model we established empirical equations for
the wall shear stress and peak fluid velocity at the cell surface
as a function of flow rate
Shear ðPaÞ ¼ FlowðmL=minÞ  1:8  108 þ 1:1  106
Flowspeed ðm=sÞ
¼ flow ðmL=minÞ  2:6  109 þ 1:3  107
Therefore, the wall shear stress at 180 and 300mL/min is,
respectively, 4.34 106 and 6.5 106 Pa and the peak
flow velocity is 5.98 107 and 9.1 107 m/s.
Bubble and Turbulence Testing
As shown in Tables I and II, the MCmB 2.0 has lower values
of shear stress, and the streamlines are parallel to the base of
the chamber, even though its height (H) is 3 mm greater
than MCmB 1.0. At a flow rate of 1,000mL/min the gel
showed signs of disaggregation after 24 h, due to the direct
high impact of fluid on the base of the chamber as well as
the high wall shear (not shown). The MCmB 2.0 was
bubble free, as the sloped roof and the position and
respective diameters of the inlet and out tubes forced
bubbles to be conveyed out of the chambers. In the
Figure 7. a: Oxygen concentration in the MCmB 1.0 for a flow rate of 180mL/min
and MCmB 2.0 for a flow rate of 180 and 300mL/min, and (b) oxygen concentration in
the MCmB 2.0 for different flow rates between 60 and 500mL/min.
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turbulence tests carried out with the alginate blob, the gel
showed no signs of wear even after 48 h under a flow of
500mL/min. The alginate blob turbulence test is not only a
simple method for investigating turbulent, high impact, or
disturbed flow in the system but can also be used to create a
cell culture environment more similar to the in vivo liver
environment. As shown in Vozzi et al. (2009) and Guzzardi
et al. (2009), coating the cells in an alginate or collagen
gel increases hepatocyte viability and phenotypic stability
during the culture.
Cell Culture Tests
Figure 8a illustrates the viability ratio between the MCmB
dynamic culture at different flow rates and a static control.
The figure shows that below 180mL/min the viability is
compromised, this could be due to the lower oxygen
concentration at the bottom of the bioreactor chamber for
these low flow rates (shown in Fig. 7b). For flow rates in the
range between 180 and 500mL/min the viability is very close
to the control and the viability peaks at 300mL/min, this
could be due to the high oxygen concentration as
demonstrated in Figure 7b. A further increase in flow rates
above about 500mL/min causes a significant reduction in
viability. At higher flow rates, despite the increased
availability of oxygen, the cells suffer, and this is due to
the high shear and impact angle of flow on the collagen
coating and cells.
Figure 8b shows the albumin production after 24 h in
the MCmB for different flow rates in the range 100–
1,000mL/min, and the static control. Albumin in the
bioreactor chamber is slightly upregulated except for
the 1,000mL/min flow rate, where the cells are damaged
by the shear stress as previously discussed. These results are
confirmed by several reports describing dynamic hepatocyte
cultures (De Bartolo et al., 2009; Powers et al., 2002b; Tilles
et al., 2001) where the albumin production is maintained at
control levels even in the presence of shear. We have
suggested that this induction is due to two factors: the
circulation of medium which provides a sustainable supply
of nutrients, as well as efficient removal of metabolic
products, and the mechanical stimulus due to the presence
of a low velocity porous or percolative interstitial-like flow
which is established through the collagen coating (Vinci
et al., 2009). In fact, in the human liver, hepatocytes are
never subject to direct or tangential flow; they receive
nutrients through a rich capillary network and consequently
only through interstitial flow driven by concentration and
pressure gradients (Rutkowski and Swartz, 2006; Swartz and
Fleury, 2007). Not surprisingly a large number of reports on
liver bioreactors use co-cultures of hepatocytes with non-
parenchymal cells, typically fibroblasts (Allen et al., 2005;
Park et al., 2007; Tilles et al., 2001). These supporting cells
not only provide heterotypic signals but also secrete collagen
which likely forms a protective coating over the cells
shielding them from direct fluid flow.
Conclusions
The objective of this study was to design, realize, and test a
modular bioreactor chamber for culture of hepatocytes and
other cells, which do not support high shear stress, with
dimensions similar to a MW. The various steps of modeling
and design of the modular bioreactor, as well as its
fabrication using ‘‘milli-molding’’ are described. The main
features of the final design are the complete absence of
bubbles, due to the particular design of the top part of the
chamber, and the very low wall shear stress in the cell culture
region. In addition, the bioreactor chambers can be
connected together in series or in parallel as desired, using
different cell types, tissue slices, or scaffolds in order to
recreate in vitro models of metabolism or diseases. Two
chambers were connected in series and tested over 24 h using
primary rat hepatocytes.
At flow rates below about 500mL/min the maximum wall
shear stress at the base of the chamber chamber is of the
order of 105 Pa or less. Cell viability is maintained at these
flow rates, while the expression of albumin is increased.
The chambers are easy to assemble and use and can be
Figure 8. a: Hepatocyte viability, expressed as the ratio between viability in the
MCmB 2.0 and controls after 24 h at different flow rates, and (b) rat albumin production
after 24 h in the MCmB 2.0 and in the control. 
P< 0.05.
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employed as a generic dynamic cell culture tool, in place of
static multiwells.
The authors wish to thank Kirkstall Ltd for its contribution to the
patenting and development of the bioreactors.
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A High-Throughput Bioreactor System for
Simulating Physiological Environments
Daniele Mazzei, Member, IEEE, Federico Vozzi, Antonio Cisternino,
Giovanni Vozzi, Member, IEEE, and Arti Ahluwalia, Member, IEEE
Abstract—The optimization of in vitro cell culture for tissue en-
gineering, pharmacological, or metabolic studies requires a large
number of experiments to be performed under varying conditions.
In this paper, we describe a high-throughput bioreactor system
that allows the conduction of parallel experiments in a simu-
lated in vivo-like environment. Our bioreactors consist of tissue-,
organ-, or system-specific culture chambers and a mixing device
controlled by an embedded system that regulates the insertion of
gas in the culture medium in order to control pH and pressure.
Each culture chamber and mixing device possesses an autonomous
control system that is able to ensure an optimal environment for
cells. A computer communicates with the embedded system to
acquire data and set up experimental variables. With this appa-
ratus, we can perform a high-throughput experiment controlling
several bioreactors working in parallel. In this paper, we discuss
the architecture and design of the system, and the results of
some experiments which simulate physiological and pathological
conditions are presented.
Index Terms—Bioreactor, cell culture, high throughput, mimic
physiological environments.
I. INTRODUCTION
C ELL CULTURE is an essential tool in biological science,clinical science, and biomedical studies. This approach
is a fundamental step in preclinical drug testing, and for this
reason, it is of great interest to the pharmaceutical industry to
employ cheaper and more ethical systems which can supply
accurate and predictive information on the effects of chemicals
on the human body.
Because drug testing involves a large number of tests on
identical cell cultures, a single well culture is inadequate and
costly both in time and money. The “high-throughput screen-
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ing” (HTS) is a methodology for scientific experimentation
widely used in drug discovery, based on a brute-force approach
to collect a large amount of experimental data in less time and
using less animals.
HTS is achieved nowadays using multiwell equipment to
contain the cell cultures subject to treatment [1]. An automatic
machine collects data, usually with an optical system, during
the treatment. Collected data can vary widely in nature, for in-
stance, concentrations of physiological metabolites or proteins.
The parallel nature of HTS makes it possible to collect a large
amount of data from a small number of experiments and in a
very short time. The multiwell system, however, suffers from
a significant problem that may affect the relevance of tests:
the environment discrepancy problem [2]. The environment
discrepancy problem lies in the fact that the tissue grown in
wells is only a brutal approximation of biological reality. There
are several relevant factors that are missing in this environment;
for instance, the cells in the well are not subject to the convec-
tive flow of nutrients present in the physiological environment.
Another meaningful example is the lack of the typical pressure
peaks and the presence of constant solute concentrations, unlike
in biological systems where gradients of concentration are the
basis of most important processes. In [3], it is discussed how the
multiwell approach does not scale fully as expected by an HTS
system because the collected data are not directly usable in drug
testing. This seems to be a paradox because the multiwell has
been the core element of the HTS methodology.
In this paper, we propose to use bioreactors to obtain an
HTS system that overcomes the limits due to the environment
discrepancy problem and obtain valid data from experiments
which simulate a physiological environment.
A bioreactor is a system able to maintain a cell culture in
a controlled environment aimed at the simulation of a living
organism. Two principal elements in the system combine to
provide a biomimetic habitat: the environmental control system
and the structural, chemical, and microfluid dynamic frame-
work of the bioreactor.
Although several different types of bioreactors [4], [5] have
been reported, particularly for tissue engineering and pharma-
ceutical applications, none has been specifically designed for
HTS. Pulsatile flow systems [6], rotating wall low shear reac-
tors [7], [8], and compression bioreactors [9], for example, are
all very large and bulky devices which do not lend themselves
well to HTS or miniaturization. On the other hand, microfluidic
systems, such as those described by Kane et al. [10], and the
animal on-a-chip device in [11] are more amenable to parallel
processing.
Here, we present a new bioreactor, called multicompartment
bioreactor (MCB), through which we are able to perform
0278-0046/$25.00 © 2008 IEEE
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high-throughput experiments in an in vivo-like simulated
environment for a long time (more than a week). Two different
compartmental cell culture chambers which simulate a blood
vessel and the metabolic system, respectively, are described.
Each chamber uses the same basic environmental control sys-
tem and can be used for HTS experiments.
The first is a laminar flow chamber, in which known shear
stresses and hydrostatic pressures can be applied in order to
mimic physiological or pathological conditions in the cardio-
vascular system. The second unit is a multicompartmental
device in which different cell types are cultured in series and
in parallel to simulate a metabolic system [12]. Together with
the environmental control system, the chambers provide a bio-
mimetic habitat for cells and enable different in vivo scenarios
to be more closely approximated.
The data extracted from this kind of culture is more pre-
dictive of the in vivo response with respect to the multiwell
approach particularly for drug related studies because the biore-
actor minimizes the environment discrepancy problem.
II. MATERIALS AND METHODS
The MCB bioreactor is a complex system. In this section, we
discuss the three main elements of the system: the bioreactor
hardware, the embedded system and the control software, and
the algorithm used to regulate pH. Two HTS experimental pro-
tocols using two different culture chambers are also described.
A. Bioreactor Hardware
The bioreactor system consists of the following parts:
1) cell culture chamber;
2) mixing chamber;
3) electronic circuit and electrovalve box;
4) peristaltic pump;
5) PC;
6) heating system.
1) Cell Culture Chamber: This part of the system is the core
of the bioreactor: It contains the cell monolayer or scaffold
where cells are seeded. The chamber is made entirely of poly-
dimethylsiloxane (PDMS), a biocompatible silicone polymer
(Sylgard 184, Dow Corning).
We have developed several types of cell culture chambers
[13], [14], and each unit can be plugged into the system and
used for different kinds of experiments. A laminar flow cham-
ber was specifically designed to enable cells to be subject to a
large range of shear stresses. Several cardiovascular pathologies
are associated with altered patterns of flow and shear stress. The
study of endothelial cell response to different flow conditions is
therefore important for understanding and curing cardiovascu-
lar diseases.
Using finite-element methods and imposing a number of
design criteria such as maximum volume and minimum area
for cell culture, as well as the range of shear stresses desired,
we converged to a final design for the chamber. Fig. 1 shows the
chamber design and the constant and controlled velocity vector
in the cell culture zone.
By changing the flow rate of the fluid, constant and controlled
shear stresses ranging from 40× 10−3 to 900× 10−3 Pa can
be applied to simulate aortic as well as capillary shears in
physiological or pathological states.
Fig. 1. Finite-element method simulation of the laminar flow bioreactor
chamber with a medium flow speed of 0.05 m/s (12 mL/min).
Equation (1) allows the shear stress (τ) on the cell layer
to be calculated from the applied volume flow rate (Q) with
a medium viscosity (µ), cell chamber cross section (A), and
a distance between the center of the chamber and the cell
monolayer (z)
τ = µ
Q
A · z . (1)
A completely different chamber configuration was adopted to
simulate the metabolic system. Here, we used allometric prin-
ciples to design a series of interconnected chambers in order
to represent the principal components of the human metabolic
system, focusing on the metabolism of glucose, which is the
most important energy source for all organisms. Central to
glucose metabolism are the liver and the pancreas, followed
by insulin- and glucose-dependent target tissues. To design the
system, the relationship between different parameters such as
metabolism, time, volume distribution, and organ dimensions
was considered in order to scale the physiological interactions
present in the human body [15].
Thus, volume, flow rates, and cell numbers were downscaled
using relationships based on allometry [16]. The simplest con-
nected culture chamber device refers to a system with four cell
types considered relevant to glucose metabolism (hepatocytes,
pancreatic islets, visceral adipose tissue, and endothelial cells).
The general equation for allometric scaling is
Y = YoM
b (2)
where Y is the parameter in question (flow rate, metabolism,
etc.), Yo is the proportionality factor, M is body mass, and b
is the allometric scaling exponent. The mass of the standard
human body is 68.5 kg, and our system is approximately 20 g.
In the case of volume and of the cell ratios, the exponent
b = 1. Consequently, we first considered the ratios of cells
in the system and scaled these down linearly in accordance
with the allometric equation. The flow rate was scaled using
b = 3/4 with respect to the portal flow rate. This flow rate also
corresponds to small blood vessel and capillary flow velocities
and to the range of shear stress typically found in blood vessels
[17]. Because our main focus of interest is the study of glucose
metabolism, the reference physiological data were referred to
data on blood glucose levels in normal humans [18]. Through
these data, the distance between the liver compartment and the
other three compartments were estimated (liver–pancreas from
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Fig. 2. MCB chamber topological scheme.
Fig. 3. (a) Cell culture chamber. (b) Mixing chamber. (c) Electronic and
electrovalve box. (d) Peristaltic pump. (e) Heating box with four mixing
chambers ready for the experiment.
5 to 7 cm and liver–adipocyte from 9 to 17 cm, with times of
about 2 and 15 min, respectively) [19]–[21]. A schematic of the
connected culture MCB chamber is shown in Fig. 2.
Each MCB unit is realized using an appropriate mould, in
which silicone tubing is inserted during the fabrication process
such that it is integrated into the chamber. PDMS is cast
and cured in the mould by heating at 65 ◦C and then care-
fully removed, washed, and sterilized with H2O2 gas plasma.
Following the sterilization phase, cells are seeded onto the
chambers as necessary, and the bioreactor is assembled. The
PDMS base is then covered with a gas plasma sterile glass plate,
and the two are clamped together by a Teflon frame which can
be tightened with screws [Fig. 3(a)] [22].
Medium flow in the chambers is generated by a peristaltic
pump (P720, Instech, Plymouth, PA, USA) connected to the
tubing and controlled by the electronic control unit for the
regulation of flow rate. The electronic unit also controls a
heating system below the culture chamber, which maintains the
cell culture at constant temperature.
2) Mixing Chamber: The mixing chamber [Fig. 3(b)] is
connected in series with each cell culture chamber and serves
for pH and oxygen regulation as well as to remove air bubbles;
essentially, the medium is perfused with gas according to the
measured pH. The medium is inserted in this chamber through
a needle with the flow imposed by the peristaltic pump. pH
regulation is performed by inserting two different gases in the
mixing chamber: CO2 and air (not O2 because of flammability
risks). The culture medium contains bicarbonate buffer, and
its pH can be closely regulated through diffusion of gases;
in particular, the diffusion of O2 (Air) tends to raise the pH,
whereas CO2 tends to lower it [23].
3) Electronic Circuit and Electrovalve Unit: This part of
the system is the heart of the bioreactor control unit; there
are the electronic circuits for the sensors, for communication
with the PC, and for the actuation of the electrovalves. The
electrovalves are used to select the gas that is injected in the
mixing chambers and are connected to a pressure regulator used
to control the pressure inside the cell culture chamber.
4) Computer: The computer is plugged to the electronic
circuit and electrovalve unit through a network cable; there is an
embedded system board responsible for controlling the system.
We use a Wildﬁre 5282 [24], a microcontroller unit based on a
Motorola Coldfire microcontroller. The Wildﬁre board is used
to control the pressure regulator and the electrovalves and for
reading the sensor data; the data are stored on a secure digital
card and are sent to the computer using the user datagram
protocol (UDP) over the Ethernet connection.
The system is equipped with a liquid crystal display to
allow an immediate control of the experiment parameters with-
out a PC.
5) Heating System: The bioreactor heating system consists
of a Plexiglas box where the mixing chambers1 are inserted
[see Fig. 3(d)]. Water heated by a thermostatic bath is inserted
in the heating box, or it is also possible to equip the box with a
resistor heater placed under the culture unit.
Culture chambers are also heated independently using a ded-
icated resistive heater [25]. Both the resistive heaters are con-
trolled by the electronic unit through a pulsewidth-modulation
(PWM) power regulator. The PWM signal is generated by
one of the digital I/O wildfire channels and is amplified by a
dedicated FET-based electronic circuit.
Two thermistors are used to monitor the temperature of
the mixing and culture chambers, respectively, and feedback
control ensures that the temperature is constant [26], [27].
B. Control System
The microcontrolled board runs the µTNetOS operating sys-
tem (OS), a general purpose OS for microcontrolled systems
[28] developed for the purpose.
µTNetOS is a generated OS: The system generator takes
as input the description of an eXtensible Markup Language
(XML)-based protocol and generates an instance of the OS
with the entire communication system tailored for the particular
protocol. It uses cooperative multitasking to run concurrent
activities.
We have developed an application targeting the instance of
µTNetOS tailored for bioreactors. The goal of the application
is to make the bioreactor autonomous by monitoring the envi-
ronmental variables and taking appropriate actions according
to a policy defined through a networked computer and stored
within the controller.
Because Ethernet is a communication bus, the graphical
application used to control an experiment can receive UDP
packets from several units running in parallel. This is very im-
portant in the context of HTS methodology [29]. The network
also allows connections through the Internet, allowing remote
monitoring of experiments, an important feature because ex-
periments run for several days [30].
A high-throughput bioreactor experiment employs many
bioreactors with different cell culture chambers. A pathology
1At least four of them are allowed.
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Fig. 4. Schematic flowchart of the bioreactor system. In orange are the
electronic control unit and electronic connections; in green are the sensors, and
in red are the culture chamber and the medium circuit. The gas connection and
apparatus are represented in blue.
can be simulated in one of the Bioreactors, and the others used
a control reference; we can setup the environmental variables
of the bioreactors in order to simulate one or more pathologies
and observe the influence of this different environment on tissue
function during an experiment.
µTNetOS messaging complies with an XML-based stan-
dard defined by a robotics programming framework called
Robotics4.NET [31], [32]. The framework proposes a software
architecture inspired by the architecture of the human nervous
system. In this context, the software running on the autonomous
embedded system of the bioreactor is perceived as a roblet, a
sort of peripheral organ abstraction provided by the framework.
A program based on Robotics4.Net is composed of three
ingredients.
1) The brain: It is the core of the control system.
2) The bodymap: It is a sort of black board used to send and
receive messages.
3) The roblets: They are the appendix of the system, like
the parts of our nervous system. They read data from the
environment and convert the brain signal into an action.
In our case, each of the bioreactor systems is perceived as
a roblet that communicates with the program on the computer
hosting the bodymap.
Because the connections among the roblets and the bodymap
are based on a data gram-oriented protocol, the brain can
be powered off and restarted afterward without affecting the
activity of roblets.
In a bioreactor system, it is necessary to control many param-
eters: the amount of nutrients flowing in the cell culture cham-
ber, the hydrostatic pressure inside the system, the shear stress
of the flow on the cell culture, the flow of gas, the temperature
flux generated by the heating system, and the pH of the medium
(Fig. 4). These parameters are established using a graphical
interface and sent to the roblets running on the bioreactors.
To control the nutrient flow and the shear stress, it is neces-
sary to regulate the speed of the peristaltic pump used to perfuse
the nutrients inside the bioreactor, this control is operated by a
serial connection between the pump and the controller board
and is monitored in a feedback mode through an appropriate
control pin of the pump. The hydrostatic pressure inside the
Fig. 5. Schematic connection of the pressure regulation system.
Fig. 6. Flow diagram of the control algorithm for pH regulation.
circuit and the flow of gas through the mixing chamber are
regulated by fine control of the pressure regulator and of the
outlet; the outlet can be set manually in order to obtain the
desired pressure in the mixing chamber. The system reads
the pressure inside the mixing chamber with a pressure sen-
sor plugged in parallel with the outlet; in this way, we can
control the system in a classic feedback mode (Fig. 5).
The heat flux and the temperature of the cell culture chamber
is controlled by a feedback system, which reads the temperature
of the cell culture chamber through a negative temperature
coefficient sensor placed near the cell monolayer and imposes a
voltage across a dedicated resistive heater placed under the cell
culture chamber.
As mentioned in [33], the pH is more complex to control than
the other parameters because of delays between gas infusion
and ionic dissociation; for this reason, we studied a dedicated
control strategy based on a variable delay time, which is re-
ported in the following section.
C. pH Control Algorithm
To control the pH in the medium, we developed a control
adaptive algorithm based on a step strategy. This control algo-
rithm is a high priority service running on µTNetOS.
A formal model of the algorithm has been also defined using
the abstract state machines (ASM) formalism [34].
Authorized licensed use limited to: UNIVERSITA PISA S ANNA. Downloaded on February 24,2010 at 07:15:45 EST from IEEE Xplore.  Restrictions apply. 
MAZZEI et al.: HIGH-THROUGHPUT BIOREACTOR SYSTEM FOR SIMULATING PHYSIOLOGICAL ENVIRONMENTS 3277
The pH response to the diffusion of CO2 and air is very
difficult to predict, because it depends strongly on the en-
vironmental variables of the particular experiment such as
temperature, volume of medium, type of medium, hydrostatic
pressure, number of cells, and their metabolic state. For this
reason, we do not use the mathematical model of the CO2 and
air diffusion in water medium but instead use a function defined
by an algorithm.
Our system continuously inserts air in the mixing chamber
through an appropriate needle; when the pH goes over the safety
threshold (0.05 units of pH over a user-defined threshold), the
control inserts a known CO2 impulse, in the mixing chamber,
and waits a delay time. In this way, we can insert a known
amount of CO2 inside the mixing chamber and wait to evaluate
the effect of this operation. If the pH returns under the safety
threshold, we can stop the pH control phase; otherwise, after
the delay time has passed, the control inserts a new impulse of
CO2 and waits for the delay time. The delay time is adjusted at
every step in a manner dependent on the value of pH and the
derivative of pH with time.
The pH control strategy includes one safety logic test used to
evaluate whether the pH is decreasing or not; in the case of a
negative derivative, if the pH value is over the safety threshold,
the control does not insert CO2 because we can assume that the
last CO2 injection was sufficient for the pH control and the pH
can return under the threshold in a short time; this test prevents
an excessive fall in pH, because the CO2 injection causes a large
drop in pH but with a substantial delay (Fig. 6)
TDelay(n) = TDelay(n− 1)
× [A(pH − pH∗) + B (pH(n)− pH(n− 1) ] . (3)
Equation (3) describes how the time delay is calculated by
the roblets running on the Wildfire 5282 board. The delay time
to use at the current step is proportional to the delay time of the
last step but with an additional value that is directly proportional
to the difference of the current and expected pH values and a
part that is proportional to the first derivative of the pH signal
coming from the pH meter.
The multiplicative constants A and B are between zero and
one; in this way, we added only a part of the (n− 1) delay time
for every control step.
These constants can be predicted by the formal model based
on ASM [35] for a water environment but are very sensitive to
the physical condition of the experiment (volume and type of
medium, pressure, and temperature). Consequently, we have to
calibrate the system through the user interface before starting a
new session, in order to match the pH control parameter with
the experimental setup.
D. GUI Software
Our graphical user interface (GUI) is developed in C#.Net
and is based on a multitab structure; we use the GUI to read data
from the bioreactors and to set up the experimental variables
of each one. The user interface also features a tool for sensor
calibration, in order to perform the sensor calibration with the
same software that we used for bioreactor control.
The user has control over the experiments, including a
manual overdrive, although the autonomous control software
running on the embedded systems avoids commands that could
damage the system or the experiment.
When the user interface is open, it seeks out connected
bioreactors; when one is found, the GUI switches in the view
mode. In this section, we can see data of the bioreactor selected
by the menu, and experimental settings can be changed through
the configuration tab.
E. Cell Culture Experiments
The MCB bioreactor system was tested in a “virtual labo-
ratory,” in which we simulated a typical parallel experiment
with four “animals.” For each experiment, we installed four
bioreactors, and we performed laminar flow and connected
culture HTS trails, respectively, with cells in the bioreactor
under a constant flow of nutrients and gas.
These experiments demonstrate how our bioreactors can be
used to conduct experiments in a high-throughput manner with
four parallel chambers and how we can control and store data
with a single computer placed in any location.
1) Laminar Flow Chamber: The cells used for the laminar
flow experiments were human umbilical vein endothelial cells
(HUVEC) [36]. They were placed in the cell culture chambers
and in an incubator for 24 h in order to ensure their adhesion
on the gelatin-treated PDMS base. After incubation, the cell
culture chambers were plugged into the bioreactor system, and
we ran four sets of experiments at four different flow rates
(including zero) for 24 h. At the end of each experiment, we
analyzed the culture medium for nitric oxide (NO), a vasodila-
tor, and endothelin (EN-2) [37], a powerful vasoconstrictive
molecule which counteracts the effects of vasodilation. Cell
morphology and orientation were also assessed by calculating
cell eccentricity.
2) Connected Culture Chamber: To demonstrate the appli-
cation of HTS in the MCB connected culture chamber, hepa-
tocytes and endothelial cells (HUVEC) were used in a ratio
similar to that in the liver. Hepatocytes were extracted directly
from freshly explanted murine (black mice, strain C57BL/6)
liver and cultured according to standard procedures [38]. The
endothelial cells were prepared according to the method de-
scribed by Jaffe et al. [36].
Glass slides of 12-mm diameters with 80 000 hepatocytes
and 8000 HUVEC were inserted into the connected culture
bioreactors and then connected to the mixing device and pump
and filled with 30-mL William’s culture medium. Controls us-
ing only hepatocytes in the absence of HUVEC were also con-
ducted. For these experiments, a flow rate of 175 µl/min was
applied to four systems running in parallel. Experiments were
carried out for 24 h, during which 2 mL of the medium was
withdrawn for analysis at 2 h 40 min, 4 h 20 min, 6 h, and 24 h
and was replaced with 2 mL of fresh medium. During each
withdrawal, albumin, an important biomarker for hepatocyte
synthetic function, was quantified using a commercial enzyme-
linked immunosorbent assay kit and the data compared with
standard static multiwell cultures.
III. RESULTS
The experiments showed how the high-throughput bioreac-
tors system can run for up to 24 h in order to simulate the classic
parallel “animal” experiments; in this way, we can greatly
Authorized licensed use limited to: UNIVERSITA PISA S ANNA. Downloaded on February 24,2010 at 07:15:45 EST from IEEE Xplore.  Restrictions apply. 
3278 IEEE TRANSACTIONS ON INDUSTRIAL ELECTRONICS, VOL. 55, NO. 9, SEPTEMBER 2008
Fig. 7. The pH in the four bioreactor systems during the laminar flow
experiment; the numbers in the legend are the four bioreactors ID labels. The
acquisition was carried out over 24 h but a 300-s window is shown here.
Fig. 8. Pressure graph shows how the control system is able to maintain the
desired value of pressure inside the bioreactors.
reduce the number of “animals” that are necessary for the exper-
iments. Another important aspect of the new bioreactor system
is that, in this mode, it is possible to perform experiments in an
in vivo-like biomimetic habitat instead of in a multiwell, which
is a brutal approximation of the physiological environment.
The data extracted from the bioreactors during the experi-
ments show how the new system is able to correctly control the
environmental variables.
Fig. 7 shows how the new bioreactor system is able to
maintain a pH value in the medium around the physiological
value of 7.4. It has a maximum error deviation of −1.2 and
+0.3; the asymmetry of the pH error deviation is a consequence
of the pH control strategy. In fact, when CO2 is inserted inside
the chamber, we have a rapid drop of pH; otherwise, when air
is inserted, the pH increases slowly; for this reason, it is very
difficult to prevent the excessive undershoot of pH because an
opening time of the CO2 electrovalve of only 0.5 s is necessary
to control the pH but at the same time gives rise to a slow but
large drop in pH. The pressure graph (Fig. 8) shows a pressure
step experiment; in this experiment, we choose to increase the
pressure in the cell culture chamber with a step in order to
simulate hypertensive stress.
A. HTS Laminar Flow
The vascular endothelium is a dynamic organ that responds
to various physical and humoral conditions by producing sev-
eral biologically active substances, both vasoconstrictors and
vasodilators, which control these processes. Therefore, to as-
sess the ability of the laminar flow system in maintaining func-
tional properties that cells possess in physiological conditions,
we examined the production of these important vasoactive
factors (NO and EN-2) by endothelial cells in different shear
stress conditions. The results are shown in Figs. 9 and 10.
Endothelin production decreases even at very low shear
stresses, indicating that the cells respond to static conditions by
overexpressing vasoconstrictive functions in an effort to com-
Fig. 9. NO production (micromole per 106 cells) after 24 h in the laminar
flow bioreactor chambers with different shear stresses.
Fig. 10. Endothelin production (picogram per 106 cells) after 24 h in the
laminar flow chamber with different shear stresses.
Fig. 11. Change in the cell eccentricity E during a 24-h experiment in a
laminar flow chamber with different shear stresses compared with the capillary
physiological eccentricity (E = a/(2b)) with a as the major radius and b as
the minor).
pensate for the lack of mechanical stimulus normally produced
by flow. This is also reflected in NO production, which in-
creases steadily with shear stress. Fig. 11 shows the change
in eccentricity of endothelial cells, which respond to shear
stress by orienting and elongating along the direction of flow
as observed in vivo.
In Fig. 12, a cell culture after 24 h of laminar flow treatment
with the MCB laminar bioreactors is shown. We can observe the
vitality of the cells, that do not show any type of cell membrane
damage or formation of picnotic nuclei.
The cells can be used as sensors of the environment, to
evaluate the consequence of flow treatment. In the micrograph,
the endothelial cells are oriented with the medium flow and
have elliptical shapes similar to their in vivo morphology.
B. HTS Connected Cultures
The connected culture system was conceived using bio-
mimetic principles to reproduce salient features of the
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Fig. 12. Cell culture after 24 h of treatment; we can observe how the cells
have an elliptical shape and are oriented with the medium flow (indicated by
the arrow).
Fig. 13. Albumin production after 24 h of experiment in an HTS MCB
connected culture; the MCB CC system is a dynamic (175 µl/min) connected
culture of hepatocytes and HUVEC, MCB SC is a dynamic culture in MCB
with only hepatocytes, and MW is a static hepatocyte multiwell culture.
metabolic system with particular regard to the metabolism of
glucose, fat, and protein. The chamber was designed using allo-
metric laws conserving proportions and ratios between different
organs. It allows cell–cell crosstalk to be studied in a rigorous
and controlled manner, by addressing and interrogating one cell
type at a time, and could lead to a better understanding of the
physiological and biochemical complexity. Obviously, a focal
point of the system is the hepatocyte chamber, because the liver
is the principal metabolic organ in the body. This initial study
was therefore on a hepatocyte–endothelial connected culture
model considering only proportions between the two cell pop-
ulations in the liver. Overall, large differences in albumin pro-
duction were observed between static multiwell and dynamic
cultures, and smaller but nonetheless significant differences
were observed between dynamic monocultures and connected
cultures: evidence of crosstalk between two cell types. Strictly
speaking, the static monoculture conditions cannot be directly
compared with the connected culture as the medium volumes
are quite different. The availability of oxygen and nutrients is
increased, the fluid is well mixed, and nutrient depletion in the
medium is negligible in the bioreactor system. This is shown in
Fig. 13, which shows that albumin production is upregulated
by about 1.5 times when compared with connected cultures
with dynamic monocultures and over 50 times when comparing
dynamic and static multiwell monocultures.
IV. CONCLUSION
In this paper, we have presented an alternative HTS approach
for cell culture. Using a purposely designed and constructed
autonomous software and electronic control and acquisition
system combined with specific cell culture chambers, it is
possible to simulate a biomimetic habitat for cells. The control
system and software enable the temperature, pH, pressure, and
flow to be tightly regulated or modulated to simulate physiolog-
ical or pathological environments. Special chamber designs can
be used for approximating the geometry, fluid dynamics, and
chemical environment of different organs or systems.
The experiments demonstrate how the high-throughput MCB
bioreactor system is able to perform experiments in parallel,
combining the advantages of in vivo-like simulated environ-
ments with an HTS control strategy. So as not to limit the
applications of the systems, the OS µTNetOS was generated
and not written ad hoc; in this way, we can easily change
the hardware platform without reengineering the OS. A further
innovative aspect is the modular architecture of the hardware
which is mirrored by the human nervous system-inspired soft-
ware architecture.
Our efforts are now being directed to predictive drug toxi-
cology, nanotoxicology, and the works of hypertension-related
cardiovascular diseases.
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1 Introduction
A great deal of effort is being made to preserve liv-
er-specific function in vitro.There are several driv-
ing forces for this, perhaps the two most important
are drug testing and bioartificial liver devices. For
the moment, the prevailing opinion in the literature
is that it is impossible to maintain an adequately
differentiated hepatic phenotype after isolation
from the liver for more than a week [1]. Several pa-
rameters are known to play a role in maintaining
liver function; among these are the presence of an
adequate nutrient supply, an extracellular environ-
ment rich with ligands for adhesion and signalling,
and a spatial architecture resembling that of the
native liver, as well as a multicomponent medium.
These parameters form what we call here the tri-
partite of cues: a trio of biochemical, biophysical
and biomechanical signalling systems that interact
synergically to support both form and function in
all living tissues [2].
A wide variety of methods have been and are
being developed to maintain and study the function
of hepatocytes in vitro. Many of these are based on
devising complex cocktails of culture medium,
which often include inducing agents to drive hepa-
tocytes towards expression of P450 cytochromes
[3]. Others use engineering-based methods such as
scaffolds and bioreactors. Several authors have
used 3-D structures such as collagen [4], or loofa
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sponges in static and perfused cell culture condi-
tions [5] and hydrogel encapsulated hepatocytes
[6]. In the past few years the use of bioreactors has
become very popular because a dynamic cell cul-
ture system allows efficient metabolite exchange,
and may also provide an indirect physical stimulus
through percolative or interstitial-like flow [7].The
bioreactors can be divided into two main groups:
those for large-scale culture, such as flat mem-
brane systems, and microfabricated systems, which
involve 2- or 3-D cultures and microfluidics. The
simplest systems are continuous flow reactors,
such as that proposed by Catapano and De Bartolo
[8], which are useful for large-scale culture, partic-
ularly for artificial liver applications. A microfabri-
cated array reactor with deep wells for hepatocyte
spheroids was described by Powers et al. [9, 10]. In
this system, the wells were perfused by the medi-
um and the cells were reported to remain viable for
2 weeks, with high levels of urea and albumin se-
cretion. Hongo et al. [11] and Kataoka et al. [12] de-
scribe the culture of porous scaffolds in a radial
flow bioreactor, so combining two of the cues in a
single experiment. It is also recognised that co-cul-
ture of hepatocytes and non-parenchymal cells
augments liver phenotypic function. Bhatia and
colleagues [13, 14] pioneered the use of 2-D mi-
cropatterns in mono- and co-culture, and they have
reported on various combinations of heterotypic
cultures as well as a comparative study that high-
lights the differences in gene expression in differ-
ent co-culture combinations. Several reports by the
group of Yarmush and Toner on microfabricated
grooved substrates for hepatocyte co-cultures have
been published, showing the advantage of grooves
with respect to flat surfaces [15, 16]. Finally, sand-
wich cultures, in which hepatocytes are either sup-
plied with an adhesive protein-based roof and floor
to recreate a pseudo 3-D extracellular matrix envi-
ronment, have also been widely reported to en-
hance hepatic function [17]. Despite the extensive
literature on the subject, it is not clear how strong-
ly each of these parameters influence hepatic phe-
notype; quite likely the biochemical, biophysical
and mechanical stimuli provide multiple cues that
act in unison to mimic the in vivo hepatic environ-
ment.The aim of this work was to gain a better un-
derstanding of the role of a 3-D architecture and
convective mass transfer on hepatocytes in vitro.
We therefore designed an in vitro model of the liv-
er using a bottom-up engineering approach, i.e. a
step-wise increase of the number of cues in the
system. For this study we considered only cues that
can be controlled externally using mechanical and
structural design parameters. Biochemical control
of hepatocyte function is far more complex because
the cells themselves modulate the chemistry of
their environment. Firstly, the influence of a 3-D
open-pore microfabricated scaffold on HepG2 cell
proliferation and metabolic function was assessed
using two different biomaterials.The most suitable
material was then selected for experiments using a
low-shear, high-flow bioreactor (Mazzei et al., A
low shear stress modular bioreactor for connected
cell culture under high flow rates; Biotech. Bioeng.,
submitted), and both cell proliferation and metab-
olism were analysed and compared with controls.
2 Materials and methods
2.1 Microfabrication with pressure-activated 
microsyringe
The pressure-assisted microsyringe (PAM) deposi-
tion method has been described in several refer-
ences [18]. Basically it consists of a pressure-activ-
ated syringe, which is controlled by a computer-
aided design/computer-aided manufacturing
(CAD/CAM) fabrication system. The syringe is a
stainless steel barrel with a glass capillary needle
with a diameter of 5–20 µm. It is filled with a vis-
cous polymer solution and mounted on a three-axis
micropositioner. Pressurised air is used to extrude
the polymer solution through the micro-needle and
deposit it on a solid substrate such as a glass cover
slip.The CAD/CAM system allows an infinite range
of structures with a lateral resolution of 5 µm to be
designed and fabricated. 3-D polymeric scaffolds
are assembled by depositing a water-soluble poly-
meric spacer (Hydrofilm, Lucart, Italy) of about
10–20 μm between the layers. This avoids the col-
lapse of subsequent layers and creates large pores
in which cells are able to penetrate and adhere.Af-
ter the microfabrication step, scaffolds are im-
mersed in water. During this process the polymer
spacer is dissolved away and the scaffolds float off
the substrates and can be handled with tweezers.
PAM has the highest resolution of all 3-D
CAD/CAM microfabrication methods used in tissue
engineering, and the fidelity of the scaffolds is
about 10% [19].Apart from the machine-dependent
deposition parameters such as needle-bore size
and motor speed and precision, the fidelity de-
pends mainly on the viscosity and surface tension
of the polymer.
2.2 Polymer and scaffold treatment
The polymers used in this study were: poly-DL-lac-
tide-co-glycolide (PLGA) 75:25 and poly-L-lactide
(PLLA) (Lactel, NPPharm-F, Bazainville, France).
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PLGA and PLLA are biodegradable polymers
widely used in tissue engineering applications. Our
group has tested these polymers in the form of
spin-coated films and PAM scaffolds and their suit-
ability for cell adhesion and tissue engineering has
been evaluated [20]. Solutions of 20% PLGA and
10% PLLA in chloroform have excellent deposition
characteristics in terms of their viscosity and sur-
face tension, and these concentrations were used
for all experiments. Hexagonal unit cell structures
were microfabricated with 50-μm line width and
500-μm unit side length (Fig. 1A illustrates the def-
inition of these terms), and were composed of three
layers with 70 hexagons each (Fig. 1A). Each layer
was laterally offset by 250 µm so that the hexagons
were not piled flush but formed small open pores
in the scaffold. The dimensions were chosen be-
cause they mimic the characteristic size of hepatic
lobules [21]. Figure 1B shows an example of a
PLGA 3-D scaffold. Polymer films were realised by
spin coating (Delta 10TT, SÜSS MicroTec) at
7500 rpm for 15 s on 13-mm diameter glass cover
slips. These films were used as a monolayer static
control to investigate how cell function is influ-
enced by a 3-D topology and to compare and nor-
malise the experimental data with respect to the
polymer’s intrinsic characteristics rather than lab-
oratory tissue culture plastic.
Before cell seeding, to remove all traces of sol-
vent, the scaffolds and films were placed in a des-
iccator under vacuum for at least 1 week, and then
washed extensively with deionised water and dried
in an oven at 50°C. Following this, the structures
were placed in 24-well plates (Sarstedt, Verona,
Italy) and sterilised using a standard hospital H2O2
Gas-Plasma protocol available at our clinical facil-
ities.To promote cell attachment, 5 µg/cm2 purified
collagen, PureColTM (INAMED, Leimuiden, The
Netherlands), was pipetted over the structures and
after 1-h incubation at 37°C, they were washed with
PBS three times and equilibrated with fresh medi-
um overnight in the incubator.
2.3 Bioreactor design and assembly
The multicompartment modular bioreactor (MCmB)
bioreactor was developed to enable cell and tissue
culture in a variety of configurations ([22] and
Mazzei et al., submitted). Its main characteristics
are high flow rates and low wall shear stresses. In
its simplest form, as used in this work, it is made of
polydimethyldisiloxane (PDMS; Dow Corning,
Italy), and has the same dimensions as a 24-mi-
crowell plate (15 mm diameter and 2 mL volume).
A patented sloping roof ensures the absence of
bubbles in the chamber. A finite element modeling
(FEM) model of the cell culture chamber was de-
veloped to study the shear stress at the cell surface.
Cosmos Floworks, a Solidworks™ (Dassault Sys-
tèmes SolidWorks Corp. Concord, MA, USA) exten-
sion, which allows fluid-dynamic FEM analysis as
well as 3-D CAD was used for this purpose. In the
fluid dynamic model we used the following system
constants: viscosity, 10–3 Pa·s; fluid densi-
ty, 1000 kg/m3; medium flow rate, 250 μL/min;
pressure, 1 atmosphere (760 mmHg); temper-
ature, 37°C; and no slip boundary conditions. Fig-
ure 2A shows a 3-D representation of the chamber,
and in Fig. 2B the velocity streamlines modelled us-
ing SolidWorksTM are drawn.
Three MCmB bioreactors were connected in
parallel to a pump (Instec P720, Instec, Boulder,
Colorado, USA) and a mixing chamber, which
serves to facilitate assembly of the flow circuit, al-
lows gaseous mixing and acts as a bubble trap. A
flow rate of 250 µL/min was used in all experi-
ments, and the average shear stress in the cell cul-
ture zone was calculated by fluid dynamic simula-
tion. The maximum wall shear stress at the flow
rate used was about 10–5 Pa.
In our experience, even small flow rates may
damage hepatocytes. Therefore, all the cultures
were protected with a thin coating of alginate as
described in the section on cell culture. In the
Biotechnol. J. 2009, 4 www.biotechnology-journal.com
Figure 1. (A) CAD design of one layer of the hexagonal scaffold showing
approximate total dimensions which define the nominal area. On the
right, the terms unit side length and line width are defined for one unit
hexagon. (B) Optical micrograph of a 3-D PLGA scaffold.
A
B
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bioreactor experiments the medium was not
changed since sufficient nutrients were present in
the 10-mL closed loop circuit (2 mL in each biore-
actor, 7 mL in the mixing chamber and about 1 mL
in the tubing).
2.4 Cell culture
Since primary hepatocytes rapidly lose liver mor-
phology and differentiated functions in vitro, in this
study we used the HepG2 cell line as an alternative
model cell. HepG2 cells maintain the main syn-
thetic and endogenous functions of primary hepa-
tocytes, as well some exogenous metabolic func-
tions [23]. Furthermore, the HepG2 cell line is sim-
ple to culture and, by virtue of its immortality, it is
possible to make standard comparisons that re-
main valid over time and for all experiments.
HepG2 human hepatoblastoma cells were a
kind gift from Dr. S. Quarta, University of Padova.
The cells were grown in Eagle’s minimal essential
medium (EMEM, 1 g/L glucose) supplemented with
5% foetal bovine serum, 1% non-essential amino
acids, 1% EMEM vitamins, 2 mM L-glutamine,
100 U/mL penicillin and 100 µg/mL streptomycin
in a humidified incubator at 37°C, 5% CO2 (Heraeus
SpA, Milan, Italy). The cells were all used at the
same passage (no. 22 after receipt) and passaged
using 0.05% trypsin with 0.02% EDTA in PBS (all
reagents from Eurolone, Milan, Italy). Cells were
seeded (100 000 cells/cm2) on the films or scaffolds
using 2 mL of complete medium per well. After
24 h, the structures were moved to a new microwell
plate to eliminate interference from non-adherent
cells.
Both scaffolds and films were coated with an al-
ginate film consisting of 250 μL 1% sodium alginate
dissolved in serum-free medium, cross-linked with
50 μL 1% CaCl2 (both from Sigma-Aldrich, Milan,
Italy). Excess alginate was removed with a pipette.
The resulting film had a thickness of a few tens of
microns as measured by an optical profilometer
(Opto NCDT, model ILD1400-10, UK), having a
nominal resolution of 1 μm. The profilometer uses
a small laser spot (0.7 mm × 0.5 mm) which is re-
flected off a surface. Displacements were calibrat-
ed using an uncoated glass slide as a reference.The
coating was not uniform and flat as observed by an
optical microscope, and this was also reflected in
the scatter of the profilometer readings across the
slide (40–100 µm). At the low alginate concentra-
tions used, the diffusion coefficient of oxygen and
of small solutes is similar to that in water [24–26].
Finally, 2 mL fresh medium was added to each
well to begin the experiment. Cells were main-
tained on the structures for a week and cell count-
ing and medium collection was performed daily.
The experiment was performed in triplicate using
21 structures, three samples were sacrificed for
counting per day, and the culture medium was
changed every third day.
2.5 Bioreactor culture
For the dynamic experiments, cells were seeded as
described for the static cultures. At 24 h after seed-
ing, the scaffolds were transferred to a glass slide,
placed in the MCmB (one scaffold per bioreactor)
and coated with an alginate film.The alginate coat-
ing was used to protect the cells from direct me-
chanical stress, while allowing adequate nutrient
diffusion. The coating also stops the scaffolds from
floating off the slides. Medium was perfused and
re-circulated through the chambers at a flow rate
of 250 μL/min. A total of 21 scaffolds were used for
the bioreactor experiments. In particular, three
bioreactors with three scaffolds were used per time
point, and at the end of each time point the biore-
actors were disassembled for cell counting and a fi-
nal sample of medium collected. In addition, up to
Figure 2. (A) A 3-D representation of the MCmB cell culture chamber, 
(B) velocity streamlines at a flow rate of 250 μL/min.
A
B
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200 μL media (50 μL per assay) was withdrawn
from the mixing chambers for analysis at fixed in-
tervals. All cell culture experiments were carried
out in the same incubator.
2.6 Cell analysis and assays
2.6.1 Cell viability and density
At the end of each time period, the cells adhered on
the structures were trypsinised off the scaffolds
and membranes and counted using a Burker cham-
ber. Cell viability was evaluated using trypan blue
exclusion, and this was always greater than 95%.To
ensure that all cells had been accounted for, the
scaffolds were also stained with trypan blue and
typically only a few cells were observed on the scaf-
folds after trypsinisation. Cell morphology was as-
sessed using an optical microscope (AX70, Olym-
pus Italia, Milan).
Because the 3-D scaffolds are composed of
three layers of hexagons, the “true” area available
for cell adhesion is difficult to estimate. According
to the CAD model shown in Fig. 1A, the total sur-
face area of one layer of the scaffold is about
0.06 cm2; however, a 3-D scaffold may also have ad-
hesive surfaces in more than one plane. Therefore,
we use the term “nominal area” to refer to the over-
all area of the scaffold or film. Cell densities are ex-
pressed as the total number of cells counted divid-
ed by the nominal 2-D surface area of the samples.
The PAM scaffolds have a nominal surface area of
0.8 cm2 and a large percentage of this is free space
of the pores, while the spin-coated films have an
area of 1.33 cm2.
2.6.2 Biochemical assays
Albumin production, which characterises the spe-
cific functional activity of liver cells, was measured
by an enzyme-linked immunosorbent assay
(ELISA) (Bethyl Laboratories, Montgomery, TX,
USA). A standard curve was made using purified
human albumin under the conditions recommend-
ed by the manufacturer. Species specificity of the
anti-human albumin antibodies was verified using
foetal bovine serum (FBS). Glucose consumption
and urea production were quantified using com-
mercial enzymatic kits according to the manufac-
turers’ instructions (Megazyme International Pon-
carale, Italy, and Urea Kit, Sigma-Aldrich, respec-
tively). To compare data from different experi-
ments with different cell numbers and media
volumes the glucose, albumin and urea data were
expressed as quantities consumed or produced per
cell per day, and therefore as rates, not cumulative
quantities.
2.7 Statistical analysis
Statistical analysis was performed using analysis of
covariance (ANCOVA) for comparison of trends
(Matlab Statistics Toolbox, The MathWorks Inc.); a
p value of less than 0.05 was considered statistical-
ly significant. Each data point is represented as the
mean and SD of three samples and at each time
point three scaffolds were analysed destructively
(by trypsinisation) for cell counting.
3 Results
3.1 Comparison between 2-D films and 
3-D scaffolds in static culture
As shown in Fig. 3, the cell density was higher on
the scaffolds than on films particularly from day 4
onwards (ANCOVA, p<0.01). The cells seeded on
3-D structures proliferated throughout the dura-
tion of the experiment and the rate of increase was
modulated by the media changes (day 3 and 6),
whereas the cells seeded on 2-D films proliferated
until the day 4 and the rate of increase did not ap-
pear to be influenced by the media changes (day 3
and 6). This could be due to removal of loosely ad-
herent cells when the medium was aspirated.
Figure 4 shows the glucose consumption rate.
Glucose was consumed at a constant rate
(5.2 ± 0.3 ng/cell per day, p=0.004, ANCOVA) by
cells seeded on 3-D scaffolds and the consumption
was not influenced by the continuous cell prolifer-
ation in three dimensions. The cells on the 2-D
films consumed a higher quantity of glucose than
3-D scaffolds in the first 2 days. After this period,
the glucose consumption per cell was constant and
similar to that of the 3-D scaffolds. The initial high
glucose consumption by cells seeded on polymeric
films does not seem to depend on the rate of prolif-
Biotechnol. J. 2009, 4 www.biotechnology-journal.com
Figure 3. Cell density (defined as cell number/nominal surface area in
cm2) for 2-D PLGA and PLLA films, 3-D PLGA and PLLA scaffolds (n=3 per
data point).
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eration but could represent increased energetic re-
quirements due to cell-matrix interactions. In fact,
2-D films present a large surface area to the cells
for adhesion, whereas the 3-D scaffold is more
porous and there are fewer adhesive sites per unit
area. Once the adhesion process is over, all cells
converge to a constant glucose consumption rate.
Albumin is one of the functional marker pro-
teins of the liver. Human albumin was produced in
similar quantities by 3-D scaffolds and 2-D films
during the experiment (Fig. 5), and the production
rates are similar to those reported in [23, 27]. An
analysis of the production rates using ANCOVA in-
dicated that the albumin production rate was high-
er in the first 2 days than on subsequent days
(days 1–2: 0.82 ± 0.32 pg/cell per day, days 4–7:
0.49 ± 0.05 pg/cell per day, p<0.05). Although the
cell proliferation rate was higher on the 3-D scaf-
folds than on the 2-D films, we found no differ-
ences in cell behaviour with respect to the two
polymers. PLGA and PLLA are known to have dif-
ferent surface and mechanical properties, and this
result implies that in our experiments only the mi-
crotopology influences cell proliferation and not
the differences in physico-chemical properties be-
tween the polymers.
3.2 3-D scaffolds in dynamic conditions
in the MCmB
Having established that 3-D scaffolds can increase
the cell density consistently for up to 7 days, the
next step was to select the polymer to be used.
Since there were no significant cell metabolic and
proliferative differences between the two poly-
mers, PLGA was selected for successive experi-
ments because of its deposition characteristics.The
choice was based on the fact that 20% PLGA is
slightly more viscous than 10% PLLA, and the scaf-
folds obtained using the PAM system are of higher
fidelity than the corresponding PLLA scaffolds
[28].
For each time point three bioreactors were set
up in parallel with one 3-D scaffold per chamber. In
the bioreactors, the cell density increased smooth-
ly over time, as the peaks due to media changes
were absent, and density values were similar to
those in static conditions (Fig. 6).
Glucose consumption was slightly higher in the
MCmB with a constant consumption rate of
7.6 ± 0.1 ng/cell per day (p=0.0001 ANCOVA) with
respect to the 3-D scaffold in static conditions
(5.2 ± 0.2 ng/cell per day, p=0.001, ANCOVA)
(Fig. 7).Therefore, the cell energy requirements are
greater in the bioreactor, and glucose is used as a
substrate. This may be due to an up-regulation of
liver-specific synthetic function in the bioreactor,
as shown in Fig. 8; a large increase in albumin pro-
duction rate per cell was observed in dynamic cul-
ture. In the first 2 days, the albumin production rate
was ten times higher in the MCmB than in static
Figure 4. Glucose consumption rate in static conditions in 2-D films and
3-D scaffolds of PLGA and PLLA (n=3 per data point).
Figure 5. Albumin production rate in static conditions for 2-D films and 
3-D scaffolds of PLGA and PLLA (n=3 per data point).
Figure 6. Cell density (defined as cell number/nominal surface area in
cm2) for PLGA scaffolds in the bioreactor and in static conditions (n=3 per
data point).
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analysis, indicating that the volume of medium
does not influence the secretion rate of this protein
in static conditions.
Figure 9 shows the that urea production rate, in-
dicative of an intact nitrogen metabolism pathway, is
significantly enhanced in the dynamic 3-D culture
with respect to both the 2-D and 3-D static condi-
tions. In static conditions, the 2-D films and 3-D
scaffolds converged to the same production rate to-
wards the end of the culture period (136 ±
101 pg/cell per day), while the average urea produc-
tion rate in the bioreactor was significantly higher
throughout the experiment (559 ± 71 pg/cell per day
for the 3-D scaffolds in static conditions compared
to 1248 ± 71 pg/cell per day for the 3-D scaffolds in
dynamic conditions; p<0.00001, ANCOVA).
We also monitored the macroscopic morpholo-
gy of the cells on the 3-D scaffolds and 2-D films
(Fig. 10). Although we found little difference be-
tween cell morphology and spreading on scaffolds
in the dynamic and static cultures, the cells grown
for 5 days on 2- and 3-D surfaces were quite differ-
ent. On the films, cells were spread evenly and typ-
ically had larger dimensions than on the 3-D sub-
strates, and even after 5 days free spaces between
cells were apparent. This indicates greater cell-
substrate interaction than cell-cell contact on the
films. Cultures grown on 3-D scaffolds spread and
migrated into the structure so that even the voids
were colonised. The cells were closely packed, and
smaller, forming aggregates. This is indicative of
greater interactions between adjacent cells.There-
fore, even though the quantity of solid substrate is
minimal, the cells seeded on the 3-D scaffolds as-
semble in the pores to maximise cell-cell interac-
tion and cell density.
4 Discussion
Hepatocytes, like all cells, are dramatically affected
by the physical and chemical nature of their mi-
croenvironment. This is one of the reasons why in
vitro cell culture experiments are so difficult to
compare from laboratory to laboratory. The hepat-
ic cell habitat comprises three main features, or
cues, which are known to influence cell behaviour;
the biochemistry, the architecture and the supply of
nutrients to meet the metabolic demands of the
cells. In this work we investigated two of the main
cues known to influence hepatocyte function, a
3-D topology and convective flow.
Several investigators have shown that cell cul-
ture in three dimensions represents a more physi-
ologically relevant environment. However, the ex-
tent to which this influences hepatocyte function
Biotechnol. J. 2009, 4 www.biotechnology-journal.com
conditions and then decreased progressively, main-
taining a value four to five times greater than in
static culture. In fact, the average albumin produc-
tion rate in the bioreactor over the 7 days was
3.12 ± 0.43 pg/cell per day, compared with
0.65 ± 0.16 pg/cell per day (p=0.02,ANCOVA) in the
scaffolds in static conditions.
To ensure that the increased albumin produc-
tion rate was not due to the increased volume of
medium in the bioreactor, a final experiment was
performed using 3-D scaffolds cultured in 50-mm
petri dishes in which the total medium volume was
10 mL. The albumin production rate was
0.50 ± 0.14 pg/cell per day over the 2-day period of
Figure 7. Glucose production rate in static and dynamic conditions for
PLGA 3-D scaffolds (n=3 per data point).
Figure 9. Urea production rate in static conditions for PLGA 2-D films and
3-D scaffolds and in dynamic conditions for PLGA 3-D scaffolds (n=3 per
data point).
Figure 8. Albumin production rate in static and dynamic conditions for
PLGA 3-D scaffolds (n=3 per data point).
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with respect to the provision of oxygen and other
nutrients is unclear. Moreover, the relationship be-
tween the topological features of a scaffold and he-
patic function has not been studied in depth.As far
as HepG2 cells are concerned, our results show that
the main contribution of the scaffold is to increase
cell density and to promote the formation of aggre-
gates, which allows greater cell-cell contact with
respect to cell-substrate interactions. Thus, we ob-
served a large increase in the number of cells per
unit area, but the expression of albumin per cell
was the same as on a monolayer, as was the glucose
consumption rate per cell, while the urea produc-
tion rates also converged to similar values after
5 days in culture. Similar results have also been re-
ported by Glicklis et al. [29] and Bokhari et al. [30].
On the other hand, convective transport is often
mandatory in 3-D scaffolds, especially if they are
thicker than a few hundred microns. Indeed, biore-
actors for hepatocyte culture are generally de-
signed for allowing adequate mass transfer to high
density 3-D cultures in porous sponges or encap-
sulated spheroids. One of the main engineering is-
sues in bioreactors for in vitro liver models is the
balance between high mass transfer and low wall
shear stress to cells. There appears to be some de-
bate on the effects of shear stress on hepatocytes.
Some papers cite extremely high values of shear
(0.5 Pa [31]) and some also report on enhancement
of cytochrome expression in conditions of fairly
high shear stress [32]. Other investigators cite
somewhat lower values of maximum shear stress
that these cells can support (0.03 Pa [33]), even in
the presence of non-parenchymal cells, which af-
ford support and protection. The application of di-
rect fluid flow parallel to the cell surface is certain-
ly not physiological, since hepatocytes are not in di-
rect contact with flowing blood in capillaries. In this
context, Wang and Tarbell’s model [34] is often cit-
ed to justify direct shear stress on cells of the order
of 0.1 Pa [9]. These values should be applied with
caution as some models predict even lower values
of wall shear from porous flow [35]. Here, we effec-
tively shield the cells from the effect of direct flow,
although the highly permeable alginate coating al-
lows low velocity porous or percolative flow per-
pendicular to the convective flow provided by the
pumps. This flow is similar to interstitial flow [7],
and allows the passage of essential nutrients and
catabolites thanks to concentration gradients es-
tablished between the scaffold and the moving flu-
id. In the bioreactor then, the cell density on 3-D
scaffolds remains unchanged with respect to static
cultures, but the metabolic and synthetic function
in the form of albumin and urea production rates
per cell are greatly enhanced, as reported in
Figs. 6–9. Similar results have also been reported
for 2-D cultures in dynamic and static conditions
[27, 36], suggesting that these observations can also
be generalised to 2-D systems.
The objective of this work was to recreate a bio-
mimetic environment for hepatocytes and to deter-
mine, first singly and then together, the influence of
a 3-D porous architecture and enhanced mass
transport on liver cultures. HepG2 cells were initial-
ly studied on 2-D polymeric membranes and 3-D
scaffolds.The results of this first stage demonstrat-
ed that the 3-D scaffolds promote cell proliferation,
such that final cell densities are significantly high-
er than on 2-D surfaces. Other metabolic parame-
ters were unchanged, indicating that the baseline
metabolic cell function was unaltered. While the
endogenous synthetic and metabolic functions
(glucose consumption rate, albumin and urea pro-
duction rates) of hepatocytes do not appear to be
significantly related to cell morphology and 3-D
organisation, this does not necessarily mean that
all functions are unaltered in three dimensions. In
fact, Bokhari et al. [30] observe an increase in ex-
ogenous metabolic function in HepG2 cells on 3-D
scaffolds with respect to 2-D cultures, while the en-
dogenous functions are unaltered. In the second
phase of experiments, the scaffolds were placed a
bioreactor and culture medium was pumped
Figure 10. Micrographs of HepG2 cells on (A) PLGA film, and 
(B) 3-D PLGA scaffold after 5 days in culture. The bar indicates 50 μm.
A
B
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through the system in a closed-loop. Neither cell
proliferation nor glucose consumption rate per cell
increased significantly with respect to the scaffolds
in static conditions, but protein synthesis rates in-
creased dramatically about four- to tenfold, and
urea production rates by two- to fivefold.These ex-
periments established then that 3-D HepG2 cul-
tures in a dynamic environment are metabolically
more efficient than static monolayer hepatocyte
cultures and that the critical factor that drives en-
dogenous metabolism in our experiments is the in-
terstitial-like flow.
Our results demonstrate that, to more closely
approximate functional hepatic tissue, it is impor-
tant to give to cells two important stimuli, the top-
ographical and the physical stimulus. The micro-
topology and porosity of the 3-D scaffolds increas-
es cell density due to the formation of cell/cell ag-
gregates, thus maximising cell-cell interactions.
The second stimulus is produced by the flow of cul-
ture medium in the bioreactor which contributes to
an increased metabolic turnover. Although the he-
patocytes are protected from direct open channel
flow by a thin coating of gel, the flow allows a sus-
tainable supply of nutrients to the cells, as well as
a physical stimulus in the form of indirect intersti-
tial-like flow.
The authors have declared no conflict of interest.
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